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It is not the strongest of the species that survive,  
nor the most intelligent, but the one most adaptable to change. 
 
Wrongly attributed to Charles Darwin. 
Leon Megginson, 1964. 
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Abstract 
 
Brucella suis is divided into five biovars of which only biovars 1, 2 and 3 infect Suidae. Biovars 1 
and 3 cause severe disease in humans and are mainly prevalent in South America and South-East Asia. 
In contrast, biovar 2 has been rarely isolated from humans, and its zoonotic role is questioned. Currently, 
B. suis biovar 2 is the unique biovar isolated in Portugal and Spain, representing an emerging disease in 
domestic swine throughout Europe, being associated with the increase of extensive pig farms and the 
high density of infected wild boars (Sus scrofa).  
In the present work the genetic structure of a collection of B. suis strains was characterized. 
Molecular fingerprinting with restriction enzymes and Variable Number Tandem Repeats (VNTR) 
showed differences between strains from Iberian Peninsula and others from Central Europe. The 
majority of strains isolated in Portugal and Spain share specific molecular characteristics establishing an 
Iberian clonal lineage. However, strains isolated from wild boars in the North-East region of Spain were 
similar to those isolated in other Central-European countries.  
In order to deeply understand genomic differences between Iberian and Central-European 
clones and further unveil B. suis pan-genome and evolutive history, the genomes of five B. suis biovar 2 
strains isolated from wild boars and representative of both clonal lineages circulating in Iberian 
Peninsula were sequenced and compared with 18 publicly available sequenced genomes from eight of 
the 12 recognized Brucella species. This full genome comparative analysis showed that Brucella is a 
highly conserved genus with two chromosomes and apparently slow evolutionary rates at species level. 
Nevertheless, B. suis biovar 2 strains from Iberian clonal lineage can be differentiated from those from 
Central-European clonal lineage not only by the presence of one large inversion in Chromosome I but 
also by a number of specific SNPs, deletions and insertions. Furthermore, 10 different target-PCRs 
protocols were established and validated for the differentiation of strains from a specific clonal lineage, 
being useful to be used as epidemiological markers for future investigations. The mutational enrichment 
of Iberian lineage was associated to genes encoding membrane proteins described with potential of 
interaction with external stimulus, as well as to genes with impact on the metabolism of the pathogen. 
The genomic specialization and local adaptation of B. suis biovar 2 strains establish an Iberian ecovar, 
raising an important question regarding the mechanisms responsible for putative tropisms as response 
to adaptation to a specific host and/or pathobiological conditions.  Future work should be done to better 
understand the consequences of these disarrangements and their impact in pathogenicity or virulence 
in wide range of hosts, including man.  
 
Keywords: B. suis biovar 2; Whole-genome sequencing; Optical mapping; Comparative genomics; 
Genomic specialization. 
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Resumo  
 
A brucelose em suínos é uma infecção causada por Brucella suis. Esta espécie apresenta cinco 
biovares, sendo a infecção em suínos causada apenas pelos biovares 1, 2 e 3. Os biovares 1 e 3 são 
patogénicos para o homem e prevalecem sobretudo na América do Sul e Sudeste da Ásia. O biovar 2 
não é patogénico para o homem e é enzoótico nas populações de javalis (Sus scrofa) e lebres (Lepus 
europaeus) do Norte, Centro e Sudeste da Europa, sendo estes animais silváticos os agentes 
transmissores da infeção aos suínos. De facto, a brucelose devida ao biovar 2 representa uma doença 
emergente em suínos domésticos em toda a Europa e está associada ao aumento de explorações 
extensivas e à alta densidade de javalis infetados, representando um perigo importante especialmente 
para a população de porcos ibéricos criados em sistemas extensivos.  
Na Península Ibérica, o biovar 2 é o único biovar isolado em porcos e javalis. Apesar da escassez 
de estudos para compreender as relações epidemiológicas e a filogenia deste agente patogénico, a 
tipificação molecular baseada em polimorfismos no tamanho de fragmentos de hidrólise com enzimas 
de restrição (RFLPs) de genes codificantes de proteínas da membrana externa (Omp2a, Omp2b, Omp31) 
e em variações no número de repetições em tandem em regiões micro- ou minissatélites do genoma 
(VNTRs) mostraram diferenças entre as estirpes da Península Ibérica e as da Europa Central. Assim, o 
trabalho desenvolvido ao longo desta tese visou aumentar o conhecimento das estirpes de B. suis biovar 
2 que circulam na Europa e, em particular, em Portugal, bem como evidenciar variações genómicas 
associadas a estirpes de origem geográfica específica.  
Em Portugal, o diagnóstico bacteriológico da brucelose é apenas realizado no Laboratório de 
Bacteriologia e Micologia da Unidade Estratégica de Produção e Saúde Animal do Instituto Nacional de 
Investigação Agrária e Veterinária (INIAV, IP). No entanto, este diagnóstico está especialmente focado 
no isolamento de B. abortus e B. melitensis na sequência das campanhas de controlo e erradicação da 
brucelose em bovinos e pequenos ruminantes. Relativamente aos suínos, não é efetuada qualquer 
vigilância sistemática, desconhecendo-se a prevalência da infeção em Portugal. 
Os estudos efetuados neste trabalho visaram alargar o conhecimento sobre a diversidade 
genética das estirpes de B. suis biovar 2 que circulam em Portugal. Inicialmente foi desenvolvido e 
avaliado um meio seletivo, LNIV-M, que foi formulado utilizando antibióticos menos inibitórios, 
permitindo aumentar a sensibilidade do diagnóstico bacteriológico e aumentar o número de isolados 
de B. suis. Uma vez que o conhecimento das estirpes predominantes é um pré-requisito para qualquer 
estudo epidemiológico, foram aplicados diferentes métodos moleculares a uma coleção de isolados de 
B. suis, que incluiu não só os isolados de Portugal como também de outros países europeus. Foram 
identificados cinco perfis de restrição (haplótipos) entre os isolados de biovar 2, com dois haplótipos 
específicos restritos a Portugal e Espanha (2d e 2e). Os três haplótipos restantes (2a, 2b e 2c), 
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encontram-se disseminados pela Europa (exceto na Península Ibérica). A diversidade genética da 
população de B. suis foi determinada pela análise do número variável de repetições em tandem em 
múltiplos locais do genoma, vulgarmente designada por MLVA. O ensaio de MLVA aplicado à 
genotipificação de estirpes de Brucella spp. utiliza um conjunto de 16 VNTRs que estão distribuídos por 
três painéis: painel 1, composto por oito minissatélites, painel 2A e painel 2B, compostos 
respetivamente por três e cinco microssatélites. A análise alocou os isolados de biovar 2 em dois clusters 
de acordo com as suas origens geográficas e haplótipos, definindo assim uma linhagem clonal ibérica 
(Portugal e Espanha) e uma linhagem clonal Central-Europeia. A análise de 350 estirpes adicionais de 
todas as biovariedades de B. suis revelou ainda uma elevada divergência genética entre as estirpes com 
base nos seus hospedeiros, realçando a estreita relação entre as estirpes de suínos, javalis e lebres. Além 
de corroborar a existência das duas linhagens clonais de biovar 2, os resultados obtidos sugerem que a 
evolução da linhagem clonal Ibérica ocorre devido a um evento de especiação alopátrica. 
Para comparar a estrutura genómica e avaliar a diversidade genética entre as estirpes de B. suis 
biovar 2, foram construídos os mapas ópticos de cinco estirpes de campo isoladas de javalis e 
representativas das linhagens clonal Ibérica (PT09143, PT09172, Bs143CITA) e Central-Europeia 
(Bs364CITA, Bs396CITA), bem como da estirpe de referência B. suis biovar 2 ATCC 23445 (linhagem 
Central-Europeia, origem: Dinamarca), utilizando a tecnologia Optical Mapping (mapeamento óptico). 
Cada estirpe apresentou um perfil único de restrição, de 228 a 232 fragmentos, distribuídos pelos dois 
cromossomas, tendo-se observado baixa divergência no cromossoma II (1,6%) relativamente ao 
cromossoma I (2,4%). O mapeamento óptico revelou no cromossoma I a presença de um evento de 
inserção-deleção (INDEL, 3,5 kb) específico da estirpe de referência ATCC 23445, e uma grande inversão 
(944 kb) exclusiva da linhagem clonal Ibérica.  
Além de validar a existência de uma inversão na linhagem clonal Ibérica, reforçando a 
plasticidade genómica de Brucella spp., os mapas ópticos permitiram também determinar o 
posicionamento e a orientação das sequências consenso (contigs), agilizando o processo de montagem 
e finalização dos genomas. Assim, as sequências genómicas completas e anotadas, das cinco estirpes de 
B. suis biovar 2 referidas anteriormente, foram prontamente obtidas utilizando-se uma estratégia que 
combinou: (1) a sequenciação das estirpes, utilizando a plataforma de sequenciação de nova geração 
(NGS), Illumina HiSeq 2000; (2) a re-sequenciação, por Sanger, das regiões de baixa qualidade ou 
contendo bases ambíguas; (3) a montagem de novo e finalização dos genomas guiada por Optical 
mapping. À semelhança do genoma da estirpe de referência de B. suis biovar 2, os cinco genomas 
sequenciados neste trabalho são compostos por dois cromossomas circulares (Chr I e Chr II) com 
aproximadamente 1,93 e 1,40 Mb. Em média o teor GC (%) dos Chr I e Chr II foi de 57,1% e 57,3%, 
respetivamente. Os cinco genomas contêm três operões idênticos de genes de RNA ribossomal (rRNA), 
um localizado no Chr I e dois no Chr II. Todos os genomas possuem 54 genes de RNA de transferência 
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(tRNA). O número de regiões codificantes (CDS) foi estimado tendo por base a homologia e a 
identificação dos domínios funcionais das proteínas, que variaram de 3 014 (PT09143) a 3 027 
(Bs396CITA) e o número de pseudogenes entre 87 (Bs396CITA) e 91 (Bs364CITA).  
A fim de melhor compreender os mecanismos envolvidos na evolução e especialização das 
linhagens Ibéricas, foi realizada uma análise genómica comparativa entre os cinco genomas de B. suis 
biovar 2 e os 18 genomas disponíveis nas bases de dado públicas, incluindo oito espécies de Brucella. A 
análise efetuada confirmou que o género Brucella é altamente conservado, com dois cromossomas e 
taxas de evolução aparentemente lentas a nível de espécie. No entanto, as estirpes de B. suis biovar 2 
da linhagem clonal Ibérica foram diferenciadas da Central-Europeia não só pela presença de uma grande 
inversão no Chr I, mas também por um conjunto de polimorfismos de base única (SNPs) e deleções-
inserções (INDELs) específicas. Estes resultados permitiram desenvolver e validar diferentes protocolos 
de PCR para 10 regiões polimórficas com potencial epidemiológico para a diferenciação das estirpes de 
uma linhagem clonal específica. Foi ainda observado que o enriquecimento mutacional da linhagem 
Ibérica está associado a genes que codificam proteínas de membrana, bem como a genes com impacto 
no metabolismo deste agente patogénico. No entanto, outros estudos são necessários para 
compreender melhor as consequências destas variações genómicas e o seu impacto na patogenicidade 
ou virulência numa ampla gama de hospedeiros, incluindo o Homem. 
Em conclusão, com este trabalho foi demonstrado que existem duas linhagens clonais de B. suis 
biovar 2 a circular na Europa, sendo que a especialização genómica e adaptação local das estirpes 
pertencentes à linhagem clonal Ibérica estabelecem um ecovar Ibérico, levantando uma importante 
questão sobre os mecanismos responsáveis por tropismos putativos como resposta à adaptação a um 
hospedeiro específico e/ou condições patobiológicas. 
  
 
Palavras-chave: B. suis biovar 2; Optical Mapping; Sequenciação de Nova geração; Genómica 
Comparativa; Filogenómica.  
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1.1. The Genus Brucella: a taxonomic and phylogenetic overview 
 
In the year of 1887 in Malta, with the isolation and identification of a bacterium by David Bruce 
and Themistocles Zammit, now known as Brucella melitensis (Figure 1.1), began the history of 
Brucellosis, one of the most extended bacterial zoonosis at a global level and a complex infection of 
animals and humans with a worldwide impact. This bacteria was first isolated in Malta from the spleens 
of soldiers with fatal cases of brucellosis, also known as undulant fever or Malta fever.  The genus 
Brucella, created in 1920 by Meyer and Shaw (De Ley et al., 1987), belongs to the family Brucellaceae 
within the order Rhizobiales of the class Alphaproteobacteria, which is one of the largest and most 
diverse groups within the phylum Proteobacteria (Scholz et al., 2012; Godfroid et al., 2011; Ficht, 2010; 
Audic et al., 2009; Bergey and Holt, 1994).  The order Rhizobiales includes a variety of bacteria 
strategically important for their diversity in function and in niche occupancy, including animal intra or 
pericellular pathogens (Afipia, Anaplasma, Bartonella, Brucella, Erlichia, Ricketsia), opportunistic 
animal pathogens (such as Ochrobactrum), plant pathogens (e.g. Agrobacterium) and several plant 
endosymbionts (Carvalho et al., 2010; Velasco et al., 1998). Phylogenetic reconstructions based on 
whole-genome sequences have confirmed the evolutionary proximity between Brucella genus and 
members of the subgroup of the alpha-2 Proteobacteria, that includes soil organisms (e.g. 
Ochrobactrum spp.), plant symbionts (e.g. Rhizobium spp.) and phytopathogens (e.g. Agrobacterium 
spp.), and identified the Ochrobactrum, a soil living facultative human pathogen, as the most closely 
related genus (Bohlin et al., 2010; Whatmore et al., 2009; Wattam et al., 2009; Scholz et al., 2008b).  
 
 
Figure 1.1. Mediterranean fever Commission (MFC) in 1904. Standing: Dr. T. Zammit; Capt. Crawford Kennedy; 
Major J.C. Weir; Seated: Major J.G. McNought; Dr. J.W.H. Eyre; Col. David Bruce.; Major T. McCulloch; Staff 
Surgeon E.M.A. Clayton.  
Source:http://wellcomeimages.org/indexplus/obf_images/a5/20/95da16f04714583a1a503321854a.jpg 
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The genus Brucella was created with two species, B. abortus and B. melitensis, which 
preferential hosts are cattle and small ruminants (sheep and goats), respectively.  B. suis was isolated 
for the first time from aborted pigs fetus in Europe in 1909, and after in the United States. For many 
years, it was believed that the agent was a highly pathogenic variant of B. abortus but, in 1929, B. suis 
was finally considered a separate species. In the following years, new species were added to the genus: 
B. ovis isolated from sheep (1956), B. neotomae (1957) from the desert wood rat, and B. canis (1968) 
from dogs. Like the first two species, they were exclusively classified and characterized on the basis of 
their phenotype and host preference (Alton, 1990). The three major species in terms of disease and 
economic impact for man, B. melitensis, B. abortus and B. suis are further divided into biovars based 
on a range of phenotypic and serological characteristics: B. melitensis with 3 biovars, B. abortus with 8 
biovars, and B. suis with 5 biovars. Since the genetic homogeneity of these “classical” species seems 
to support the hypothesis of a monospecific genus, B. melitensis has been proposed as the sole 
representative species with different biotypes (Verger et al., 1985). This classification was accepted by 
the Sub-committee on the Taxonomy of Brucella in 1986. However, the host range was a long-
recognized biological criterion and the presence of species specific markers in outer membrane protein 
genes and in other genes showed that B. melitensis, B. abortus, B. suis, B. ovis, B. canis and B. neotomae 
were not mere pathovars (or nomenspecies) but biologically meaningful species. Consequently, in 
2003, the Sub-committee approved to return to the multi-nomen species classification with the 
readoption of the “classical” species with a series of biovars (Osterman and Moriyón, 2006; Moreno et 
al., 2002). 
Since 2007, more species were included in the genus: B. ceti and B. pinnipedialis, isolated from 
marine mammal (Foster et al., 2007), B. microti from voles (Scholz et al., 2008a), B. inopinata from an 
inflamed breast implant of a 71 year-old patient in USA (Scholz et al., 2010) and, more recently, B. 
papionis, isolated from baboons (Whatmore et al., 2014) and B. vulpis, isolated from foxes (Scholz et 
al., 2016). The natural reservoir of B. inopinata remains unclear (Eisenberg et al., 2016). Like most 
Brucella species, B. ceti, B. pinnipedialis and B. papionis are fastidious and slow growing pathogens, 
with limited metabolic activity; in contrast, B. microti, B. inopinata and B. vulpis, are fast growing 
bacteria with a biochemical profile that resemble the members of the genus Ochrobactrum (Hammerl 
et al., 2016; Mühldorfer et al., 2016; Scholz et al., 2016, 2008a; Al Dahouk et al., 2010). Other “atypical” 
Brucella strains have been isolated from diverse animal sources such as wild rodents (Tiller et al., 2010), 
frogs (Eisenberg et al., 2012) and fish (Eisenberg et al., 2016) that will likely to be proposed as new 
species in the future. Despite of Brucella spp. difference in host affinity, they display very similar 
pathogenic behavior, while varying in virulence. The preferential hosts and the pathogenicity for 
humans of the 12 recognized Brucella species are described in Table 1.1.   
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Table 1.1. Brucella species, preferred host(s) and pathogenicity for humans. 
Brucella species Biovars Preferential host(s) Pathogenicity for humans 
B. melitensis 1–3 Sheep, goat High 
 
B. abortus 
 
1–7, 91 
 
Cattle 
 
High 
 
B. suis 
 
1, 3 
 
Swine 
 
High 
2 Wild boar, hare Low or no pathogenicity 
4 Reindeer, caribou High 
5 Rodents No 
 
B. neotomae 
 
- 
 
Rodents 
 
No 
 
B. ovis 
 
- 
 
Ram 
 
No 
 
B. canis 
 
- 
 
Dog 
 
Moderate 
 
B. ceti 
 
- 
 
Cetaceans 
 
Unknown 
 
B. pinnipedialis 
 
- 
 
Pinnipeds 
 
Unknown 
 
B. microti 
 
- 
 
Soil, vole, fox 
 
Unknown 
 
B. inopinata 
 
- 
 
Unknown 
 
High 
 
B. papionis  
 
- 
 
Baboons 
 
Unknown 
 
B. vulpis  
 
- 
 
Foxes 
 
Unknown 
1  B. abortus biovar 8 was deleted by the Brucella Subcommittee in 1978 (Osterman and Moriyón, 
2006) 
 
 All Brucella species have identical 16S ribosomal (r)RNA- and recA gene sequences, and are 
almost identical in the majority of housekeeping genes (Whatmore et al., 2009, 2007; Scholz et al., 
2008b; Gee et al., 2004). The current understanding of Brucella spp. phylogeny has been elucidated by 
several methods such as Multilocus Variable Number Tandem Repeat Analysis (MLVA, Scholz & 
Vergnaud, 2013; Al Dahouk et al., 2012; Le Flèche et al., 2006), Multilocus Sequencing Typing (MLST) 
and MLS Analysis (MLSA) (Whatmore et al., 2016, 2009, 2007), microarray studies (Foster et al., 2012; 
Bohlin et al., 2010; Rajashekara et al., 2004), and Single Nucleotide Polymorphisms (SNP, Wattam et 
al., 2014, 2012, 2009; Foster et al., 2009, 2008; Chain et al., 2005). The phylogenetic analysis showed 
that all Brucella species are monophyletic and distinct from Ochrobactrum. Moreover, most of the 
analysis referred in the literature distinguish at least six lineages within Brucella spp.: B. abortus-B. 
melitensis; B. canis-B. suis, B. ovis, B. ceti-B. pinnipedialis, B. neotomae, and B. microti (Figure 1.2). 
From these, B. abortus and B. melitensis are the most closely related, and a close relationship has also 
been detected between B. canis and B. suis biovars 3 and 4, while B. suis biovars 1, 2 and 5 were 
allocated to different branches. B. neotomae and B. ovis demonstrate greater divergence levels from 
Chapter 1. General Introduction 
6 
other Brucella species (Olsen & Palmer, 2014; Wattan et al., 2014; Scholz & Vergnaud, 2013). Few 
studies have been made that include the novel species B. inopinata, B. papionis and B. vulpis. 
Nevertheless, a recent work confirms the abovementioned lineages and place B. papionis more closely 
related to B. ovis. The “atypical” B. inopinata and B. vulpis are placed in two separate branches 
(Whatmore et al., 2016). 
 
1.2. The Brucella species: approaches on diversity and epidemiology 
 
The accessibility of whole-genome sequence data opened the way for comprehensive 
molecular analyses and subsequent development of molecular typing tools that allow identification 
and differentiation of Brucella at the species, biovar and individual strain level (Scholz & Vergnaud, 
2013). Since the 90’s, several PCR-based methods have been developed and implemented in diagnostic 
laboratories to confirm pure cultures of brucellae and differentiate among Brucella species and biovars 
and vaccine strains (Whatmore et al., 2016; Scholz & Vergnaud, 2013; López-Goñi et al., 2011; Yu & 
Nielsen, 2010; Mayer-Scholl et al., 2010). Moreover, considering that distinguishing individual bacterial 
lineages within a species is the basis of infectious disease epidemiology, several PCR-based genotyping 
tools have been developed, including enterobacterial repetitive intergenic consensus sequence PCR 
(ERIC-PCR), repetitive intergenic palindromic sequence PCR (REP-PCR), randomly amplified 
polymorphic DNA PCR (RAPD-PCR) or arbitrarily primed PCR (AP-PCR), and restriction fragment length 
polymorphism PCR (RFLP-PCR) of the omp2 (including omp2a and omp2b genes) and omp31 loci. From 
these, only RFLP-PCR assay targeting the omp2 (Cloeckaert et al., 1995) or omp31 (Vizcaíno et al., 1995) 
loci are more commonly used in laboratories. In fact, PCR-RFLP analysis of omp2a, omp2b and omp31 
genes define five different restriction patterns (haplotypes) for each B. suis biovar (1 to 5) and four 
additional haplotypes are further disclosed within biovar 2 isolates. This method have been useful to 
differentiate among Portuguese and Spanish isolates from those isolated in other European countries 
(Muñoz et al., 2010; Garcia-Yoldi et al., 2007; Ferrão-Beck et al., 2006).  
As already mentioned, current approaches to study Brucella spp. diversity and phylogeny 
include methods such as MLVA, MLST/MLSA, SNPs analysis as well as whole-genome sequencing, 
which serves as a robust and unbiased method to resolve intraspecies relationships for closely related 
species such as Brucella spp. (Tan et al., 2015). Nevertheless, the highly discriminatory MLVA or MLSA 
represent a perfect first-line tools for molecular epidemiological studies within outbreak 
investigations, and MLSA is also appropriate for phylogenetic reconstructions, owing to the highly 
clonal evolution of the different species (Whatmore et al., 2016; Allen et al., 2015; Scholz & Vergnaud, 
2013). 
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Figure 1.2. Phylogenetic analysis of the Brucella species. (A) Minimum spanning tree based on multilocus variable number of tandem repeats analysis (MLVA) data from 1,925 
isolates. Branch lengths up to three are shown. Adapted from Scholz & Vergnaud, 2013. (B) Unrooted phylogenetic reconstruction of the relationships between sequence types 
based on multilocus sequencing analysis (MLSA). The tree was constructed with the concatenated sequence data of the nine loci (4,396 bp) using the neighbour joining approach. 
Adapted from Whatmore et al., 2007; (C) Phylogenetic tree based on maximum parsimony of the core Brucella genomes. The tree was rooted with B. microti. All branches have 
100% support unless otherwise noted. Adapted from Wattan et al., 2014. 
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The epidemiological surveillance of animal and human brucellosis has clearly benefited from 
the appearance and improvement of molecular typing (Valdezate et al., 2010). To date one of the best 
approaches to obtain valuable discrimination in brucellae is MLVA-16 (using 16 VNTR markers), as it is 
an easy and cost effective methodology. Since brucellosis has a worldwide distribution, laboratories of 
different countries try to apply the same genotyping techniques, thus facilitating the exchange of 
information. In this way, a collaborative public online database based on a MLVA-16 scheme has been 
built up with the aim of promoting the creation of a global epidemiological map of Brucella spp. 
(http://mlva.u-psud.fr/), where data can be submitted and compared to other published results. 
MLVA-16 exhibits an intraspecies discriminatory power and is extremely discriminant and highly 
efficient in differentiating strains within a local outbreak. Most of the epidemiological studies were 
applied to B. melitensis or B. abortus due to its important economic and medical concerns. The 
epidemiological relationship between B. melitensis isolates using MLVA-16 assay has shown that three 
separate clusters are observed when geographical origin is considered: the American, the Eastern 
Mediterranean, and the Western Mediterranean groups (Valdezate et al., 2010). For instance, in a 
study using 126 Portuguese isolates, the majority of the isolates (83%) were included in the Eastern 
Mediterranean group, which also include isolates from Spain and Turkey, and the remainder (17%) was 
included in the American group (Ferreira et al., 2012). In contrast, most isolates from Italy belong to 
the Western Mediterranean lineage (Garafolo et al., 2013). Although less variability is found within B. 
abortus populations, MLVA is still a useful tool in ongoing disease surveillance of B. abortus outbreaks, 
especially when combined with accurate epidemiological information on disease tracings, 
geographical clustering of cases and chronology of infection (Allen et al., 2015). Furthermore, although 
the validity of B. abortus or B. melitensis biovars established by classical microbiological methods 
cannot be confirmed by MLVA clustering, this method can significantly contribute to epidemiological 
trace-back analysis of human Brucella infections and may advance surveillance and control of human 
brucellosis (Ferreira et al., 2012; Al Dahouk et al., 2007). In addition, it was also showed that MLVA-16 
can be an essential assay to guarantee the quality and stability of live anti-bacterial vaccines being 
produced worldwide, such as the B. melitensis REV1 vaccine (Garcia-Yoldi et al., 2007).  
Regarding B. suis species, recent studies using both MLVA and MLSA have also shown that 
considerable intraspecies genetic diversity is observed even when considering isolates sharing the 
same biovar (Whatmore et al., 2016; Kreizinger et al., 2014; Muñoz et al., 2010; Garcia-Yoldi et al., 
2007). However, less work have been made in order to better understand the phylogeny and the 
epidemiologic relationships of this pathogen. 
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1.3. Brucella suis biovar 2 and brucellosis 
 
Within the species B. suis, biovars 1, 2 and 3 are the most relevant constituting the main 
etiological agents involved in swine brucellosis.  B. suis infection due to biovars 1 and 3 have been 
reported in several non-natural domestic and wild host animal species, such as cattle, dogs, horses, 
sheep, reindeer, caribou, hares, red foxes and various murine species. These biovars 1 and 3 are 
important human pathogens mainly prevalent in South America and South-East Asia (EFSA, 2009). In 
Europe they have only been reported in Croatia, indicating that may be restricted to this geographic 
region (Cvetnic et al., 2009; Garcia-Yoldi et al., 2007; Cvetnic et al., 2005). 
 B. suis biovar 2 has a very specific pathogenicity for suidae and hares but does not infect 
humans (Olsen & Palmer, 2014). It is usually the causative agent of swine brucellosis in Europe 
(Godfroid et al., 2011; Muñoz et al., 2010; EFSA, 2009; Garcia-Yoldi et al., 2007) and is  widely spread 
amongst Eurasian wild boar (Sus scrofa) and European brown hare (Lepus europaeus) populations, 
which are identified as the potential source of transmission of biovar 2 to outdoor or extensively reared 
pigs (Olsen & Palmer, 2014; Munoz et al., 2010; Galindo et al., 2010; Cvetnic et al., 2009; Bergagna et 
al., 2009; Leuenberger et al., 2007). Moreover, it is known that biovar 1, 2 and 3 can be transmitted 
from swine to cattle, inducing transient seroconversion, which can confound B. abortus diagnostic 
assays (Olsen & Palmer, 2014; Musser et al., 2013).  
Brucellae produce abortion and infertility in infected pigs and is easily transmitted in extensive 
production systems where animals share the same environment and have contacts with wild animals, 
namely wild boars and hares. The control and eradication of the disease is only possible with well-
planned strategies, adapted to the local reality and globally integrated in the production cycle, serving 
the interest of public and animal health and also of the production economy. Although the infections 
in wildlife reservoirs are a lesser threat for causing human infection, they can be a source for the 
reintroduction of infection into domestic livestock, which poses a new challenge to eradication of the 
disease worldwide (Musser et al., 2013; Plotkin, 2009).  The pathogenesis and pathobiology of 
brucellosis in domestic pigs are likely to be identical to those in wild boar. In a primary infection the 
bacteria can spread within a few months from one infected animal to more than 50% of animals on 
the farm. The infection can often reach 70% to 80% of infected animals at the start of the outbreak, 
and the infected herds manifest a high percentage of abortions, increased neonatal mortality and 
infertility, with adverse economic consequences (Aparício, 2013). Nevertheless, as there tend to be 
few -or mild clinical signs, the disease can go unnoticed in infected groups (EFSA, 2009) and abortion 
may be the only clinical sign observed, usually occurring during the second or third month of gestation 
(Poester et al., 2013).  
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Swine brucellosis is considered to be inexistent or of low prevalence in domestic pigs, therefore 
it is usually excluded from National Surveillance Programs in the European Union. Consequently, 
diagnosis is only performed on pigs for International Trading purposes, in selected Artificial 
Insemination Centers or for investigation of suspected cases. However, the increasing number of 
outbreaks in pig farms all over Europe, and the high prevalence of B. suis biovar 2 in wild boars and 
hares, suggest that swine brucellosis could be an emergent but still unrecognized problem in many 
countries (Olsen & Palmer, 2014; Godfroid et al., 2013; Munoz et al., 2010; Godfroid & Käsbohrer, 
2002).  
 
Occurrence of B. suis biovar 2 infection in Portugal 
 
 The existence of B. suis biovar 2 infection has been confirmed by isolation of the agent from 
animals belonging to different pig farms in diverse regions of Portugal where sporadic outbreaks 
occurred. However, no systematic surveillance is carried out and few studies have been performed to 
evaluate the real status of the infection in Portugal.  
There are three recognized autochthonous pig breeds in Portugal reared in extensive 
production systems, and therefore more susceptible to B. suis biovar 2 infection: the Bísaro (produced 
in Trás-os-Montes), the Alcobaça Spotted (“Malhado de Alcobaça”, created in the Centre region), and 
the Iberian pig (“Porco Alentejano”, raised in an unique integrated agricultural-forestry-livestock 
system in Alentejo, called "montado"). The first documented B. suis biovar 2 outbreak in domestic pigs 
occurred in 1999, where a farm in Alentejo (rearing “Porco Alentejano” breed) was traced back as the 
source of infection of two other farms (one in the North and other in the Centre, with an intensive 
production system) due to the introduction of infected males. As the majority of the animals in each 
farm were serologically positive (near 90%) and there was a high number of abortions, the Veterinary 
Services decided to slaughter the totality of the animals. After that, between 1999 and 2000, about 12 
new outbreaks were identified in Alentejo by the veterinary services.  The occurrence of abortions and 
the increase of serologically positive animals have major economic implications as it prevents the free 
movement of animals and products. For that reason, the surveillance of brucellosis in domestic pigs as 
well as in wild boars is an important issue and, when feasible, control and eradication programs should 
be implemented in the affected areas.  
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1.4. From the outside-in: the cell envelope and virulence of brucellae 
 
All of the various surface components of a bacterial cell are important in its ecology since they 
mediate the contact of the bacterium with its environment and consequently supports its own 
existence and survival in that environment.  
Electron microscopy of Brucella spp. cells shows the classical structure of the Gram-negative 
cell envelope with an outer-membrane (OM) of 6.5–8.0 nm and an inner membrane (IM) of similar 
thickness, both separated by a periplasmic space (PS) (Moreno & Moriyón, 2006). The IM is a 
phospholipid bilayer that contains proteins involved in subtract transport and other metabolic 
processes. The PS encloses a peptidoglycan (PG) mesh layer and some periplasmic soluble 
components, such as cyclic β-glucans, and proteins. The OM is the most external layer of the cell 
constituting an important barrier for survival in hostile environments and an accessible target for the 
interaction of bacterial pathogens with the host and defense mechanisms of the immune system 
(Vizcaíno & Cloeckaert, 2012). Structurally, it is an asymmetrical lipid bilayer composed of 
lipopolysaccharide (LPS) and other haptenic polysaccharides, such as hapten native (NH), proteins and 
phospholipids (PL), with the LPS molecules and PL located in the outer and inner leaflet, respectively 
(Figure 1.3). Most of Gram-negative bacteria share this basic structure with OM molecules bearing 
pathogen-associated molecular patterns (PAMPs) easily recognized by innate immunity. However, 
brucellae OM has an atypical composition giving distinctive traits to the bacterium when compared 
with other Proteobacteria (Vizcaíno & Cloeckaert, 2012), and it has been proposed that some of its 
OM molecules, such as LPS, lipoproteins, flagellin and ornithine lipids, display a reduced PAMP (Gil-
Ramírez et al., 2014; Palacios-Chaves et al., 2011; Barquero-Calvo et al., 2007).  
 The different surface molecules are involved in various important processes, such as bacterial 
growth, sensing of and protection from environmental stresses, adhesion, and invasion of host cells, 
signaling, and interaction with the immune system (Bierne & Cossart, 2007). Likewise, a 
comprehensive characterization of the OM repertoire is required to better understand the factors that 
contribute to the success of a bacterial pathogen in colonizing different environmental niches and its 
mammalian host. Smooth brucellae such as B. abortus, B. melitensis and B. suis have OMs that are 
unusually resistant to the disrupting action of bactericidal peptides and complement (Palacios-Chaves 
et al., 2011). It is believed that this stability is related to several specific characteristics, namely: (1) 
brucellae OMs contain large amounts of phosphatidylcholine (PC) and blockage of the synthesis of PC 
with the subsequent replacement by phosphatidylethanolamine (PE, which is the major PL in Gram-
negative bacteria) generates attenuation, suggesting that PC is essential for brucellae virulence 
(Conde-Álvarez et al., 2006); (2) the presence of positively charged ornithine lipids (OL), locate in the 
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outer leaflet of the OM (Moriyón & López-Goñi, 1998), although recent studies indicate that OL have 
become dispensable in the existing brucellae. This is consistent within the trend observed in α-
Proteobacteria animal pathogens to reduce and eventually eliminate the envelope components 
susceptible of recognition by innate immunity (Palacios-Chaves et al., 2011); (3) the strong association 
of some outer membrane proteins (OMPs) to LPS and PG (Moriyón & López-Goñi, 1998), and (4) the 
presence of very long chain fatty acids (VLCFAs) in the lipid A of LPS that have the potential to span the 
OM displaying the terminal hydroxyl group in the periplasmic space, probably favoring a strong 
anchorage of the LPS and the integrity of the OM  (Vizcaíno & Cloeckaert, 2012; Barquero-Calvo et al., 
2009).  
In addition, it was confirmed that the B. abortus LPS core has a branched structure. Based on 
the observation that the mutation of glycosyltransferase WadC, results in a lipopolysaccharide that, 
while keeping the O‐polysaccharide essential for optimal protection, shows a truncated core that is 
more readily recognized by elements of innate immunity, it was proposed that the Brucella LPS core 
branch is a virulence-related structure accounting in part for the stealthy behavior of these bacteria 
(Gil-Ramírez et al., 2014; Kubler-Kielb & Vinogradov, 2013; Conde-Álvarez et al., 2012). The 
characteristic surface properties make brucellae furtive pathogens and more resistant to several host 
defense compounds, contributing to the intracellular survival and its ability to establish chronic 
infection (Ruiz-Ranwez et al., 2015).  
The brucellae LPS possess unusual immunological properties such as low toxicity, high 
resistance to macrophage degradation and protection against immune responses, being a major 
virulence factor in Brucella (Lapaque et al., 2005). Since LPS is the most relevant antigen during 
infection and vaccination, LPS and LPS-related molecules are extensively used in immunological studies 
and in the diagnosis of brucellosis (Moreno & Moriyón, 2006; Cardozo et al., 2006; Aragón et al., 1996). 
Among Gram-negative bacteria, the genus Brucella is the unique in which some species express the 
smooth (S)-type LPS (B. abortus, B. melitensis, B. suis, B. microti, B. neotomae, B. ceti, B. pinnipedialis, 
B. inopinata, B. papionis and B. vulpis) and others have naturally rough (R)-type LPS (B. canis and B. 
ovis). The S-LPS and R-LPS differ mostly in the most external LPS moiety (the O-polysaccharide), which 
is not synthetized in rough Brucella species and is also missing in the surface of the rough mutants of 
the smooth species that appear spontaneously during culture dissociation (Moreno & Moriyón, 2006).  
It is known that the production of a complete LPS is necessary for virulence of smooth Brucella strains 
(González et al., 2008; Rittig et al., 2003). However, the rough species B. canis and B. ovis are virulent 
in their respective preferred natural hosts and in animal models, and it was shown that rough brucellae 
attract and infect monocytes more effectively than smooth brucellae although only S-LPS phenotypes 
establish a specific host cell compartment permitting successful parasitism (Rittig et al., 2003).  
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Figure 1.3. Schematic representation of Brucellae cellular membrane. Adapted and modified from Moreno & Moriyón (2006), Fabienne et al. (2008), Ferooz and Letesson 
(2010), Ferooz et al. (2011), Vizcaíno and Cloeckaert (2012), Gíl-Ramírez et al. (2014), Sankarasubramanian et al. (2016). The cellular membrane is constituted by the inner 
membrane (IM), the periplasmic space (PM) with the peptidoglycan (PG, light grey), and the outer membrane (OM). IM proteins are represented in grey; the OM contains 
the LPS (constituted by the lipid-A diaminoglucose disaccharide backbone represented by yellow trapezoids, the core oligosaccharide with its branch, and the O‐polysaccharide 
chain), several outer membrane proteins (OMPs), ornithine lipids (green rectangles), phospholipids, mainly phosphatidylcholine (dark circles) and lipoproteins, namely the 
Braun’s lipoprotein (B, grey circles) that can be linked to peptidoglycan or free in the OM. The purples squares mark the reducing ends of the native haptens (NH), an unknown 
sugar that in some cases may be linked to a lipid (NH-L). NH of various sizes are intertwined with the O-polysaccharides of the LPS in the OM, forming a dense layer.  It is also 
shown the hypothetical model of the brucellae VirB Type IV secretion system (T4SS) and flagellum. B1 to B11 represent the 11 proteins that constitute the VirB T4SS. Numbers 
1 to 26 symbolize proteins that compose the flagellum: 1.FliC (filament); 2.FlgL and 3.FlgK (Hook-filament junction); 4.FlgE and 5.FlgD (Hook); 6.FlgH, 7.FliL, 8.FlgG, 9. FlgL, 
10.FlgA, 11.FlgB, 12.FlgC, 13.FlgF, 14.FliE and 15.FliF (Basal body); 16.MotA and 17.MotB (Motor); 18.FliP, 19.FliQ, 20.FliR, 21.FliG, 22.FliM, 23.FliN, 24.FlhA and 25.FlhB (Export 
apparatus); 26.FliI (ATP synthetase). 
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The most virulent species with higher zoonotic spectrum are those from domesticated animals, 
such as B. melitensis, B. suis (with the exception of biovar 2), B. abortus and B. canis; while those 
displaying lower pathogenicity and zoonotic potential are B. ovis and those from wildlife animals, like 
B. suis biovar 2 and biovar 5, B. neotomae, B. microti, B. papionis, B. vulpis, B. pinnipedialis and B. ceti. 
Brucella spp. are able to infect multiple hosts but some species are highly adapted to a single-host 
species, such B. ovis which is a pathogen for rams but does not infect other hosts (Figure 1.4) (Moreno, 
2014; Olsen, 2014; Godfroid et al., 2011; Tsolis et al., 2009).  In order to understand the 
pathomechanisms of infectious diseases with clinical significance in animals and humans we must first 
understand the biology of these agents, and their hosts, in order to unravel the interactions that occur 
at the host-agent interface. A comprehensive understanding of the basis of host specificity can provide 
insights into molecular pathogenesis, the evolution of pathogenic Brucella species, and the potential 
for these pathogens to cross the species barrier to infect new hosts. 
 
 
Figure 1.4. Zoonotic and non-zoonotic Brucella species, modified from Moreno, 2014. Hosts in 
clockwise direction: (A) cattle, camel, sheep, goat, reindeer, swine, dog, unknown; (B) rams, wild boar, 
hare, wild rodent, wild rodent, common vole, baboon, red fox, pinnipeds, porpoise, dolphin. Regarding 
B. microti, B. papionis, B. vulpis, B. pinnipedialis and B. ceti, pathogenicity for humans is still unknown.  
 
 
One of the striking features that distinguish brucellae organisms from other pathogenic 
bacteria is that they do not display obvious virulence factors such as exotoxins, cytolysins, capsules, 
fimbria, plasmids, lysogenic phages, resistant forms, antigenic variation, endotoxic LPS or apoptosis 
inducers. Also unlike other pathogenic bacteria, brucellae virulence does not appear to be the result 
of relatively few virulence genes that can be transferred horizontally via plasmids, phages, or 
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assembled in pathogenicity islands. Instead, the true virulence elements of brucellae are those 
molecular determinants that allow to control their intracellular trafficking and adapt to the 
intracellular niche as well as on the extremely efficient adaptation to shield itself from the immune 
recognition and to manipulate key aspects of host cell physiology (apoptosis, vacuolar trafficking) 
(Ruiz-Ranwez et al., 2015; Gomez et al., 2013; von Bargen et al., 2012; Lamontagne et al., 2010; 
Rambow-Larsen et al., 2009; Gorvel, 2008; Seleem et al., 2008; Barquero-Calvo et al., 2007; Moreno & 
Moriyón, 2006; Lapaque et al., 2005; Gorvel and Moreno, 2002; Letesson et al., 2002). However, in 
recent years, various virulence factors have been identified as essential for infection, including LPS 
(Cardozo et al., 2006; Lapaque et al., 2005; Ugalde et al., 2000), β-cyclic glucan (Martirosyan et al., 
2012; Arellano-Reynoso et al., 2005), BvrR/BvrS two component system (TCS) (Martín-Martín et al., 
2012; Lamontagne et al., 2010; Viadas et al., 2010; Guzman-Verri et al., 2002), some Omps (Lim et al., 
2012; Vizcaíno and Cloeckaert, 2012), and the VirB Type IV secretion system (T4SS) (Seleem et al., 
2007; Celli et al., 2003; Boschiroli et al., 2002). Quorum sensing (QS) is also known to be involved in 
the regulation of brucellae virulence determinants mostly linked to the cell surface (T4SS, flagellum, 
Omps and exopolysaccharide), contributing to the adaptation of the metabolic network during the 
nutrient shift faced by brucellae all along its intracellular trafficking (Gorvel, 2014; Weeks et al., 2010; 
Rambow-Larsen et al., 2009; Letesson et al., 2002).  
In both humans and animals, brucellae first target the respiratory epithelium, the conjunctiva, 
and sexual organs. However, even nowadays, the mechanisms involved in brucellae entry into host 
cells still remain to be characterized (Gorvel, 2014). The ability of Brucella spp. to successfully survive 
and replicate within different host cells explains their pathogenicity. Extensive replication of Brucella 
spp. in placental trophoblasts is associated with abortion in their preferential animal hosts, and 
persistence in macrophages leads to chronic infections that are a hall mark of brucellosis in both 
natural animal hosts and humans (Kim, 2015; Gorvel, 2014; Grilló et al., 2012; Roop et al., 2009). 
In vitro studies were used as models to understand adhesion, internalization, intracellular 
trafficking, survival, and replication of brucellae in susceptible hosts. After attachment to the epithelial 
cell surface receptors that contain sialic acid and sulfated residues, brucellae induces a zipper-like 
mechanism for internalization. Binding promotes activation of small GTPases that trigger a signaling 
cascade that reorganizes the actin cytoskeleton to induce a host cell membrane rearrangement along 
the surface of the pathogen that enhances invasion, and entry occurs within a few minutes after 
interaction (Rossetti et al., 2012). Brucella spp. organisms are capable of colonizing macrophages, 
monocytes, and dendritic cells as well as trophoblasts, fibroblasts, endothelial cells, and epithelial cells 
(Gorvel, 2014; Hamer et al., 2014; Martirosyan et al., 2011; Starr et al., 2008). Brucellae enters into 
host cells through lipid rafts (Barquero-Calve et al., 2007; Porte et al., 2003; Watarai et al., 2002), and 
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its entry depends on the expression of BvrR/BvrS TCS (Manterola et al., 2005; Guzman-Verri et al., 
2002). In fact, it has been shown that mutants lacking LPS O-chain do not use lipid rafts and are killed 
by the host cell suggesting that O-chain plays an important role in early events of host infection (Porte 
et al., 2003). Brucellae survive and replicate inside nonprofessional phagocytic cells up to 72 hours in 
vitro and move across the epithelium in vivo by subverting the mucosal epithelial barrier function to 
facilitate brucellae migration. At the same time, this interaction initiates a minimal innate immune 
response with weak proinflammatory activity (Rossetti et al., 2012; Barquero-Calvo et al., 2007). 
Brucellae survival strategies have been elucidated from analysis of intracellular trafficking in either 
macrophage or epithelial cell models. Once internalized (Figure 1.5), Brucella  spp. cells resides within 
the brucellae-containing vacuole (BCV), a modified phagosome in which the bacterium survives and 
ultimately proliferates (Kim et al., 2015; Gomez et al., 2013; Lee et al., 2013; Starr et al., 2008; Celli et 
al., 2003; Chaves-Olarte et al., 2002). The BCVs then fuse rapidly with the lysosome in a controlled 
manner, as suggested by the presence of the lysosomal markers, lysosomal-associated membrane 
protein (LAMP), and CD63, on the surface of bacteria (Starr et al., 2008; Celli et al., 2003; Pizarro-Cerdá 
et al., 1998). In this transient stage, most of the contents of the BCVs are subjected to phagolysosomal 
degradation, and 90% of internalized brucellae cells are killed by the action of hydrolyzing enzymes 
(Celli et al., 2003). However, the remaining 10% evade the host killing mechanisms through an 
unknown mechanism that probably involves the acidification of the BCVs, subsequent triggering of the 
virB operon and release of a large variety of effectors into the host cells' cytosol (Boschiroli et al., 
2002). The bacteria then traffic and arrive at the endoplasmic reticulum (ER). Within the ER, the 
bacteria survive and establish their replicative niche, and multiply to large numbers (Celli et al., 2003). 
Recent studies have shown that autophagy-like vacuoles (i.e. autophagic “brucellae-replicating 
organelle”, aBCV) provide a replication-permissive compartment following the ER stage, that is 
essential for the completion of the intracellular lifecycle of brucellae and for cell-to-cell spreading  
(Starr et al., 2008). 
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Figure 1.5. Working model of brucellae intracellular trafficking in macrophage cells, extracted from Kim, 2015. 
Plasma membrane-associated lipid rafts mediate the internalization of smooth brucellae into macrophage cells. 
As the BCV matures, it sequentially associates with markers for early (EEA1, purple circle; Rab5, blue diamond) 
and late (Rab7, orange square) endosomes. The biogenesis and trafficking of BCVs is regulated by bacterial 
effector proteins (white circles), which are secreted through the brucellae T4SS. BCVs that contain virulent 
organisms do not fuse with lysosomes (cathepsin D, gray trapezoid), although transient association with LAMP1-
positive membranes (orange triangles) is observed. The pathogen replicates in tight rBCVs that are decorated 
with calreticulin (green triangle), a marker for the ER. At a later point after infection (48 to 72 hours), the 
pathogen is observed in LAMP1-positive aBCVs that also contain LAMP1. Finally, the pathogen is released from 
the cell through lytic or nonlytic (shown) mechanisms. aBCV, autophagic brucellae-containing vacuole; BCV, 
brucellae-containing vacuole; Beclin1, coiled-coil myosin-like BCL2-interacting protein; EEA1, early endosome 
antigen 1; ER, endoplasmic reticulum; LAMP1, lysosome-associated membrane protein 1; rBCV, replicative 
brucellae-containing vacuole; T4SS, type IV secretion system; ULK1, Unc-51-like kinase 1. 
 
 
 
1.5. Comparative genomics as a tool to understand evolution in brucellae 
 
The way in which we perceive the taxonomic relationships among different bacteria influences 
our understanding of their basic biological and ecological features (Moreno & Moriyón, 2002). 
Distinguishing individual bacterial lineages within a species, initially by phenotypic and subsequently 
by genotypic typing techniques, has been the cornerstone of infectious disease epidemiology, allowing 
the identification and tracking of the organisms responsible for infection and disease (Parkhill and 
Wren, 2011). During the past decade, the understanding of evolution at the genomic level has been 
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shaken to its core by many reports showing that genomes from closely related species can vary in 
terms of gene content (Williams et al., 2010).  
The genome from B. melitensis biovar 1 strain 16M was the first to be sequenced (DelVecchio 
et al., 2002) followed by those from strains of B. suis biovar 1 strain 1330 (Paulsen et al., 2002) and B. 
abortus biovar 1 strain 9-941 (Halling et al., 2005). To date, genome sequences from more than 350 
different Brucella strains, representing all species, have been published either as complete genomes 
or as draft assemblies. In 2009, the complete genome of B. suis biovar 2 (ATCC 23445) was sequenced 
and annotated, and, more recently, also the complete genomes of B. suis biovar 3 strain 686 (ATCC 
23446), biovar 4 (ATCC 23447) and biovar 5 strain 513 (NCTC 11996) were released in NCBI. The 
sequences were very highly homologous, although regions of unique genetic material were also 
observed that could be involved in establishing the distinct host preferences and biological behavior 
of the different Brucella species (Lamontagne et al., 2010). Table 1.2 summarizes the general 
characteristics of the reference genomes for B. abortus (strain 9-941), B. melitensis (strain 16M), B. 
suis (strain 1330) and B. suis ATCC 23445 (strain Thomsen). The genomes of B. abortus, B. melitensis 
and B. suis biovar 1, like the majority of the Brucella species, consist of two circular chromosomes of 
2.1 Mbp (Chr I) and 1.2 Mbp (Chr II), whereas B. suis biovar 2 has a smaller Chr I (1.9 Mbp) and a larger 
Chr II (1.4 Mbp). This last structure is also observed in the genome of the reference strain B. suis biovar 
4 (strain 40). Moreover, a third structure was detected in B. suis biovar 3, strain 686, which have a 
single circular replicon of 3.3 Mbp. These three possible genomic structures appear to be the products 
of recombination events between the three rrn loci (Figure 1.6) (O’Callaghan and Whatmore, 2011; 
Jumas-Bilak et al., 1998). 
Genomic analysis indicates that the two chromosomes probably have distinct evolutionary 
origins. The origin of replication of Chr I is typical of bacterial circular chromosomes, while that of Chr 
II possesses a cluster of plasmid-like replication genes including a replication initiation protein RepC 
and partitioning proteins RepA and RepB, similar to plasmid replication genes from Agrobacterium Ti 
plasmids, and plasmids from other organisms including Rhizobium spp. (Paulsen et al., 2002). Further, 
most of the essential genes for protein synthesis are located in Chr I while those encoding enzymes for 
sugar metabolism, protein regulators and membrane transport proteins for sugar, dipeptides and 
amino acids reside on Chr II (Halling et al., 2004; Paulsen et al., 2002). 
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Table 1.2. General characteristics of the reference genomes for B. abortus strain 9-941, B. melitensis 
strain 16M, B. suis strain 1330 and B. suis ATCC 23445 (strain Thomsen). 
Genomic 
features 1 
B. abortus 9-941 (bv 1) B. melitensis 16M (bv 1) B. suis 1330 (bv 1) B. suis ATCC 23445 (bv 2) 
Chr I Chr II Chr I Chr II Chr I Chr II Chr I Chr II 
NCBI RefSeq NC_006932             NC_006933 NC_003317 NC_003318 NC_004310 NC_004311 NC_010169 NC_010169 
Length (bp) 2,124,241 1,162,204 2,117,144 1,177,787 2,107,792 1,207,381 1,923,763 1,400,844 
Topology Circular Circular Circular Circular Circular Circular Circular Circular 
% GC 57.2 57.3 57.2 57.3 57.2 57.3 57.2 57.3 
Protein-coding 
gene 
2,034 1,084 1,996 1,089 1,934 1,087 1,773 1,247 
Pseudogenes 15 17 58 55 30 27 36 51 
         
rRNA  6 3 6 3 6 3 3 6 
tRNA 41 14 40 14 41 14 35 19 
1 Data obtained from NCBI; bv, biovar 
 
 
 
 
Figure 1.6. Graphical circular map of the genome for B. suis 1330 and B. suis ATCC 23445. From the outside to 
the center: Chromosomes I and II (blue), putative genes in forward (dark green), putative genes in reverse 
(green), tRNA (red), rRNA (dark red), GC plot (orange) and GC skew (purple). Circular graphics were obtained 
from the Pathosystems Resource Integration Center (PATRIC) website (www.patricbrc.org). 
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The similarity of the genomic sequences among B. melitensis, B. suis, B. abortus, B. canis, and 
B. ovis is evident by direct comparisons of their genomes showing more differences in Chr II than Chr 
I (Wattam et al., 2009; Foster et al., 2005; Halling et al., 2004, 2005; Paulsen et al., 2002). The major 
difference in Chr I was previously identified by physical mapping in B. suis biovar 2 strain Thomsen 
(ATCC 23445), where a 210 kb segment of Chr I has been translocated to Chr II (Jumas-Bilak et al., 
1998; Wattam et al., 2009). For the somewhat more variable Chr II, more internal rearrangements, 
including one large chromosomal inversion of 640 kb in B. abortus, has been described (Figure 1.7) 
(Michaux-Charachon et al., 1997; Halling et al., 2005; Wattam et al., 2009). 
 
 
 
Figure 1.7. Mauve alignment of both chromosomes from nine complete Brucella genomes. A phylogenetic map 
of the strains, derived from the maximum likelihood tree and based on a concatenated alignment of 2,246 
protein families (topology only, not branch lengths) is shown on the left side: abo, B. abortus; mel, B. melitensis; 
ovis, B. ovis; canis, B. canis; suis, B. suis. Shared anomalous regions (SARs) of interest are noted by filled boxes, 
with the names of those regions directly below them. The translocation event in B. suis ATCC 23445 is highlighted. 
Adapted from Wattam et al., 2009. 
 
 
The comparison of B. suis 1330 and B. melitensis 16M genomes defined a finite set of 
differences that could be responsible for the differences in virulence and host preference between 
these organisms and indicated that phage have played a significant role in their divergence. The 
sequencing of the entire genomes of these strains has revealed the existence of 33 DNA regions greater 
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than 100 bp specific to each strain. The discovery of B. melitensis 16M (11 regions) or B. suis 1330 (22 
regions) specific DNA regions suggests that other specific DNA regions may also be present or absent 
in other Brucellae. Moreover, based on the whole genome alignments, only 42 B. suis genes were 
identified that are completely absent in the other genome (Paulsen et al. 2002).  
Ratushna et al. (2006), carrying out a three-way genome comparison of B. suis, B. melitensis 
and B. abortus sequences, at both the nucleotide and predicted coding sequence (CDS) levels, found 
that the majority (>90%) of annotated genes were found to share 98–100% sequence identity and that 
most of differentiating genes identified are in large regions with functional assignments in existing 
annotation. Fewer than 100 genes were identified as present in only one or two of the three genomes, 
with an additional group of close to 100 genes having significant deletions in one or two of the 
genomes relative to the others. According to these authors, computational and experimental analysis 
identified and confirmed a set of 22 ORFs to be present in B. suis 1330, but not in B. melitensis 16 M 
or B. abortus 9-941, and another 22 ORFs found in both B. suis 1330 and B. abortus 9-941, but not in 
B. melitensis 16 M. Only B. suis was found to have a significant number of unique genes. Among these 
B. suis unique genes, two ABC transporters permeases and a cluster of transfer genes (tra/trb) and 
potentially significant to secretion (island S2) were identified (Ratushna et al., 2006; Paulsen et al., 
2002).  
Once limited genome diversity exists among different Brucella species, the analysis of full 
genome sequences of the different species (and biovars) is of crucial importance since it will enhance 
the knowledge on the biochemical pathways and will open the road for the identification of virulence 
factors. Because the genomes of Brucella species are highly conserved, host preference and virulence 
difference must stem from the limited genome diversity. 
 
 
1.6. Objectives, research strategy and thesis organization 
 
The work developed throughout this thesis aimed to improve our knowledge on B. suis biovar 
2, the causative agent of swine brucellosis in Europe, and further unveil specific genomic variations 
associated with strains of specific geographic origin, namely, with Iberian strains. Further sequencing 
of the genomes of Iberian field strains seemed thus crucial to disclose the structure and distinctive 
features of B. suis pan-genome, as well as its evolutive history, host preference and geographic 
partitioning. 
Although infection due to B. suis biovar 2 is recognized, few information is available about the 
strains circulating in swine and wild boar populations across Portugal, as well as on their genetic 
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diversity relatively to strains circulating in Spain and other European countries. Likewise, the first aim 
of this study was to develop a new selective medium in order to increase the sensitivity of the 
bacteriological diagnosis and consequently to enlarge the number of B. suis isolates in INIAV Brucella 
spp. culture collection. Subsequently, all isolates were identified and characterized using a polyphasic 
approach, in order to extend our understanding on the prevalence and molecular epidemiology of B. 
suis biovar 2 infection. 
In accordance with other authors, the former studies showed that B. suis biovar 2 isolates were 
grouped in closely related clusters according to their geographic origins, distinguishing two biovar 2 
clonal lineages in Iberian Peninsula. The third objective of this thesis was to evaluate the usefulness of 
optical mapping technology as an epidemiological tool. For that, the ordered restriction fragment maps 
(optical maps) of five B. suis biovar 2 strains representative of the two lineages circulating in Iberian 
Peninsula were constructed, with the purpose of disclosing genomic variations among them and 
assessing the universality of these markers, as well as the usefulness of this technology as an 
epidemiological tool in a large set of field strains. 
To achieve a better understanding of the mechanisms of evolution and specialization of Iberian 
lineages, the last aim of this thesis was the full comparative genomic analysis of B. suis biovar 2 with 
other Brucella species to disclose the genomic and structural differences between Iberian and Central-
European clonal lineages and further discuss the potential factors that favour the evolution of host 
specialization. The complete genomes of the five biovar 2 strains used for construction of optical maps 
were sequenced using the next-generation sequencing platform from Illumina (HiSeq 2000 system 
version 1.9), with a paired-end protocol. The full genome sequences were obtained using a 
combination of Illumina, Sanger and optical mapping technologies. The following comparative genomic 
analysis was performed with the intention of disclose common organizational and structural features, 
assess intra- and inter-biovar genomic diversity, and identify candidate-virulence genes and 
polymorphic regions. Polymorphic regions with marker potential (e.g. exclusive of B. suis Iberian clonal 
lineage) were further analysed to search for consensus regions suitable for the subsequent design of 
specific amplification primers. With this approach, it was intended to identify genetic variations that 
were consistently found associated with strains of a specific geographic origin. The genomic regions 
with wide distribution in field samples may also be elected as molecular markers with potential 
diagnostic and/or epidemiological value.  
At the end of this PhD project, it was expected to have identified some specific genomic 
variations associated with strains of specific geographic origin, namely, with Iberian strains of B. suis 
biovar 2. However, other avenues can be explored and additional outcomes can be achieved, 
depending both on the obtained data and the temporal feasibility. 
Chapter 1. General Introduction 
23 
The wet-lab work was mostly developed at the Bacteriology and Mycology Laboratory from 
the Strategic Unity of Production and Animal Health from the Instituto Nacional de Investigação Agrária 
e Veterinária (INIAV, I.P.), with the cooperation of the Research Group on Microbiology & 
Biotechnology (M&B), from Biosystems and Integrative Sciences Institute (BioISI), Faculdade de 
Ciências, Universidade de Lisboa, Portugal. 
 
Thesis organization 
 
This thesis is organized into five chapters. In this Chapter 1, a general introduction to the 
subject of the thesis was presented, including the history and current status of knowledge, the 
objectives and the research strategy of the work developed in this thesis. Chapter 2 is divided in two 
complementary studies. The first part (subchapter 2.1) includes the development and evaluation of a 
selective medium for the primary isolation of B. suis, LNIV-M, that has been developed and compared 
to the currently used selective media in the bacteriological diagnosis of brucellosis. This work allowed 
to follow up a bacteriological study which included the isolation of B. suis strains from wild boars and 
swine from different regions of Portugal, enhancing the number of isolates in the INIAV Brucella culture 
collection. In the second part (subchapter 2.2) is presented the molecular characterization of B. suis 
field strains using PCR-RFLP analysis for omp2a, omp2b and omp31 genes and Brucella MLVA-16 assay, 
that endorsed the observation that two specific B. suis biovar 2 clonal lineages were circulating in 
Portugal and Spain, the Iberian and the Central-European clonal lineages. In Chapter 3 it is described 
the application of optical maps to compare closely-related B. suis biovar 2 strains. Optical maps of five 
B. suis biovar 2 strains belonging to the Iberian and Central-European clonal lineages, as well as the 
optical maps of the B. suis biovar 2 reference strain, were produced allowing the identification of 
chromosomal rearrangements and insertions/deletions events, permitting to distinguish between 
clonal lineages and strains at the individual level. Chapter 4 is divided in two separate works. In 
subchapter 4.1 is presented the complete and annotated genome sequences of the five 
abovementioned B. suis biovar 2 strains from the two circulating clonal lineages, which have been 
released in GenBank. In subchapter 4.2 a full genomic comparative analysis was performed, 
encompassing the genomes of the five B. suis biovar 2 strains belonging to the main circulating clonal 
lineages in Iberian Peninsula and the publicly available Brucella spp. genomes. Lastly, Chapter 5 
summarizes all major contributions from this PhD project and suggests directions for future research. 
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1. Introduction 
 
In Europe, Brucella suis biovar 2 is the most commonly isolated biovar in domestic pigs. It is also 
frequently isolated from wild boar (Sus scrofa) and European hares (Lepus europaeus), which are 
considered its natural reservoirs (Al Dahouk et al., 2005; Cvetnic et al., 2003; Godfroid and Käsbohrer, 
2002; Garin-Bastuji et al., 2000; Godfroid et al., 1994). Wild boar seems to be the main source of 
infection for domestic pigs in the Iberian Peninsula (Muñoz et al., 2010; EFSA, 2009). Due to the lack 
of specificity of serological tests, the unequivocal diagnosis depends on the isolation of Brucella from 
abortion material, udder secretions or from tissues removed at post-mortem. Likewise, bacteriological 
isolation although slow, expensive and cumbersome, should be performed whenever possible to 
confirm the disease and to determine the Brucella species/biovars involved (OIE, 2016). Primary 
isolation of the slow growing Brucella species requires selective media to inhibit overgrowing 
contaminants present in field samples. The most widely selective medium used in primary isolation is 
Farrell’s medium (FAR; Farrell, 1974) and modified Thayer-Martin’s medium (MTM; Marín et al., 1996a; 
Brown et al., 1971). FAR is an excellent medium but some antibiotics present in its composition, namely 
nalidixic acid and bacitracin, have inhibitory effects on some B. suis strains (OIE, 2016; De Miguel et al., 
2011; Jensen and Halling, 2010; Marín et al., 1996a, 1996b). On the other hand, the MTM is suitable 
for isolating most brucellae and is the most effective selective medium for the isolation of B. ovis, B. 
abortus and B. melitensis but lacks inhibitory effects on many overgrowing contaminants, and hinders 
the assessment of colonial morphology by direct observation of culture plates (De Miguel et al., 2011; 
Marín et al., 1996a, 1996b). To overcome these problems some laboratories use both media in parallel, 
what makes the isolation procedure more expensive and troublesome. Therefore, in a routine 
laboratory that has to analyze a great amount of samples, it would be preferable to have a single 
selective medium for all the Brucella strains, without the drawbacks of the currently used media. 
The objective of this work was to develop a new selective medium (named herein LNIV-M) for the 
isolation of B. suis and to assess its diagnostic performance in the isolation of B. suis biovar 2.  It was 
evaluated the growth of B. suis reference and field strains from domestic pigs in different basal media 
and the susceptibility to different antibiotics contained in the currently used FAR and MTM media and 
the results obtained confirmed the adequate diagnostic performance of LNIV-M in the isolation of B. 
suis. 
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2. Material and Methods 
 
2.1. Brucella strains 
To select basal medium for LNIV-M, we used the reference strains, B. suis 1330 (biovar 1, ATCC 
23444), B. suis Thomsen (biovar 2, ATCC 23445) and B. suis 686 (biovar 3, ATCC 23446) and 22 B. suis 
biovar 2 field strains from domestic pigs, identified and typed according to Alton et al. (1988).  
 
2.2. Culture media 
Blood Agar Base (BAB), GC medium (GC), Trypticase Soy Agar (TSA) (all from Becton–Dickinson, 
USA), Brucella Medium Base (BMB; Oxoid, England) and Plommet Medium (PM; Plommet, 1991) were 
evaluated as basal media by colony counting, alone or supplemented with 5% sterile horse serum (-S; 
Euro-Lone, Canada) or 1% haemoglobin (-H; Becton–Dickinson, USA). BMB, GC and TSA were also 
supplemented with 0.1% yeast extract (-YE; Becton–Dickinson, USA). 
 
2.3. Culture conditions 
Each strain was grown in TSA slants at 37 ºC with 10% CO2 for 48 h, harvested in sterile phosphate- 
buffered saline (PBS) pH 7.2 and spectrophotometrically (S2100 Diode Array Spectrophotometer, 
WPA) adjusted in the same diluent to about 109 CFU/ml (OD600 = 0.170). Then, six 10-fold dilutions of 
each suspension were performed in PBS and 0.1 ml of each dilution were plated by triplicate in each 
medium. After incubation at 37 ºC for 5 days in 10% CO2 atmosphere, the mean (n = 3) number of 
CFU/plate was determined in each medium, and statistically compared by ANOVA followed by LSD 
multiple comparison test, using the PROC GLM procedure of SAS statistical package (SAS/STAT version 
9.2; SAS, 2008; Zar, 1984).  
 
2.4. Evaluation of the relative diagnostic performance of LNIV-M in the primary isolation of B. 
suis with respect to FAR and MTM 
We cultured 1649 samples (spleen; liver; lung; peripheral lymph node; reproductive organs) from 
918 hunter-harvested wild boars, sampled during the hunting season (November–March) across 
Portugal. All tissue samples were processed as described by Alton et al. (1988) and 0.2 ml/plate of each 
tissue homogenate were cultured in duplicate plates on the three media. Samples were considered 
positive when at least one CFU was isolated after incubation at 37 ºC (10% CO2) for up to 10 days. 
Brucella species and biovars were identified according to Alton et al. (1988). 
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3. Results and Discussion 
 
Our results proved that B. suis growth was significantly (p < 0.0001) inhibited in GC-S and GC-YE 
with respect to GC-H, BAB-S or TSA-S as described by others (De Miguel et al., 2011). The later three 
basal media performed similarly and yielded the highest number of CFU/plate (results not shown). 
Considering the cost of BAB-S and that GC-H is a no-translucent medium and cumbersome to prepared, 
TSA-S was finally chosen as LNIV-M basal medium. In a second step, the antimicrobial supplement was 
formulated according to the results of Minimal Inhibitory Concentration (MIC; Sahm and Washington, 
1991) and Concentration Enabling Growth (CEG; Marín et al., 1996a) obtained with the 22 B. suis biovar 
2 field strains against bacitracin, vancomycin, polymyxin B, nalidixic acid, cycloheximide, nystatin, 
colistin, nitrofurantoin and amphotericin B (all from Sigma–Aldrich, Germany), in the range of 512–1 
mg/L, using Mueller–Hinton broth and agar (Becton–Dickinson, USA). Results are presented in Table 
2.1.1. The variations in susceptibility to the antibiotics were notorious, except for amphotericin B and 
cycloheximide antifungal agents which, as expected, did not affect the growth of B. suis bv. 2. In 
particular, most of the strains (13/22; 59.1%) were inhibited by low concentrations of polymyxin B 
(MIC ≤4 mg/L and CEG ≤1 mg/L), but all are resistant to higher concentrations of colistin (MIC ≥16 mg/L 
and CEG ≥4 mg/L). These results are in agreement with those obtained by De Miguel and colleagues 
(2011). 
Considering the MIC and CEG results (Table 2.1.1), LNIV-M was formulated with TSA-S 
supplemented with 20 mg/L vancomycin (bactericidal for most gram positive bacteria), 4 mg/L colistin 
and 16 mg/L of nitrofurantoin (active against most gram negative bacteria), and 100 mg/L 
cycloheximide and 16 mg/L (95 000 IU/L) nystatin (active against yeasts and moulds). The efficacy of 
LNIV-M for culturing B. suis was compared with that of FAR and MTM media (both prepared as 
described elsewhere; Marín et al., 1996a; Farrell, 1974), using the B. suis reference and field strains 
described above. The number of CFU/plate grew in LNIV-M, FAR and MTM selective medium and TSA-
S (control) was determined and statistically compared as detail above. The overall results are shown 
in Table 2.1.2. No significant differences were found for LNIV-M and MTM with respect to the TSA-S 
medium used as control, but FAR significantly (p < 0.05) reduced the number of CFU. These data 
confirm our preliminary studies and the results obtained for other Brucella species (De Miguel et al., 
2011; Marín et al., 1996a, 1996b). Moreover, colonial size on LNIV-M and MTM were smaller than on 
TSA-S but larger than on FAR. Since MTM contains hemoglobin, the translucent LNIV-M has the 
advantage to allow a better direct identification of Brucella. 
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Table 2.1.1. Minimal Inhibitory Concentration (MIC) and Concentration Enabling Growth 
(CEG) for 22 B. suis field strains 
Antibiotics No. of strains MIC (mg/L) CEG (mg/L) 
Bacitracin 18 512 256 
4 256 128 
Vancomycin  2 >512 512 
10 512 256 
8 512 128 
2 256 64 
Colistin methanosulfonate 7 64 16 
12 32 8 
3 16 4 
Polymixin B sulphate 9 64 16 
11 4 1 
2 1 <1 
Nalidixic Acid 19 64 32 
3 32 16 
Nitrofurantoin 8 512 256 
6 512 128 
6 512 64 
2 512 32 
Amphotericin B 22 >512 512 
Cycloheximide  21 512 256 
1 256 128 
Nystatin  7 512 256 
9 256 64 
5 128 32 
1 64 16 
 
 
 
Table 2.1.2. Susceptibility of B. suis reference and field strains to the new LNIV-M selective 
culture medium, in  comparison to modified Thayer-Martin (MTM) and Farrell (FAR) media.  
Culture media 
CFU/plate (mean ± SD) of B. suis* 
Reference strains Field strains 
biovar 1  
ATCC 23444 
biovar 2  
ATCC 23445 
biovar 3 
ATCC 23446 
biovar 2 
(n=22) 
TSA-S (control) 84.0   7.81 B 75.0   15.10 B 78.7   5.51 B 72.1   21.57 B 
LNIV-M 77.3   8.08 B 83.3   6.66 B 81.3   1.53 B 67.0   20.77 B 
MTM 68.3   15.04 B 73.3   7.57 B 46.0   14.00 B 64.4   23.12 B 
FAR 22.3   2.08 A 25.7   3.06 A 21.0   1.00 A 48.6   18.74 A 
* Mean and SD (n=3 from independent experiments with the corresponding reference strain; or n=22 
field strains) of the number of CFU/plate were determined, after triplicate plating of 0.1 ml of a 
suspension containing around 103 CFU/ml in each culture medium. TSA-S was used as control.  
A,B Values with the same letter indicate that means were statistically equivalent (p>0.05) 
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Finally, to evaluate the relative diagnostic performance of LNIV-M in the primary isolation of B. 
suis with respect to FAR and MTM, we cultured 1649 samples (spleen; liver; lung; peripheral lymph 
node; reproductive organs) from 918 hunter-harvested wild boars, sampled during the hunting season 
(November–March) across Portugal. All tissue samples were processed as described by Alton et al. 
(1988) and 0.2 ml/plate of each tissue homogenate were cultured in duplicate plates on the three 
media. Samples were considered positive when at least one CFU was isolated after incubation at 37 ºC 
(10% CO2) for up to 10 days. Brucella species and biovars were identified according to Alton et al. 
(1988). The number of plates rejected due to overgrowing contaminants in LNIV-M was lower than in 
MTM but higher than in FAR (data not shown). From the 918 wild boars tested, 63 animals (6.9%) were 
found to be infected with B. suis biovar 2, showing a total of 139 (8.4%) positive samples (63 spleens; 
21 livers; 21 lymph nodes; 21 lungs; 13 reproductive organs). LNIV-M detected 59 out the 63 (93.6%) 
positive animals and 87 out the 139 (62.6%) positive samples, while FAR and MTM detected, 
respectively, 58 (92.1%) and 50 (79.4%) of animals, and 81 (58.3%), and 83 (59.7%) of samples. The 
combined use of LNIV-M and MTM detected 95.2% (60) positive animals, whereas LNIV-M and FAR 
detected 100% positive animals. The results obtained in the diagnostic performance of FAR and MTM 
are not in agreement with those from efficacy studies. This can be explained by the high inhibitory 
effect of FAR for most contaminants present in field samples, allowing the growth of Brucella colonies 
and showing that this medium is more suitable for diagnostic purpose than MTM. The Cohen’s Kappa 
coefficient (K) and McNemar’s Chi-square test (Χ2; Zar, 1984) were used to calculate the level of 
agreement between media. A p less than 0.05 (p < 0.05) was considered statistically significant. 
Analysis of samples showed a substantial agreement between media, except for lung tissue, where 
poor recovery of Brucella was achieved. The best value was observed when comparing LNIV-M and 
FAR (K = 0.699, 95% CI; Χ2= 1.25, p ≥ 0.05, data not shown). 
 
 
4. Conclusion 
 
In conclusion, for an adequate bacteriological diagnosis of brucellosis and to increase its sensitivity, 
more than one selective culture medium should be used. Data obtained in this study indicate that 
LNIV-M is a useful selective medium for isolation of B. suis and the combined use of LNIV-M and FAR 
has shown to improves the performance of the bacteriological diagnosis of brucellosis in swine. 
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1. Introduction 
 
Brucella suis consists of five biovars (named from 1 to 5) that affects a wide range of hosts including 
man. The infection in swine is caused by biovars 1, 2, and 3. B. suis has received meager attention 
comparatively to other Brucella species and, despite the greater internal diversity and wide host range, 
studies have been focused on biovar 1 (EFSA, 2009). The infection caused by biovar 2 differs from 1 
and 3 in its host range, its limited geographical distribution and its pathology. Infections due to B. suis 
biovar 1 and 3 have been reported worldwide in several animal species and humans. Brucellosis due 
to biovar 2 represents an emerging disease in domestic swine throughout Europe and is associated 
with the increase of extensive swine farms and the high density of infected wild boars, representing 
an important hazard particularly for the Iberian pig population reared in outdoor breeding systems 
(Muñoz et al., 2010; EFSA, 2009). This infection has been placed in evidence in Belgium (Grégoire et al, 
2012), Croatia (Cvétnic et al., 2005), Czech Republic (Hubalek et al., 2002), Denmark (Jungersen et al., 
2006), France (Garin-Bastuji et al., 2000), Germany (Al Dahouk et al., 2005), Hungary (Hubalek, et al., 
2002), Italy (De Massis et al., 2012), Poland (Szulowski et al., 2013), Portugal (Ferreira et al., 2012), 
Romania (EFSA, 2009), Serbia and Montenegro (Djuricic, 2010), Spain (Muñoz et al., 2010) and 
Switzerland (Koppel et al., 2007). In contrast, B. suis has never been found in Finland, Norway, Sweden 
and the United Kingdom (EFSA, 2009).  
The identification of B. suis biovars is usually performed by standard bacteriological methods. 
However, these tests lack specificity and are not straightforward particularly for the identification of 
biovars 1, 2, and 3 (Ferrão-Beck et al., 2006). Since accurate typing procedures are essential for 
epidemiological studies, different PCR-based methods have been proposed to improve B. suis 
molecular characterization. Suis-ladder multiplex PCR is a rapid and robust system that allows a fast 
and precise identification of B. suis at the biovar level (López-Goñi et al., 2011). The PCR-restriction 
fragment length polymorphism (PCR-RFLP) analysis of genes omp2a and omp2b (Cloeckaert et al., 
1995), and gene omp31 (Vizcaíno et al., 1997) showed to be useful for differentiation between biovars 
and revealed additional polymorphism within biovar 2 (Muñoz et al., 2010; Garcia-Yoldi et al., 2007; 
Ferrão-Beck et al., 2006). Molecular typing by Multilocus Variable Number Tandem Repeat Analysis 
(MLVA) is an accurate method to determine the relatedness amongst bacterial isolates and has been 
frequently used to disclose genetic relationships inside Brucella genus, at species, biovar and strain 
level (Scholz & Vergnaud, 2013). In fact, the Brucella MLVA-16 assay, originally developed by Le Flèche 
et al. (2006) and modified by Al Dahouk et al. (2007), consists of 16 genetic markers comprising eight 
minisatellite markers most appropriate for species-level identification, and eight microsatellite 
markers with higher discriminatory power. This assay is easily performed and reproducible, and 
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demonstrated the high heterogeneity at the genomic level between B. suis isolates (Duvnjak et al., 
2015; Kreizinger et al., 2014; Li et al., 2013; Garcia-Yoldi et al., 2007). 
In this work, different PCR-based methods, including the Suis-ladder multiplex PCR, PCR-RFLP 
analysis for omp2a, omp2b and omp31 genes and MLVA-16 assay, were used to assess the biovar, the 
different haplotypes and the epidemiological relationship between strains from diverse host and 
geographic origins, including Portugal and other European countries, in order to disclose the genetic 
diversity of B. suis biovar 2 strains circulating in Europe. 
 
 
2. Material and Methods 
 
2.1. B. suis isolates and genomic DNA bank 
One hundred and seventy six B. suis isolates were used in this study, comprising 11 isolates from 
biovar 1, 160 from biovar 2, one from biovar 3 and four from biovar 4. Isolates were obtained from 
diverse geographic origins and hosts (Table 2.2.1), including human (n=4), bovine (n=1), caribou (n=1), 
goat (n=2), hare (n=6), reindeer (n=3), sheep (n=2), swine (n=62) and wild boar (n=94). Reference 
strains from biovar 1 (strain 1330, ATCC 23444), biovar 2 (strain Thomsen, ATCC 23445), biovar 3 (strain 
686, ATCC 23446), biovar 4 (strain 40, ATCC 23447) and biovar 5 (strain 513, NCTC 11996) were also 
included in the study. All B. suis isolates were typed according to standard bacteriological procedures  
(Alton et al., 1988), and a bank of genomic DNA extracts for all isolates and reference strains was 
prepared using the High Pure PCR Template Preparation Kit (Roche Diagnostics, Mannheim, Germany), 
according to the manufacturer, and conserved at -80ºC.  
 
2.2. Suis ladder multiplex PCR and PCR-RFLP analysis 
All B. suis isolates were subjected to the Suis-ladder multiplex PCR (López-Goñi et al., 2011) and 
PCR-RFLP analysis for omp2a and omp2b (Cloeckaert et al., 1995), and omp31 (Vizcaíno et al., 1997) 
genes to accurately assess the biovar and the different haplotypes, as previously described. All DNA 
primers were purchased from Invitrogen and restriction enzymes were from Biolabs (EcoRI and NcoI) 
or Promega (AvaII, HaeIII, StyI and KpnI). 
 
2.3. MLVA-16 assay and data analysis 
Single-locus amplifications of the 16 genetic markers were performed as described elsewhere 
(Ferreira et al., 2012). The 16 loci have been classified in three panels, named panel 1, composed of 8 
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minisatellite (bruce06, bruce08, bruce11, bruce12, bruce42, bruce43, bruce45 and bruce55), panel 2A 
(bruce18, bruce19 and bruce21) and panel 2B (bruce04, bruce07, bruce09, bruce16 and bruce30) 
composed of three and five microsatellite markers, respectively. Briefly, PCR reactions were performed 
in a total volume of 15 µl containing 3 ng of DNA, 1X PCR Reaction Buffer, 1 U of Taq DNA polymerase 
(Roche Diagnostics, Germany), 200 µM of each dNTPs and 0.3 µM of each flanking primers. 
Amplifications were performed in a MyCycler thermal Cycler (Biorad, France). An initial denaturation 
step at 96 ºC for 5 min was followed by 30 cycles of denaturation at 96 ºC for 30 s, primer annealing at 
60 ºC for 30 s and elongation at 70 ºC for 1 min. The final extension step was performed at 70 ºC for 5 
min. Five microliters of amplification products were loaded on a 3% standard agarose gel to analyze 
panel 2A and 2B loci (tandem repeats with a unit length shorter than 8 bp) and on a 2% standard 
agarose gel for panel 1 loci (tandem repeats with a unit length larger than 10 bp) and run under a 
voltage of 8 V/cm for 120 min. Depending on the tandem repeat unit length, a 20 bp (20 bp PCR 
Molecular Ruler, Biorad, France) or a 100 bp ladder was used as molecular size marker (100 bp DNA 
ladder, Invitrogen). The total number of repeats at each locus was determined by the correlation with 
the amplicon size according to the 2013 Brucella allele assignment table (Le Flèche et al. 2006 version 
3.6 available at http://mlva.u-psud.fr). Genomic DNA from B. melitensis biovar 1 strain 16M (ATCC 
23456) and B. suis biovar 2 strain Thomsen were used as controls for alleles assignment. Cluster 
analysis of MLVA-16 data was based on the categorical coefficient (with equal weight for all markers) 
and unweighted pair group method with arithmetic averages (UPGMA) using BioNumerics version 6.5 
(Applied Maths, Belgium). The MLVA-16 genotypes of the reference strains were also included in the 
analysis and a standard minimum spanning tree (MST) was applied to the set of 181 strains. MLVA data 
from this work was compared to results obtained by other authors with B. suis strains from different 
origins that were deposited in the Brucella MLVA database (available at http://mlva.u-psud.fr). The 
genetic diversity of the loci was calculated using the Hunter–Gaston diversity index (HGDI) (Hunten & 
Gaston, 1988), via the online tool V-DICE available at the HPA website (http://www.hpa-
bioinformatics.org.uk/cgi-bin/DICI/DICI.pl).  
A similar MST analysis of MLVA-11 genotypes (including only mini-/microsatellite markers from 
panels 1 and 2A) was also performed for a total of 526 strains, including 345 additional B. suis strains 
from different biovars, using the data available in the Brucella database hosted at 
http://microbesgenotyping.i2bc.paris-saclay.fr.  
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Table 2.2.1. Brucella suis isolates used in the study. 
Species /biovar Country 
Number of 
isolates 
Hosts a 
B. suis biovar 1 Croatia (HR) 2 G; SW 
 France (FR) 5 H; M; SW 
 Mexico (MX) 1 M 
 Netherlands (NL) 1 M 
 French Polynesia (PF) 1 SW 
 United States (US) 1 SW 
                          Total 11  
B. suis biovar 2 Belgium (BE) 20 SW 
 Croatia (HR) 1 SW 
 France (FR) 10 G; H; SW; WB 
 Denmark (DK) 1 n.a. 
 Germany (DE) 5 H; WB 
 Italy (IT) 7 WB 
 Portugal (PT) 92 B; SW; S; WB 
 Spain (SP) 22 SW; WB 
 Switzerland (CH) 1 WB 
 Unknown  1 SW 
                          Total 160  
B. suis biovar 3 India (IN) 1 M 
B. suis biovar 4 Alaska 1 C 
 Poland (PL) 3 R 
                          Total 4  
 
a B, bovine; C, caribou; G, goat; H, hare; M, man; R, reindeer; S, sheep; SW, Swine; WB, wild boar; 
n.a., information not available. 
 
 
3. Results and Discussion 
 
The genetic structure of 176 B. suis isolates and five reference strains representative of each biovar 
was characterized using the Suis-ladder multiplex PCR, the PCR-RFLP analysis for omp2a, omp2b and 
omp31 genes and the MLVA-16 assay. Full information on B. suis isolates, including geographic origin 
and molecular typing data obtained with Suis-ladder multiplex PCR and RFLP-PCR is detailed in 
Supplementary Table S2.2.1. A perfect correlation was found between classical typing and Suis-ladder 
multiplex PCR, since all isolates allocated to a particular biovar displayed the expected specific band 
profile according to López-Goñi et al. (2011). Likewise, PCR-RFLP analysis of omp2a, omp2b and omp31 
genes also detected different haplotypes according to the specific biovar (Vizcaíno et al., 1997; 
Cloeckaert et al., 1995). However, additional polymorphism within biovar 2 isolates was identified, 
describing five different restriction patterns named 2a, 2b, 2c, 2d and 2e. Haplotype 2a was 
characteristic of the B. suis biovar 2 Thomsen reference strain and was found in hare and swine isolates 
from France and Germany; haplotype 2b was only observed in four isolates from France (three from 
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hare and one from swine); and haplotype 2c was observed in 36 swine and wild boar isolates from 
Belgium, Croatia, France, Italy, Spain and Switzerland, as well as in one goat isolate from France. 
Haplotypes 2d and 2e were restricted to Iberian Peninsula. In Portugal, 79.3% (73/92) of the isolates 
(including swine, wild boar, bovine and sheep as hosts) corresponded to haplotype 2d and 20.7% 
(19/92) were haplotype 2e (only found in isolates from wild boar). Considering the Spanish isolates, 
haplotype 2d (54.5%; 12/22) and haplotype 2e (31.8%; 7/22) were both present in isolates from swine 
and wild boar. A DNA-based study in isolates from wild boar performed by Muñoz and colleagues 
(2010) have also shown that haplotype 2d is the most frequent in Spain in both swine and wild boar.  
Identification of species and biovars of Brucella field strains isolated from outbreaks, paired with 
a genotyping approach such as MLVA, is essential to fully understand the epidemiology of the disease 
and to trace sources of infection, as well as to detect the introduction of any new strains. MLVA-16 has 
been applied to evaluate the epidemiological relationships among Brucella spp. isolates from different 
geographical origins, showing to be extremely discriminant and highly efficient to confirm 
epidemiological linkage in outbreak investigations. Nevertheless, most of the studies were applied to 
B. abortus or B. melitensis (Sun et al., 2016; Allen et al., 2015; De Massis et al., 2015; Shevtsov et al., 
2015; Tay et al., 2015; Garafolo et al., 2013; Jiang et al., 2013; Ferreira et al., 2012; Aftab et al., 2011; 
Kiliç et al., 2011; Valdezate et al., 2010; Al Dahouk et al., 2007; Le Flèche et al., 2006) and fewer studies 
targeted the epidemiological context of B. suis (Duvnjak et al., 2015; Tay et al., 2015; Kreizinger et al., 
2014; Jiang et al., 2013; Li et al., 2013; Garcia-Yoldi et al., 2007). In this report, MLVA-16 was performed 
to study the genetic diversity of 176 B. suis isolates, and the results of this investigation represent the 
first data concerning the B. suis biovar 2 genotypes (GTs) circulating in Portugal (Supplementary Table 
S2.2.2). 
To assess the diversity of B. suis populations and to compare the discriminatory power of MLVA 
typing approaches, HGDI values were calculated for all individual markers, as well as for the combined 
MLVA-16, MLVA-11 (panels 1 and 2A markers) and MLVA-8 (panel 1 markers) subsets (Table 2.2.2). All 
16 loci have been identified for all strains except bruce09 in two swine isolates from France. Two 
markers (bruce45 and bruce21) were monomorphic in all biovars, two others (bruce06 and bruce43) 
only showed a different repeat copy number in biovar 5 and a moderate discrimination was found in 
bruce18 and bruce55 (0.60 ≤ HGDI ≤ 0.70). In contrast, bruce09, bruce04, bruce30 and bruce07 from 
panel 2B were highly discriminatory (HGDI > 0.80). Although bruce16 is usually included in the more 
variable panel 2B (Le Flèche et al., 2006), it showed a low diversity index for B. suis (0.20). This was due 
to the fact that this locus is monomorphic for biovar 2 isolates, results that were also obtained in 
previous studies encompassing isolates from Spain (Garcia-Yoldi et al., 2007), Hungary (Kreizinger et 
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al., 2014) and Croatia (Duvnjak et al., 2015). It is also noteworthy that bruce12 and bruce42 from panel 
1 clearly differentiated isolates with PCR-RFLP haplotypes 2d and 2e from the others (Table 2.2.2). 
The dendrogram of the genetic relatedness of all B. suis strains is depicted in Figure 2.2.1 (A 
and B). MLVA-16 distinguished a total of 126 GTs with 101 singleton GTs. The VNTR profiles are shown 
in Supplementary Table S2.2.2 and were uploaded in the Brucella MLVA database at http://mlva.u-
psud.fr. B. suis represented an heterogeneous group (global similarity of 21.2%), showing an extreme 
diversity among strains (HGDI = 0.99), mainly due to diverging panel 2B VNTR markers. However, 
MLVA-16 was highly consistent among isolates with known epidemiological links and sharing the same 
MLVA-16 GTs (Supplementary Table S2.2.2). Considering a similarity cutoff value of 40%, B. suis 
isolates were grouped into three major clusters. Cluster I grouped all isolates from biovar 1, 3 and 4 
and the respective reference strains, with biovar 3 more closely related to biovar 1 than to biovar 4. 
Cluster II included all biovar 2 isolates and was further separated into two sub-clusters (IIA and IIB), 
using a cutoff value of 50% similarity. Sub-cluster IIA included the biovar 2 reference strain (isolated in 
Denmark), all isolates from Central-European countries (Belgium, Croatia, France, Denmark, Germany, 
Italy and Switzerland) and 3 isolates from Spain, sharing PCR-RFLP haplotypes 2a, 2b and 2c. All 
Portuguese isolates and the remaining Spanish isolates, encompassing haplotypes 2d and 2e, were 
grouped in sub-cluster IIB. Lastly, B. suis biovar 5 reference strain formed a separate simplicifolious 
line (cluster III). A MST was also constructed to display the relationships of the various MLVA-16 types 
(Figure 2.2.1C). A considerable geographical structure was found among isolates and two clonal 
lineages can be defined for biovar 2 isolates: the Central-European clonal lineage (sub-cluster IIA; 
haplotypes 2a, 2b and 2c) and the Iberian clonal lineage (sub-cluster IIB; haplotypes 2d and 2e), with 
Iberian clonal lineage isolates more distant from biovar 1, 3 and 4 (cluster I) than Central-European 
isolates. It is also noteworthy that biovar 5 (cluster III), although distinct from other B. suis biovars, 
may be more closely related to biovar 2 isolates from Iberian clonal lineage. The results obtained in 
this report were consistent with those previously identified by other authors (Muñoz et al., 2010; 
Garcia-Yoldi et al., 2007; Ferrão-Beck et al., 2006). 
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Table 2.2.2. Repeat copy numbers at each locus in the MLVA-16 assay and Hunter-Gaston Diversity Index (HGDI) for each locus and MLVA-16, MLVA-11 and MLVA-
8 subsets.      
a MLVA-16 markers are defined as described in Le Flèche et al., 2006 and Al Dahouk et al., 2007. 
b PCR-RFLP haplotypes are defined as described in Material and Methods section and shown in Additional file 1.  
c Only the genotype of the reference strain B. suis biovar 5 is considered.  
d n.a.: not applicable. 
VNTR 
markersa 
No. of tandem repeat copies  at each locus in the following PCR-RFLP haplotypesb 
HGDI CI 95% d 
1a 2a 2b 2c 2d 2e 3a 4a 5aC 
Panel 1            
Bruce06 2 2 2 2 2 2 2 2 1 0.01 0.00 – 0.03 
Bruce08 3;4 4;5 3-5 3-5 5 5 3 3 2 0.49 0.42 – 0.56 
Bruce11 6;8 8;9 8 8 8 8 4 9 9 0.21 0.14 – 0.29 
Bruce12 10 14 14 14 9 9 11 10 16 0.54 0.48 – 0.60 
Bruce42 4 6 6 6 5 5 3 3 1 0.54 0.48 – 0.60 
Bruce43 1 1 1 1 1 1 1 1 2 0.01 0.00 – 0.03 
Bruce45 5 5 5 5 5 5 5 5 5 0.00 n.a. 
Bruce55 2 2;7 2 6;7 5 4 2 2 5 0.68 0.63 – 0.73 
 
Panel 2A 
           
Bruce18 4-6 4;6 4;6;7 4-6 5-7 5-7 4 4;5 7 0.62 0.58 – 0.67 
Bruce19 38;43 43 38;43 38;43 38 38 38 36;40 44 0.44 0.38 – 0.50 
Bruce21 9 9 9 9 9 9 9 9 9 0.00 n.a. 
 
Panel 2B 
           
Bruce04 5-7 6;8;9;12;14;20 4;11;13;14 4;6-16;20;22;23 3;5;8-
15;17;20;21 
7;9;11-13;20 7;8 4;5;8;12 9 0.92 0.90 – 0.93 
Bruce07 5-7 9;10;12;14 5;7;12 5-10 4-10;15 5;7;9-15 5;6 5;6;8 5 0.83 0.80 – 0.86 
Bruce09 5-7;10 10;12;16;18-20 3;5;9;21 3;7;9-12;15-19;22 7-21 7-11;13;15;17 10;12 9;10;16 3 0.93 0.93 – 0.94 
Bruce16 4-6 2 2 2 2 2 4 5;6;9 9 0.20 0.13 – 0.28 
Bruce30 3;4 4;6;11 4;5 5;7-12 5-10 4;5;7;8 5;7 3;5 5 0.85 0.83 – 0.87 
MLVA-8 (16 genotypes) 0.71 0.65 – 0.77 
MLVA-11 (26 genotypes) 0.86 0.83 – 0.89 
MLVA-16 (126 genotypes) 0.99 0.98 – 1.00 
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MLVA-11 subset is usually used to better describe epidemiological linkages of genotypes with 
the geographic origin (De Massis et al., 2015; Shevtsov et al., 2015; Kreizinger et al., 2014; Li et al., 
2013; Ferreira et al., 2012; Valdezate et al., 2010; Le Flèche et al., 2006). In this work, MLVA-11 
discriminated 26 genetic variants that were compared with typing data published by other authors 
(Duvnjak et al., 2015; Kreizinger et al., 2014; Jiang et al., 2013; Garcia-Yoldi et al., 2007; Le Flèche et 
al., 2006). Two MLVA-11 GTs were recorded for the first time for biovar 1 isolates, eight for biovar 2 
and one for biovar 4 (Supplementary Table S2.2.2). Even though the variability observed in the number 
of GTs, all variants involved only one or two loci. 
Considering the biovar 2 population, 12 MLVA-11 GTs were assigned to Central-European 
cluster IIA isolates (n=48), from which seven were novel (GT236, GT237, GT239, GT244, GT246, GT253 
and GT254) and five (GT41, GT44, GT45, GT48 and GT50) were formerly described (Kreizinger et al., 
2014; Le Flèche et al., 2006). Although GT244 was formally assigned in this work, it was previously 
observed in one wild boar isolate from Switzerland by Kreizinger et al. (2014). In this cluster, only two 
isolates, one from hare and one from unknown host, shared the same GT50 as biovar 2 reference 
strain, and the most predominant genotype was GT44 (41.7%; 20/48), found in isolates from Belgium, 
France, Italy and Switzerland. Less variability was found in B. suis Iberian isolates (cluster IIB; n=111), 
which were allocated only to five different specific GTs: one GT recorded for the first time (GT233) and 
four (GT58, GT59, GT60 and GT61) previously described by other authors (Kreizinger et al., 2014; Le 
Flèche et al., 2006). The MLVA-11 GT58 was assigned to 47.7% (53/111) of the Iberian isolates, 
suggesting the existence of an ongoing colonization of Iberian Peninsula with this specific MLVA-11 
lineage. The lower diversity of the Iberian lineage is also evident from the less variable MLVA panel 1 
markers (MLVA-8), since only two specific GTs (GT18 and GT19) were found in Iberian Peninsula, while 
eight GTs were assigned to isolates from Central-European countries.  
In order to get additional insights into the evolutionary associations between B. suis lineages 
and their host species of origin, a MST analysis of 526 strains was performed using the MLVA-11 typing 
data (Figure 2.2.2), including those from this study and others previously published (Duvnjak et al., 
2015; Kreizinger et al., 2014; Jiang et al., 2013; Garcia-Yoldi et al., 2007; Le Flèche et al., 2006) and 
available in the Brucella database hosted at http://microbesgenotyping.i2bc.paris-saclay.fr. The 
analysis included 85 strains from biovar 1, 422 from biovar 2, four from biovar 3, 11 from biovar 4, 
three from biovar 5 and one rough strain.  
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Figure 2.2.1. MLVA-16 clustering analysis. (A) MLVA-16 dendrogram of 176 B. suis isolates compared to the 
reference strains. Cluster analysis was performed based on the categorical coefficient and UPGMA. Cut-off 
similarity values were defined at 40% similarity for major clusters (I to III) and 50% similarity for sub-clusters (IIA 
and IIB). (B) Frequency distribution of all isolates in clusters I, IIA, IIB and III. The PCR-RFLP haplotypes (1a, 2a-2e, 
3a, 4a and 5a), the number of isolates by number of MLVA-16 genotypes, the country of origin and host species 
are shown. Colored circles code to PCR-RFLP haplotypes. Country of origin: Alaska, Belgium (BE), Croatia (HR), 
Denmark (DK), Germany (DE), India (IN), Italy (IT), Mexico (MX), Netherlands (NL), Poland (PL), Portugal (PT), 
Polynesia (PF), Spain (SP), Switzerland (CH), United States (USA) and former USSR (RU; reference strain B. suis 
513). (C) MLVA-16 minimum spanning tree describing the relationships of B. suis isolates. Circles represent 
MLVA-16 genotypes, colored according to PCR-RFLP haplotypes, and the size of the circle indicates the number 
of strains with that genotype. Dendrogram clusters (I, IIA, IIB and III) are also pointed out. 
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The MLVA-11 MST topology (Figure 2.2.2A) is similar to the one found with MLVA-16 analysis 
(Figure 2.2.1C), clearly depicting the Iberian and Central-European clonal lineages in biovar 2 and the 
clustering of strains from biovars 1, 3 and 4. Regarding biovar 5, a more close relation to biovar 2 
Central-European clonal lineage was found with the less variable markers of MLVA-11. Beyond biovar 
associations, also host species associations can be observed in the MST analysis (Figure 2.2.2B). In 
biovar 2 Iberian clonal lineage, the prevailing host species are swine (59.6%; 99/166) and wild boar 
(38.6%; 64/166); in contrast, in biovar 2 Central-European clonal lineage, hare seems to be a relevant 
host (18.4% of the strains; 47/256), along with the most common hosts swine (34.4%;88/256) and wild 
boar (43.4%; 111/256). The majority of biovar 1 strains (50.6%; 43/85) were isolated from swine, 
although isolates from hare (8.2%; 7/85) and wild boar (3.5%; 3/85) were observed. The B. suis 
collection also includes a small number of isolates from man and other animal hosts (cattle, small 
ruminants and horse), that occurred probably due to spillover infections. With one exception, all 
isolates from humans were from biovar 1, 3 or 4, which is in agreement with the known virulence of 
those biovars for man and the belief that biovar 2 is not a zoonotic threat (EFSA, 2009). 
Wild boar is an important threat regarding B. suis biovar 2 infection, representing an important 
hazard particularly for the Iberian pig population reared in outdoor breeding systems (Muñoz et al., 
2010; EFSA, 2009) but this infection in other animal species should not be ignored. In fact, two isolates 
from sheep, one from goat and two from bovine were isolated in Portugal and France. We agree with 
other authors that this situation could become of great concern if brucellosis control programs in 
domestic pigs are envisaged (Muñoz et al., 2010).  
The evolutionary relationships inferred from the MLVA-11 genotypes revealed a B. suis 
population with high genetic divergence among strains based on their host species. The ancestor of 
the domesticated pig is the wild boar (Sus scrofa), which is one of the most numerous and widespread 
large mammals (Chen et al., 2007). Considering the two biovar 2 lineages circulating in Europe, strains 
from swine were closely related to strains isolated in both wild boars and hares, supporting the idea 
that wild animals are a source of brucellosis infection for domestic pigs and also suggesting the 
movement of the pathogen between regions due to natural dispersal or translocation of wild boars, 
fact that was already pointed out by other authors (Kreizinger et al., 2014). Likewise, we can speculate 
that biovar 2 Iberian clonal lineage evolved from the Central-European one and may be the result of 
an allopatric speciation event, since no isolates of this lineage were obtained above the geographical 
barriers formed by Ebro River and Pyrenees. MLVA-11 genotyping also disclosed the 
interconnectedness of B. suis biovar 1, 3 and 4 with the Central-European clonal lineage. 
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Figure 2.2.2. Minimum spanning tree (MST) analysis of B. suis strains using the MLVA-11 typing data. The MST 
was constructed with a categorical coefficient and the analysis was performed using the typing data from 526 
strains, including those from this study and others previously published (Duvnjak et al., 2015; Kreizinger et al., 
2014; Jiang et al., 2013; Garcia-Yoldi et al., 2007; Le Flèche et al., 2006) and available in the Brucella database 
hosted at http://microbesgenotyping.i2bc.paris-saclay.fr. The collection includes 85 strains from biovar 1, 422 
from biovar 2, four from biovar 3, 11 from biovar 4, three from biovar 5 and one rough strain. (A) MST showing 
relationships between B. suis clonal lineages. Colour code is associated with B. suis biovars: biovar 2 strains are 
shown in blue and all the other biovars are in grey. Each clonal lineage is highlighted by surrounding dotted lines. 
Two clonal lineages (Iberian and Central-European) are considered for biovar 2 strains, one for biovar 5 strains 
and another that includes all strains from biovar 1, 3 and 4. The size of the circle indicates the number of strains 
described in each MLVA-11 genotype and the length of the branches represents the distance between genotypes. 
(B) Same MST analysis but emphasizing relationships among host species. Strains were marked according to their 
host species of origin. Only preferential hosts were highlighted: wild boar and swine in biovar 2 Iberian clonal 
lineage; wild boar, swine and hare in biovar 2 Central-European clonal lineage and biovar 1 strains; swine for 
biovar 3 strains, and reindeer and caribou for biovar 4. All strains isolated from secondary host species are in 
grey. 
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4. Conclusion 
 
The results obtained in this work corroborate that the Suis-ladder multiplex PCR allows a fast and 
precise identification of B. suis at the biovar level while the PCR-RFLP analysis of genes omp2a and 
omp2b and gene omp31 shown to be useful for differentiation between biovars and demonstrated 
additional polymorphism within biovar 2. MLVA confirmed both a clear distinction between biovars, 
as well as the close genetic relationship among isolates within the species. While B. suis biovars 1, 3 
and 4 grouped together in the same cluster (or lineage), biovar 2 were placed into two closely related 
MLVA clusters according to their geographic origins and PCR-RFLP haplotypes, defining the Iberian 
(Portugal and Spain) and the Central-European clonal lineages. These results were reinforced when a 
larger number of strains were included in the MLVA analysis.  
 In addition, the genomic relationships based on the MLVA-11 genotypes revealed significant 
associations between B. suis biovars and host species, supporting the hypothesis that host adaptation 
contributes to this structure. Hints were also obtained for the evolution of the Iberian clonal lineage 
from the Central-European one, probably associated to restrictions of wild boars movement across 
regions. Nevertheless, a more accurate understanding of the clonal evolution of this pathogen can only 
be achieved by comparative whole-genome sequence analysis of B. suis biovar 2 strains from both 
clonal lineages. 
 
 
5. Supplementary material 
 
Supplementary Table S2.2.1. Full information on B. suis isolates, including geographic origin and 
molecular typing data obtained with Suis-ladder multiplex PCR and RFLP-PCR. 
Supplementary Table S2.2.2.  MLVA-16 allelic profile for the set of 181 B. suis strains. 
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Supplementary Table S2.2.1. Full information on B. suis isolates, including geographic origin and molecular typing data obtained with Suis-ladder multiplex 
PCR and RFLP-PCR. 
 
             RFLP-PCR analysisc 
Strain 
No. 
Strain Identification bv Hosta Year Country (geographic region) 
Suis-
ladder b 
omp2a 
NcoI 
omp2a 
StyI 
omp2b 
EcoRI 
omp2b 
KpnI 
omp31 
AvaII 
omp31 
HaeIII 
Haplotype 
Clonal  
lineaged 
1 INRA03-26 1 SW 2003 France S1 P2 P2 P1 P1 P1 P1 1a n.a. 
2 AFSSA-03/3081-2 1 G 2003 Croatia S1 P2 P2 P1 P1 P1 P1 1a n.a. 
3 AFSSA-04/115 1 H 2004 France S1 P2 P2 P1 P1 P1 P1 1a n.a. 
4 AFSSA-04/3025-3 1 SW 2004 Croatia S1 P2 P2 P1 P1 P1 P1 1a n.a. 
5 REF 1330 [biovar 1; ATCC 23444] 1 SW n.a United States S1 P2 P2 P1 P1 P1 P1 1a n.a. 
6 AFSSA-04/2987 1 M 2004 France S1 P2 P2 P1 P1 P1 P1 1a n.a. 
7 VLA-92/29 1 M 1992 Mexico S1 P2 P2 P1 P2 P1 P1 1a n.a. 
8 AFSSA-01/5744 1 SW 2001 French Polinesia S1 P2 P2 P1 P1 P1 P1 1a n.a. 
9 AFSSA-03/2067-203 1 SW 2003 France S1 P2 P2 P1 P1 P1 P1 1a n.a. 
10 VLA-64/24 1 SW 1964 United States S1 P2 P2 P1 P1 P1 P1 1a n.a. 
11 VLA-F1/04 1 M 2004 Netherlands S1 P2 P2 P1 P1 P1 P1 1a n.a. 
12 AFSSA-96/1646-01 1 SW 1996 France S1 P2 P2 P1 P1 P1 P1 1a n.a. 
13 REF 686 [biovar 3; ATCC 23446] 3 SW n.a United States S3 P2 P2 P1 NC P1 P1 3a n.a. 
14 VLA-UK6/04 3 M 2004 India S3 P2 P2 P1 NC P1 P1 3a n.a. 
15 VLA-63/252 4 C 1963 Alaska S4 P2 P2 P1 NC P1 P1 4a n.a. 
16 REF 40 [biovar 4; ATCC 23447] 4 R n.a Former USSR S4 P2 P2 P1 NC P1 P1 4a n.a. 
17 VLA-63/202 4 R 1963 Poland S4 P2 P2 P1 NC P1 P1 4a n.a. 
18 VLA-63/219 4 R 1963 Poland S4 P2 P2 P1 NC P1 P1 4a n.a. 
19 VLA-63/198 4 R 1963 Poland S4 P2 P2 P1 NC P1 P1 4a n.a. 
20 AFSSA-92/11580-4528 2 H 1992 France S2 NC NC P3 NC P2 P1 2b CE 
21 AFSSA-96/9635 2 SW 1996 France S2 NC NC P1 P1 P2 P2 2c CE 
22 A183 2 WB n.a Germany S2 NC NC P3 NC P2 P2 2a CE 
23 A196 2 WB n.a Germany S2 NC NC P3 NC P2 P2 2a CE 
24 04RB0377 2 WB n.a Germany S2 NC NC P3 NC P2 P2 2a CE 
25 05RB0007 2 WB n.a Germany S2 NC NC P3 NC P2 P2 2a CE 
26 AFSSA-04/3025-1 2 SW 2004 Croatia S2 NC NC P1 P1 P2 P2 2c CE 
27 05RB1442 2 H n.a Germany S2 NC NC P3 NC P2 P2 2a CE 
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             RFLP-PCR analysisc 
Strain 
No. 
Strain Identification bv Hosta Year Country (geographic region) 
Suis-
ladder b 
omp2a 
NcoI 
omp2a 
StyI 
omp2b 
EcoRI 
omp2b 
KpnI 
omp31 
AvaII 
omp31 
HaeIII 
Haplotype 
Clonal  
lineaged 
28 REF Thomsen [biovar 2; ATCC 23445] 2 SW 1952 Denmark S2 NC NC P3 NC P2 P2 2a CE 
29 AFSSA-92/13000 2 H 1992 France S2 NC NC P3 NC P2 P1 2b CE 
30 VLA-74/11 2 n.a 1974 Denmark S2 NC NC P3 NC P2 P2 2a CE 
31 AFSSA-00/9182 2 H 2000 France S2 NC NC P3 NC P2 P1 2b CE 
32 Bs364CITA 2 WB 2008 Spain (Añón) S2 NC NC P1 P1 P2 P2 2c CE 
33 Bs365CITA 2 WB 2008 Spain (Añón) S2 NC NC P1 P1 P2 P2 2c CE 
34 Bs396CITA 2 WB 2009 Spain (Navarra) S2 NC NC P1 P1 P2 P2 2c CE 
35 AFSSA-04/1918-1 2 WB 2004 Switzerland S2 NC NC P1 P1 P2 P2 2c CE 
36 C13B4 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
37 C2B11 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
38 C9B3 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
39 PY69 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
40 0111602/4+9 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
41 0111602/3+8 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
42 It4 2 WB n.a Italy S2 NC NC P1 P1 P2 P2 2c CE 
43 It5 2 WB n.a Italy S2 NC NC P1 P1 P2 P2 2c CE 
44 S275 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
45 C9B4 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
46 C8B3 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
47 It2 2 WB n.a Italy S2 NC NC P1 P1 P2 P2 2c CE 
48 It3 2 WB n.a Italy S2 NC NC P1 P1 P2 P2 2c CE 
49 AFSSA-04/770 2 WB 2004 Italy S2 NC NC P1 P1 P2 P2 2c CE 
50 It6 2 WB n.a Italy S2 NC NC P1 P1 P2 P2 2c CE 
51 It1 2 WB n.a Italy S2 NC NC P1 P1 P2 P2 2c CE 
52 AFSSA-97/9757 2 SW 1997 France S2 NC NC P1 P1 P2 P2 2c CE 
53 MASA07 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
54 AFSSA-97/4924-10 2 SW 1997 France S2 NC NC P1 P1 P2 P2 2c CE 
55 AFSSA-03/1483-8 2 WB 2003 France S2 NC NC P1 P1 P2 P2 2c CE 
56 C13B1 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
57 C3B3 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
58 C13B6 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
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             RFLP-PCR analysisc 
Strain 
No. 
Strain Identification bv Hosta Year Country (geographic region) 
Suis-
ladder b 
omp2a 
NcoI 
omp2a 
StyI 
omp2b 
EcoRI 
omp2b 
KpnI 
omp31 
AvaII 
omp31 
HaeIII 
Haplotype 
Clonal  
lineaged 
59 C11B4 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
60 C4B6 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
61 S120 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
62 C5B5 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
63 COSA13 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
64 RATES5-11 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
65 C6B1 2 WB n.a Belgium S2 NC NC P1 P1 P2 P2 2c CE 
66 AFSSA-00/4898 2 G 2000 France S2 NC NC P1 P1 P2 P2 2c CE 
67 AFSSA-98/7296-4204 2 H 1998 France S2 NC NC P3 NC P2 P2 2a CE 
68 AFSSA-98/6335 2 SW 1998 France S2 NC NC P3 NC P2 P1 2b CE 
69 LNIV-2948(3)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
70 LNIV-2948(10)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
71 LNIV-2948(12)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
72 LNIV-2948(20)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
73 LNIV-2948(27)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
74 LNIV-2948(29)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
75 LNIV-2948(34)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
76 Bs145 2 SW n.a Spain S2 P2 P2 P1 P1 P2 P2 2e IB 
77 S-145(PN-II) 2 WB 2005 Spain (Asturias) S2 P2 P2 P1 P1 P2 P2 2e IB 
78 Bs144 2 SW n.a Spain S2 P2 P2 P1 P1 P2 P2 2e IB 
79 Bs143CITA 2 WB 2005 Spain (Asturias) S2 P2 P2 P1 P1 P2 P2 2e IB 
80 PT09172 2 WB 2009 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
81 LNIV-44821(121)/09 2 WB 2009 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
82 LNIV-44821(122)/09 2 WB 2009 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
83 LNIV-44821(123)/09 2 WB 2009 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
84 LNIV-46685(20)/08 2 WB 2008 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
85 S22 2 SW 2000 Spain (Salamanca) S2 P2 P2 P3 NC P2 P2 2d IB 
86 Bs147 2 SW n.a Spain S2 P2 P2 P3 NC P2 P2 2d IB 
87 Bs146 2 SW n.a Spain S2 P2 P2 P3 NC P2 P2 2d IB 
88 S4 2 SW 1992 Spain (Salamanca) S2 P2 P2 P3 NC P2 P2 2d IB 
89 S21 2 SW 1999 Spain  (Huelva) S2 P2 P2 P3 NC P2 P2 2d IB 
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             RFLP-PCR analysisc 
Strain 
No. 
Strain Identification bv Hosta Year Country (geographic region) 
Suis-
ladder b 
omp2a 
NcoI 
omp2a 
StyI 
omp2b 
EcoRI 
omp2b 
KpnI 
omp31 
AvaII 
omp31 
HaeIII 
Haplotype 
Clonal  
lineaged 
90 S6 2 SW 1998 Spain  (Badajoz) S2 P2 P2 P3 NC P2 P2 2d IB 
91 S1 2 SW 1992 Spain S2 P2 P2 P3 NC P2 P2 2d IB 
92 S2 2 SW 1992 Spain (Salamanca) S2 P2 P2 P3 NC P2 P2 2d IB 
93 S3 2 SW 1992 Spain (Salamanca) S2 P2 P2 P3 NC P2 P2 2d IB 
94 LNIV-4498(J1)/08 2 WB 2008 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
95 LNIV-4498(J9)/08 2 WB 2008 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
96 LNIV-4498(J4)/08 2 WB 2008 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
97 LNIV-4498(J6)/08 2 WB 2008 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
98 VLA-63/311 2 SW 1963 Unknown S2 P2 P2 P3 NC P2 P2 2d IB 
99 LNIV-9789(J9)/08 2 WB 2008 Portugal (Entre Douro e Minho) S2 P2 P2 P3 NC P2 P2 2d IB 
100 LNIV-19122(J1)/08 2 WB 2008 Portugal (Entre Douro e Minho) S2 P2 P2 P3 NC P2 P2 2d IB 
101 LNIV-17888(J3)/08 2 WB 2008 Portugal (Entre Douro e Minho) S2 P2 P2 P3 NC P2 P2 2d IB 
102 LNIV-21346(J2)/08 2 WB 2008 Portugal (Entre Douro e Minho) S2 P2 P2 P3 NC P2 P2 2d IB 
103 LNIV-2454(J10)/08 2 WB 2008 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
104 LNIV-1344(2)/09 2 WB 2009 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
105 LNIV-2948(1)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
106 LNIV-2948(5)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
107 PT09143 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
108 LNIV-2948(8)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
109 LNIV-2948(9)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
110 LNIV-4189(1)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
111 LNIV-4189(2)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
112 LNIV-8605(2)/10 2 WB 2010 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
113 LNIV-8605(9)/10 2 WB 2010 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
114 S12 2 SW 1992 Spain (Salamanca) S2 P2 P2 P1 P1 P2 P2 2e IB 
115 LNIV-4647(1)/09 2 WB 2009 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
116 LNIV-45014(4)/08 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P1 P1 P2 P2 2e IB 
117 LNIV-4477(4)/09 2 WB 2009 Portugal (Algarve) S2 P2 P2 P1 P1 P2 P2 2e IB 
118 LNIV-J2A/08 2 WB 2009 Portugal (Beira Interior) S2 P2 P2 P1 P1 P2 P2 2e IB 
119 S27 2 SW 2000 Spain (Badajoz) S2 P2 P2 P1 P1 P2 P2 2e IB 
120 S13 2 SW 1992 Spain (Salamanca) S2 P2 P2 P1 P1 P2 P2 2e IB 
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             RFLP-PCR analysisc 
Strain 
No. 
Strain Identification bv Hosta Year Country (geographic region) 
Suis-
ladder b 
omp2a 
NcoI 
omp2a 
StyI 
omp2b 
EcoRI 
omp2b 
KpnI 
omp31 
AvaII 
omp31 
HaeIII 
Haplotype 
Clonal  
lineaged 
121 LNIV-44821(81)/09 2 WB 2009 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
122 LNIV-44821(86)/09 2 WB 2009 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
123 LNIV-44821(79)/09 2 WB 2009 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
124 LNIV-3115(9)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
125 LNIV-3514(2)/10 2 WB 2010 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
126 LNIV-3515(6)/10 2 WB 2010 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
127 LNIV-44401(3)/08 2 WB 2009 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
128 LNIV-Soc57/00 2 SW 2000 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
129 LNIV-Soc64/00 2 SW 2000 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
130 LNIV-Soc73/00 2 SW 2000 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
131 LNIV-Soc41/00 2 SW 2000 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
132 LNIV-1344(3)/09 2 WB 2009 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
133 LNIV-14256(72)/09 2 SW 2009 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
134 LNIV-231(1)/09 2 SW 2009 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
135 LNIV-14256(40)/09 2 SW 2009 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
136 LNIV-1989(112)/10 2 WB 2010 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
137 LNIV-3115(13)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
138 LNIV-4478(4)/09 2 WB 2009 Portugal (Algarve) S2 P2 P2 P3 NC P2 P2 2d IB 
139 LNIV-4187(7)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
140 LNIV-3478(3)/09 2 WB 2009 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
141 LNIV-438/00 2 SW 2000 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
142 LNIV-5346(1)/00 2 SW 2000 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
143 LNIV-5346(16)/00 2 SW 2000 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
144 LNIV-5346(3)/00 2 SW 2000 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
145 LNIV-6552(3)/00 2 SW 2000 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
146 LNIV-6552(8)/00 2 SW 2000 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
147 LNIV-6552(2)/00 2 SW 2000 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
148 LNIV-2739(18)/02 2 SW 2002 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
149 LNIV-2739(9)/02 2 SW 2002 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
150 AFSSA-PT-6552/00 2 SW 2000 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
151 LNIV-4215(20)/01 2 SW 2001 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
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             RFLP-PCR analysisc 
Strain 
No. 
Strain Identification bv Hosta Year Country (geographic region) 
Suis-
ladder b 
omp2a 
NcoI 
omp2a 
StyI 
omp2b 
EcoRI 
omp2b 
KpnI 
omp31 
AvaII 
omp31 
HaeIII 
Haplotype 
Clonal  
lineaged 
152 LNIV-6552(10)/00 2 SW 2000 Portugal (Ribatejo e Oeste) S2 P2 P2 P3 NC P2 P2 2d IB 
153 LNIV-2739(3)/02 2 SW 2002 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
154 LNIV-468/00 2 SW 2000 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
155 LNIV-Soc29/00 2 SW 2000 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
156 LNIV-Soc43/00 2 SW 2000 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
157 LNIV-7676/00 2 B 2000 Portugal (Algarve) S2 P2 P2 P3 NC P2 P2 2d IB 
158 LNIV-1262/00 2 SW 2000 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
159 LNIV-Soc39/00 2 SW 2000 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
160 LNIV-Soc35/00 2 SW 2000 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
161 LNIV-Soc50/00 2 SW 2000 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
162 LNIV-1967/00 2 SW 2000 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
163 LNIV-46685(15)/08 2 WB 2008 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
164 LNIV-9789(J10)/08 2 WB 2008 Portugal (Entre Douro e Minho) S2 P2 P2 P3 NC P2 P2 2d IB 
165 LNIV-9789(Feto)/08 2 WB 2008 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
166 LNIV-44406(3)/08 2 WB 2009 Portugal (Beira Interior) S2 P2 P2 P3 NC P2 P2 2d IB 
167 S32 2 SW 2000 Spain (Toledo) S2 P2 P2 P3 NC P2 P2 2d IB 
168 LNIV-5414(12)/03 2 SW 2003 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
169 LNIV-5414(13)/03 2 SW 2003 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
170 LNIV-5414(2)/03 2 SW 2003 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
171 LNIV-5414(13)/03 2 SW 2003 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
172 S34 2 SW 2000 Spain (Toledo) S2 P2 P2 P3 NC P2 P2 2d IB 
173 LNIV-21566(94)/09 2 WB 2009 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
174 LNIV-S-384(679) 2 SW 2009 Spain (Piensos del segre) S2 P2 P2 P3 NC P2 P2 2d IB 
175 LNIV-22497(475)/08 2 S 2008 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
176 LNIV-22498(697)/08 2 S 2008 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
177 LNIV-4193(1)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
178 LNIV-4193(2)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
179 LNIV-4193(9)/09 2 WB 2009 Portugal (Alentejo) S2 P2 P2 P3 NC P2 P2 2d IB 
180 LNIV-9H 2 SW 2011 Portugal (Trás-os-Montes) S2 P2 P2 P3 NC P2 P2 2d IB 
181 REF 513 [biovar 5; NCTC 11996] 5 WR n.a Former USSR S5 NC NC P1 P1 P1 P1 5a n.a. 
 
Subchapter 2.2. Genetic diversity of Brucella suis biovar 2 strains 
67 
 
 
a Host: B, bovine; C, caribou; G, goat; H, hare; M, man; R, reindeer; S, sheep; S, swine; WB, wild boar; WR, wild rodent; n.a., information not available.  
b Suis-ladder multiplex PCR according to López-Goñi et al., 2011. S1 to S5 refer to electrophoresis profile observed for each B. suis biovar. 
c PCR-RFLP analysis of omp31, omp2a and omp2b genes using the restriction enzymes AvaII, HaeIII, NcoI, StyI, EcoRI and KpnI. P1 to P3 refer to restriction patterns observed 
for each enzyme; NC: not cleaved. 
d Clonal lineage of biovar 2 strains: CE, Central-European; IB: Iberian; n.a.: not applicable. 
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Supplementary Table S2.2.2.  MLVA-16 allelic profile for the set of 181 B. suis strains. 
 
Strain 
no. 
Haplotype 
Clonal  
lineagea 
  
MLVA-16 molecular markersb 
MLVA-8c MLVA-11d MLVA-16e 
B06 B08 B11 B12 B42 B43 B45 B55 B18 B19 B21 B04 B07 B09 B16 B30 
1 1a n.a.   2 3 6 10 4 1 5 2 4 38 9 5 6 5 5 3 6 33 1 
2 1a n.a.   2 3 6 10 4 1 5 2 4 38 9 5 6 5 5 3 6 33 1 
3 1a n.a.   2 3 6 10 4 1 5 2 4 38 9 5 6 5 5 3 6 33 1 
4 1a n.a.   2 3 6 10 4 1 5 2 4 38 9 5 6 5 5 3 6 33 1 
5 1a n.a.   2 3 6 10 4 1 5 2 4 38 9 6 6 5 5 3 6 33 2 
6 1a n.a.   2 3 6 10 4 1 5 2 4 38 9 6 6 5 5 3 6 33 2 
7 1a n.a.   2 3 6 10 4 1 5 2 5 38 9 6 6 6 5 3 6 32 3 
8 1a n.a.   2 3 6 10 4 1 5 2 4 38 9 7 7 5 5 4 6 33 4 
9 1a n.a.   2 3 6 10 4 1 5 2 6 43 9 5 6 5 5 4 6 256 5 
10 1a n.a.   2 3 6 10 4 1 5 2 4 38 9 5 5 7 4 3 6 33 6 
11 1a n.a.   2 3 6 10 4 1 5 2 4 38 9 5 4 10 6 3 6 33 7 
12 1a n.a.   2 4 6 10 4 1 5 2 6 38 9 7 7 6 5 3 153 255 8 
13 3a n.a.   2 3 4 11 3 1 5 2 4 38 9 8 6 10 4 5 4 31 9 
14 3a n.a.   2 3 4 11 3 1 5 2 4 38 9 7 5 12 4 7 4 31 10 
15 4a n.a.   2 3 9 10 3 1 5 2 4 40 9 5 6 11 9 5 5 30 11 
16 4a n.a.   2 3 9 11 3 1 5 2 5 36 9 4 5 9 6 3 3 27 12 
17 4a n.a.   2 3 9 10 3 1 5 2 5 36 9 4 5 9 6 3 5 260 13 
18 4a n.a.   2 3 9 10 3 1 5 2 5 36 9 8 5 10 9 3 5 260 14 
19 4a n.a.   2 3 9 10 3 1 5 2 5 36 9 12 8 16 5 3 5 260 15 
20 2b CE   2 3 8 14 6 1 5 2 4 38 9 11 5 21 2 4 162 254 16 
21 2c CE   2 3 8 14 6 1 5 7 4 38 9 23 7   2 5 163 253 17 
22 2a CE   2 5 8 14 6 1 5 7 4 43 9 6 14 20 2 6 158 237 18 
23 2a CE   2 5 8 14 6 1 5 7 4 43 9 6 14 19 2 6 158 237 19 
24 2a CE   2 5 8 14 6 1 5 7 4 43 9 6 14 18 2 6 158 237 20 
25 2a CE   2 5 8 14 6 1 5 7 4 43 9 8 9 10 2 6 158 237 21 
26 2c CE   2 5 8 14 6 1 5 7 4 43 9 12 5 3 2 8 158 237 22 
27 2a CE   2 5 8 14 6 1 5 7 6 43 9 12 12 16 2 6 158 236 23 
28 2a CE   2 4 8 14 6 1 5 2 6 43 9 9 9 18 2 4 9 50 24 
29 2b CE   2 4 8 14 6 1 5 2 6 43 9 14 12 5 2 5 9 50 25 
30 2a CE   2 4 8 14 6 1 5 2 6 43 9 20 9 10 2 4 9 50 26 
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Strain 
no. 
Haplotype 
Clonal  
lineagea 
  
MLVA-16 molecular markersb 
MLVA-8c MLVA-11d MLVA-16e 
B06 B08 B11 B12 B42 B43 B45 B55 B18 B19 B21 B04 B07 B09 B16 B30 
31 2b CE   2 4 8 14 6 1 5 2 6 43 9 13 5 9 2 4 9 50 27 
32 2c CE   2 5 8 14 6 1 5 6 6 43 9 16 7 18 2 11 157 244 28 
33 2c CE   2 5 8 14 6 1 5 6 6 43 9 14 7 18 2 10 157 244 29 
34 2c CE   2 5 8 14 6 1 5 6 6 43 9 23 9 7 2 10 157 244 30 
35 2c CE   2 4 8 14 6 1 5 6 6 43 9 20 7 12 2 9 7 44 31 
36 2c CE   2 4 8 14 6 1 5 6 6 43 9 22 7 17 2 9 7 44 32 
37 2c CE   2 4 8 14 6 1 5 6 6 43 9 15 9 17 2 9 7 44 33 
38 2c CE   2 4 8 14 6 1 5 6 6 43 9 15 9 18 2 9 7 44 34 
39 2c CE   2 4 8 14 6 1 5 6 6 43 9 15 7 15 2 9 7 44 35 
40 2c CE   2 4 8 14 6 1 5 6 4 43 9 15 7 7 2 9 7 41 36 
41 2c CE   2 4 8 14 6 1 5 6 4 43 9 15 7 7 2 9 7 41 36 
42 2c CE   2 4 8 14 6 1 5 6 6 43 9 7 6 18 2 9 7 44 37 
43 2c CE   2 4 8 14 6 1 5 6 6 43 9 7 6 18 2 9 7 44 37 
44 2c CE   2 4 8 14 6 1 5 6 6 43 9 7 5 15 2 9 7 44 38 
45 2c CE   2 4 8 14 6 1 5 6 6 43 9 9 5 9 2 9 7 44 39 
46 2c CE   2 4 8 14 6 1 5 6 6 43 9 12 9 15 2 8 7 44 40 
47 2c CE   2 4 8 14 6 1 5 6 6 43 9 7 6 16 2 10 7 44 41 
48 2c CE   2 4 8 14 6 1 5 6 6 43 9 7 6 16 2 10 7 44 41 
49 2c CE   2 4 8 14 6 1 5 6 6 43 9 6 6 16 2 10 7 44 42 
50 2c CE   2 4 8 14 6 1 5 6 6 43 9 8 6 19 2 10 7 44 43 
51 2c CE   2 4 8 14 6 1 5 6 6 43 9 8 6 10 2 11 7 44 44 
52 2c CE   2 4 8 14 6 1 5 6 6 43 9 15 6 7 2 5 7 44 45 
53 2c CE   2 4 8 14 6 1 5 6 6 43 9 11 6 17 2 12 7 44 46 
54 2c CE   2 5 8 14 6 1 5 6 6 43 9 13 6   2 8 157 244 47 
55 2c CE   2 4 8 14 6 1 5 6 4 43 9 9 7 9 2 8 7 41 48 
56 2c CE   2 4 8 14 6 1 5 6 5 43 9 13 8 17 2 10 7 246 49 
57 2c CE   2 4 8 14 6 1 5 6 5 43 9 15 8 7 2 10 7 246 50 
58 2c CE   2 4 8 14 6 1 5 6 5 43 9 14 8 16 2 9 7 246 51 
59 2c CE   2 4 8 14 6 1 5 6 5 43 9 14 8 16 2 9 7 246 51 
60 2c CE   2 4 8 14 6 1 5 6 5 43 9 10 5 19 2 9 7 246 52 
61 2c CE   2 4 8 14 6 1 5 6 5 43 9 15 7 10 2 11 7 246 53 
62 2c CE   2 4 8 14 6 1 5 6 5 43 9 9 7 7 2 11 7 246 54 
63 2c CE   2 4 8 14 6 1 5 6 6 43 9 14 8 11 2 10 7 44 55 
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Strain 
no. 
Haplotype 
Clonal  
lineagea 
  
MLVA-16 molecular markersb 
MLVA-8c MLVA-11d MLVA-16e 
B06 B08 B11 B12 B42 B43 B45 B55 B18 B19 B21 B04 B07 B09 B16 B30 
64 2c CE   2 4 8 14 6 1 5 6 6 43 9 9 7 16 2 7 7 44 56 
65 2c CE   2 4 8 14 6 1 5 6 6 43 9 11 10 22 2 7 7 44 57 
66 2c CE   2 4 8 14 6 1 5 7 6 43 9 4 7 3 2 7 8 45 58 
67 2a CE   2 4 9 14 6 1 5 7 6 43 9 14 10 12 2 11 15 239 59 
68 2b CE   2 4 8 14 6 1 5 2 7 43 9 4 7 3 2 4 9 48 60 
69 2e IB   2 5 8 9 5 1 5 4 5 38 9 13 13 11 2 8 18 61 61 
70 2e IB   2 5 8 9 5 1 5 4 5 38 9 13 13 11 2 8 18 61 61 
71 2e IB   2 5 8 9 5 1 5 4 5 38 9 13 13 11 2 8 18 61 61 
72 2e IB   2 5 8 9 5 1 5 4 5 38 9 13 13 11 2 8 18 61 61 
73 2e IB   2 5 8 9 5 1 5 4 5 38 9 13 13 11 2 8 18 61 61 
74 2e IB   2 5 8 9 5 1 5 4 5 38 9 13 13 11 2 8 18 61 61 
75 2e IB   2 5 8 9 5 1 5 4 5 38 9 13 10 11 2 8 18 61 62 
76 2e IB   2 5 8 9 5 1 5 4 5 38 9 12 5 17 2 8 18 61 63 
77 2e IB   2 5 8 9 5 1 5 5 6 38 9 7 11 10 2 8 19 58 64 
78 2e IB   2 5 8 9 5 1 5 4 5 38 9 7 11 10 2 8 18 61 65 
79 2e IB   2 5 8 9 5 1 5 5 5 38 9 7 12 9 2 8 19 60 66 
80 2d IB   2 5 8 9 5 1 5 5 5 38 9 5 7 12 2 8 19 60 67 
81 2d IB   2 5 8 9 5 1 5 5 5 38 9 5 7 12 2 8 19 60 67 
82 2d IB   2 5 8 9 5 1 5 5 5 38 9 5 7 12 2 8 19 60 67 
83 2d IB   2 5 8 9 5 1 5 5 5 38 9 5 7 12 2 8 19 60 67 
84 2d IB   2 5 8 9 5 1 5 5 5 38 9 14 8 14 2 8 19 60 68 
85 2d IB   2 5 8 9 5 1 5 5 5 38 9 9 7 13 2 7 19 60 69 
86 2d IB   2 5 8 9 5 1 5 5 5 38 9 21 7 11 2 7 19 60 70 
87 2d IB   2 5 8 9 5 1 5 5 5 38 9 20 7 10 2 7 19 60 71 
88 2d IB   2 5 8 9 5 1 5 5 5 38 9 15 7 14 2 7 19 60 72 
89 2d IB   2 5 8 9 5 1 5 5 5 38 9 12 9 13 2 7 19 60 73 
90 2d IB   2 5 8 9 5 1 5 5 5 38 9 12 9 7 2 7 19 60 74 
91 2d IB   2 5 8 9 5 1 5 5 5 38 9 15 9 13 2 7 19 60 75 
92 2d IB   2 5 8 9 5 1 5 5 5 38 9 15 9 13 2 7 19 60 75 
93 2d IB   2 5 8 9 5 1 5 5 5 38 9 15 9 14 2 7 19 60 76 
94 2d IB   2 5 8 9 5 1 5 5 5 38 9 20 9 14 2 7 19 60 77 
95 2d IB   2 5 8 9 5 1 5 5 5 38 9 20 9 14 2 7 19 60 77 
96 2d IB   2 5 8 9 5 1 5 5 5 38 9 20 9 14 2 7 19 60 77 
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Strain 
no. 
Haplotype 
Clonal  
lineagea 
  
MLVA-16 molecular markersb 
MLVA-8c MLVA-11d MLVA-16e 
B06 B08 B11 B12 B42 B43 B45 B55 B18 B19 B21 B04 B07 B09 B16 B30 
97 2d IB   2 5 8 9 5 1 5 5 5 38 9 20 9 14 2 7 19 60 77 
98 2d IB   2 5 8 9 5 1 5 5 5 38 9 15 9 17 2 8 19 60 78 
99 2d IB   2 5 8 9 5 1 5 5 5 38 9 13 10 17 2 7 19 60 79 
100 2d IB   2 5 8 9 5 1 5 5 5 38 9 13 10 17 2 7 19 60 79 
101 2d IB   2 5 8 9 5 1 5 5 5 38 9 13 10 17 2 7 19 60 79 
102 2d IB   2 5 8 9 5 1 5 5 5 38 9 13 10 17 2 7 19 60 79 
103 2d IB   2 5 8 9 5 1 5 5 5 38 9 13 10 9 2 6 19 60 80 
104 2d IB   2 5 8 9 5 1 5 5 5 38 9 11 6 9 2 7 19 60 81 
105 2e IB   2 5 8 9 5 1 5 4 5 38 9 11 10 9 2 7 18 61 82 
106 2e IB   2 5 8 9 5 1 5 4 5 38 9 11 10 9 2 7 18 61 82 
107 2e IB   2 5 8 9 5 1 5 4 5 38 9 11 10 9 2 7 18 61 82 
108 2e IB   2 5 8 9 5 1 5 4 5 38 9 11 10 9 2 7 18 61 82 
109 2e IB   2 5 8 9 5 1 5 4 5 38 9 11 10 9 2 7 18 61 82 
110 2e IB   2 5 8 9 5 1 5 5 5 38 9 11 10 7 2 4 19 60 83 
111 2e IB   2 5 8 9 5 1 5 5 5 38 9 11 10 7 2 4 19 60 83 
112 2e IB   2 5 8 9 5 1 5 4 5 38 9 12 9 7 2 7 18 61 84 
113 2e IB   2 5 8 9 5 1 5 4 5 38 9 13 9 7 2 7 18 61 85 
114 2e IB   2 5 8 9 5 1 5 4 6 38 9 7 7 7 2 7 18 59 86 
115 2d IB   2 5 8 9 5 1 5 5 5 38 9 9 15 16 2 10 19 60 87 
116 2e IB   2 5 8 9 5 1 5 4 6 38 9 9 12 11 2 7 18 59 88 
117 2e IB   2 5 8 9 5 1 5 4 6 38 9 9 14 15 2 8 18 59 89 
118 2e IB   2 5 8 9 5 1 5 4 6 38 9 13 15 8 2 4 18 59 90 
119 2e IB   2 5 8 9 5 1 5 4 6 38 9 20 9 13 2 5 18 59 91 
120 2e IB   2 5 8 9 5 1 5 4 6 38 9 20 9 13 2 5 18 59 91 
121 2d IB   2 5 8 9 5 1 5 5 6 38 9 13 6 10 2 5 19 58 92 
122 2d IB   2 5 8 9 5 1 5 5 6 38 9 13 6 10 2 5 19 58 92 
123 2d IB   2 5 8 9 5 1 5 5 6 38 9 13 6 17 2 5 19 58 93 
124 2d IB   2 5 8 9 5 1 5 5 6 38 9 10 6 7 2 5 19 58 94 
125 2d IB   2 5 8 9 5 1 5 5 6 38 9 11 6 19 2 9 19 58 95 
126 2d IB   2 5 8 9 5 1 5 5 6 38 9 12 6 19 2 9 19 58 96 
127 2d IB   2 5 8 9 5 1 5 5 6 38 9 20 6 19 2 6 19 58 97 
128 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 6 18 2 7 19 58 98 
129 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 6 18 2 7 19 58 98 
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Strain 
no. 
Haplotype 
Clonal  
lineagea 
  
MLVA-16 molecular markersb 
MLVA-8c MLVA-11d MLVA-16e 
B06 B08 B11 B12 B42 B43 B45 B55 B18 B19 B21 B04 B07 B09 B16 B30 
130 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 6 18 2 7 19 58 98 
131 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 6 18 2 7 19 58 98 
132 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 6 10 2 6 19 58 99 
133 2d IB   2 5 8 9 5 1 5 5 6 38 9 21 6 15 2 7 19 58 100 
134 2d IB   2 5 8 9 5 1 5 5 6 38 9 21 6 15 2 7 19 58 100 
135 2d IB   2 5 8 9 5 1 5 5 5 38 9 21 6 16 2 7 19 60 101 
136 2d IB   2 5 8 9 5 1 5 5 6 38 9 3 8 12 2 7 19 58 102 
137 2d IB   2 5 8 9 5 1 5 5 6 38 9 10 5 7 2 6 19 58 103 
138 2d IB   2 5 8 9 5 1 5 5 6 38 9 21 5 7 2 6 19 58 104 
139 2d IB   2 5 8 9 5 1 5 5 6 38 9 21 5 8 2 6 19 58 105 
140 2d IB   2 5 8 9 5 1 5 5 6 38 9 13 5 16 2 6 19 58 106 
141 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 107 
142 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 107 
143 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 108 
144 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 108 
145 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 108 
146 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 108 
147 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 108 
148 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 108 
149 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 108 
150 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 108 
151 2d IB   2 5 8 9 5 1 5 5 6 38 9 8 5 15 2 6 19 58 108 
152 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 15 2 6 19 58 108 
153 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 15 2 6 19 58 108 
154 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 19 2 6 19 58 109 
155 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 19 2 6 19 58 109 
156 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 18 2 6 19 58 110 
157 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 14 2 6 19 58 111 
158 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 17 2 7 19 58 112 
159 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 17 2 7 19 58 112 
160 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 17 2 6 19 58 113 
161 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 17 2 6 19 58 113 
162 2d IB   2 5 8 9 5 1 5 5 6 38 9 9 5 15 2 7 19 58 114 
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Strain 
no. 
Haplotype 
Clonal  
lineagea 
  
MLVA-16 molecular markersb 
MLVA-8c MLVA-11d MLVA-16e 
B06 B08 B11 B12 B42 B43 B45 B55 B18 B19 B21 B04 B07 B09 B16 B30 
163 2d IB   2 5 8 9 5 1 5 5 7 38 9 9 5 21 2 6 19 233 115 
164 2d IB   2 5 8 9 5 1 5 5 6 38 9 13 5 7 2 8 19 58 116 
165 2d IB   2 5 8 9 5 1 5 5 6 38 9 12 5 7 2 8 19 58 117 
166 2d IB   2 5 8 9 5 1 5 5 6 38 9 17 5 17 2 8 19 58 118 
167 2d IB   2 5 8 9 5 1 5 5 6 38 9 15 5 20 2 8 19 58 119 
168 2d IB   2 5 8 9 5 1 5 5 6 38 9 15 5 20 2 8 19 58 119 
169 2d IB   2 5 8 9 5 1 5 5 6 38 9 15 5 20 2 8 19 58 119 
170 2d IB   2 5 8 9 5 1 5 5 6 38 9 15 5 20 2 8 19 58 119 
171 2d IB   2 5 8 9 5 1 5 5 6 38 9 15 5 20 2 8 19 58 119 
172 2d IB   2 5 8 9 5 1 5 5 6 38 9 15 5 12 2 8 19 58 120 
173 2d IB   2 5 8 9 5 1 5 5 6 38 9 15 7 15 2 9 19 58 121 
174 2d IB   2 5 8 9 5 1 5 5 6 38 9 15 8 15 2 9 19 58 122 
175 2d IB   2 5 8 9 5 1 5 5 7 38 9 15 6 14 2 8 19 233 123 
176 2d IB   2 5 8 9 5 1 5 5 7 38 9 15 6 14 2 8 19 233 123 
177 2d IB   2 5 8 9 5 1 5 5 7 38 9 15 5 18 2 7 19 233 124 
178 2d IB   2 5 8 9 5 1 5 5 7 38 9 15 5 18 2 7 19 233 124 
179 2d IB   2 5 8 9 5 1 5 5 7 38 9 15 5 18 2 7 19 233 124 
180 2d IB   2 5 8 9 5 1 5 5 7 38 9 12 4 19 2 6 19 233 125 
181 5a n.a.   1 2 9 14 1 2 5 5 7 44 9 9 5 3 9 5 21 2 126 
 
a Clonal lineage of biovar 2 strains: CE, Central-European; IB: Iberian; n.a.: not applicable. 
b MLVA assay using the 16 markers acording to Ferreira et al., 2012; B, bruce. 
c  MLVA-8 genotypes corresponding to each isolate in the Brucella MLVA database (including only minisatellite markers from panels 1).  
d MLVA-11 genotypes to each isolate in the Brucella MLVA database (including mini-/microsatellite markers from panels 1 and 2A). 
e MLVA-16 genotypes (including all markers). 
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1. Introduction 
 
Optical mapping is a recent genomic technology, currently referred to as whole-genome mapping 
(WGM), which produces ordered genome-wide high-resolution restriction maps (optical maps) from 
single stained DNA molecules immobilized and digested on an open glass surface and visualized by 
fluorescence microscopy. By mapping the restriction sites along the DNA, the resulting spectrum 
serves as a unique fingerprint or barcode for that sequence (Anantharaman and Mishra, 2013; Zhou et 
al., 2007) and WGM provides higher resolution for epidemiological purposes compared to the gold 
standard of pulsed-field gel electrophoresis (PFGE) restriction analysis (Miller et al., 2013). With 
hundreds of markers across the genome, optical maps differentiate strains and precisely describe 
genomic rearrangements, such as insertions, deletions, duplications, and inversions. WGM has been 
widely used in microbial genomic studies, with applications in areas of comparative genomics and 
strain typing (Bosch et al., 2013; Schwan et al., 2010; Shukla et al., 2009; Kotewicz et al., 2007) and 
whole genome sequence assembly (Wu et al., 2009; Latreille et al., 2007; Zhou et al., 2004; Aston et 
al., 1999). 
Brucellae are a group of Gram-negative, facultative intracellular pathogens that can infect a broad 
range of mammals, including livestock and humans. The main pathogenic species worldwide are B. 
melitensis, B. abortus and B. suis that may cause abortion and infertility in their hosts, resulting in vast 
economic losses. B. suis biovars 1, 2 and 3 are the etiological agents involved in swine brucellosis. B. 
suis biovar 2 is also found in hares and biovar 3 in rodents. In Europe, B. suis biovar 2 is the most 
commonly isolated biovar in pigs, wild boars and hares (Grégoire et al., 2012; Godfroid et al., 2011). 
The prevalence in wild boars appears to be high throughout continental Europe and these animals 
have been identified as the potential source of transmission of biovar 2 to outdoor or extensively 
reared pigs (Wu et al., 2012; Godfroid et al., 2011; Muñoz et al., 2010; Galindo et al., 2010). In Portugal 
and Spain, B. suis biovar 2 is the unique biovar isolated from domestic pigs and wild boars (Ferreira et 
al., 2012; Muñoz et al., 2010).  
Molecular characterization by Multilocus Variable Number Tandem Repeat Analysis (MLVA) and 
PCR-restriction fragment length polymorphism (PCR-RFLP) analysis of omp2a, omp2b and omp31 
identified the existence of two major clonal lineages, one from Central Europe (PCR-RFLP haplotypes 
2a, 2b and 2c) and other from Iberian Peninsula (PCR-RFLP haplotypes 2d and 2e), grouped in distinct 
MLVA clusters (Kreizinger et al., 2014; Muñoz et al. 2010; García-Yoldi et al., 2007). Although strains 
with Central-European haplotype 2c have also been isolated from wild boars in the North-East region 
of Spain, above Ebro’s river, this haplotype had never been reported in domestic pigs in Iberian 
Peninsula (Muñoz et al. 2010). 
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In this work we compare six B. suis biovar 2 strains by WGM to disclose genomic variations among 
them and to assess the universality of these markers as well as the usefulness of this technology as an 
epidemiological tool in a large set of field strains. 
 
 
2. Material and Methods 
 
2.1. Brucella suis strains 
In this work was used a set of 171 B. suis field strains from different hosts and geographic origins, 
and 22 reference strains representative of the five biovars of B. suis, and B. melitensis (biovars 1, 2 and 
3), B. abortus (biovars 1, 2, 3, 4, 5, 6 and 9), B. ovis, B. canis, B. ceti, B. pinnipedialis and B. microti 
(Supplementary Table S3.1). Field strains outside from Portugal were collected in the framework of 
Brucella suis ring-trial 2006 (COST 845 - Brucellosis in man and animals) and reference strains were 
obtained from the American Type Culture Collection (ATCC, USA) and National Collection of Type 
Cultures (NCTC, UK). All strains were maintained in our laboratory at -80 ºC and previously 
characterized at biovar level, according to standard bacteriological procedures (Alton et al., 1988), as 
well as at haplotype level by PCR-RFLP analysis of omp31, omp2a and omp2b genes (Vizcaíno et al., 
1997; Cloeckaert et al., 1995). 
 
2.2. Optical map construction and sequence-to-map comparison 
Genomic DNA was extracted from methanol-treated cells of five B. suis biovar 2 field strains, 
PT09172 (haplotype 2d), PT09143 and Bs143CITA (haplotype 2e), Bs364CITA and Bs396CITA 
(haplotype 2c), and consensus optical maps were generated at OpGen Technologies, Inc. (Madison, 
USA) from the restriction patterns obtained at single-molecule level with BamH I, using the Argus 
Whole Genome Mapping System. For comparison, a BamH I consensus optical map was also produced 
for the reference strain B. suis biovar 2 strain Thomsen (subsequently referred only as ATCC 23445; 
haplotype 2a).  DNA sequences of chromosome I and II from ATCC 23445 (CP000911, CP000912) and 
B. suis biovar 1 strain 1330 (ATCC 23444; CP002997, CP002998) were downloaded from National 
Center for Biotechnology Information (NCBI) and in silico BamH I restriction maps for each 
chromosome were created using MapSolver version 3.2 (OpGen Technologies, Inc.). The comparisons 
between the six optical maps were accomplished by aligning ATCC 23445 and ATCC 23444 in silico 
restriction maps with the optical maps, using the comparative genomics function of MapSolver. 
Clustering analysis of whole-genome maps (WGMs) was performed with an evaluation license of 
BioNumerics version 7.1 (kindly provided by Applied Maths, Belgium), using the proportion of matched 
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fragments as WGMs similarity measure and unweighted pair group method with arithmetic average 
(UPGMA) as the agglomerative algorithm. 
 
2.3. PCR assessment of chromosomal inversion and indel event 
By exploiting the genome sequence data of ATCC 23445, PCR primers were designed at both ends 
of the inverted region as well as of the 3.5 kb insertion, to assess their presence in all 176 B. suis strains. 
Putative inversion junction regions were identified based on alignment of the restriction pattern and 
six PCR primers, three flanking each of the putative inversion junction region, were designed and two 
multiplex PCRs, one for the left (primers F1, R1 and R2) and other for the right (primers F3, R3 and F4) 
flanking regions, were set up to (see Figure 3.3a and 3.3b). Regarding the 3.5 kb indel, two specific 
primers were designed, IndelF (5´-GTCATCACGCTCCAGGTCTT) and IndelR (5’-
CCTGCACACATCAGAACGTC). Specificity of all inversion and insertion targeting primers was confirmed 
by BLAST analysis against ATCC 23445 and B. suis strain 1330 genome sequences. Multiplex-PCR 
amplifications targeting the inversion and PCR reaction targeting the inversion were performed with 
MyCycler thermocycler (Bio-Rad, France) in a total volume of 25 µl containing 25 ng of DNA, 10x PCR 
reaction buffer, 2.5 mM MgCl2, 1 U of Taq DNA polymerase (Promega, USA), 200 mM of each dNTPs 
and 0.3 mM of each flanking primer. An initial denaturation step at 95 ºC for 5 min was followed by 35 
cycles of denaturation at 95 ºC for 30 s, primer annealing at 58 ºC for 30 s and elongation at 72 ºC for 
1 min. The final extension step was performed at 72 ºC for 5 min. All PCR products were resolved in a 
1.8-2.0% standard agarose gel in 1X Tris-Borate-EDTA buffer, using a 100 bp ladder (Invitrogen, USA) 
as molecular size marker. 
 
 
3. Results and Discussion 
 
3.1. Genomic properties and comparison of the six B. suis biovar 2 optical maps 
Whole-genome mapping (WGM) has a highly discriminant fingerprinting ability (Miller et al., 2013) 
and, by disclosing the large-scale structure of a genome, can identify genomic changes, such as 
insertions, deletions, inversions, and translocations events. This technology was applied to assess 
genomic relatedness in a set of five B. suis biovar 2 field strains and compare their genomes with the 
one of the reference strain for this biovar (ATCC 23445). Optical maps are displayed as a circle showing 
the position of cleavage sites. Restriction fragments were reassembled into overlapping contiguous 
regions to create a closed circular map, and the consensus map was built with a minimal coverage of 
50X (Supplementary Figure S3.1). BamH I restriction profiles of chromosome I and chromosome II of 
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strains ATCC 23445, Bs364CITA, Bs396CITA, PT09172, PT09143 and Bs143CITA, are presented in 
Supplementary Table S2 and quantitative analysis was performed by tabulating changes in restriction 
fragments relative to the reference genome (ATCC 23445). WGM detected 228 to 231 restriction 
fragments distributed in two chromosomes with fragment size per strain ranging from 1.2 to 85 kb. 
Strains PT09172 and Bs143CITA lost one restriction site in chromosome I; in chromosome II, PT09172 
and Bs396CITA lost two restriction sites and Bs364CITA lost one. These differences were consequence 
of BamH I polymorphisms or failure to digest at the respective positions, which created a net loss of 
fragments by its fusion. The remaining fragments were comparable in size and position 
(Supplementary Tables S3.1A and S3.1B). All genomes were very similar in size and the estimated 
chromosome sizes for the six strains ranged from 1,923,017 bp (ATCC 23445) to 1,931,579 bp 
(Bs364CITA) in chromosome I, and from 1,401,295 bp (ATCC 23445) to 1,404,445 bp (Bs364CITA) in 
chromosome II (Table 3.1).  
 
Table 3.1. Estimated size for each chromosome and respective number of restriction fragments in the 
optical maps of B.suis strains. 
a CE, Central-European clonal lineage; IB, Iberian clonal lineage. 
b Haplotype defined based on the restriction patterns in PCR-RFLP analysis of omp2a, omp2b and omp31 genes. 
 
 
The six closely-related B. suis biovar 2 optical maps, and ATCC 23445 and B. suis 1330 in silico 
restriction maps, were used to create a map similarity cluster, based on the analysis of 482 fragments 
classes among strains (Figure 3.1). Cluster analysis gathered all biovar 2 strains in a different cluster 
from the reference strain B. suis 1330 (biovar 1) displaying 76.3 % and 79.7 % similarity in chromosome 
I and II maps, respectively. Considering chromosome I optical maps, strains PT09172, PT09143 and 
Bs143CITA (haplotypes 2d and 2e) grouped together and in a different cluster from strains from 
haplotypes 2a, 2b and 2c (97.6 % similarity). Relatively to chromosome II, biovar 2 optical maps were 
B. suis strain 
Clonal lineagea / 
Haplotypeb 
Chromosome I  Chromosome II  Whole-genome 
Size (bp) 
Number of 
fragments 
 Size (bp) 
Number of 
fragments 
 Size (bp) 
Number of 
fragments 
ATCC 23445 in silico  1,923,763 145  1,400,844 98  3,324,607 243 
ATCC 23445 CE/ 2a 1,923,017 139  1,401,295 92  3,324,312 232 
Bs364CITA CE/ 2c 1,931,579 139  1,404,445 91  3,336,024 230 
Bs396CITA CE/ 2c 1,923,966 139  1,403,111 90  3,327,077 229 
PT09172 IB/ 2d 1,926,303 138  1,402,041 90  3,328,344 228 
PT09143 IB/ 2e 1,929,739 139  1,402,229 92  3,331,968 231 
Bs143CITA IB/ 2e 1,929,039 138  1,403,543 92  3,332,582 230 
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highly closely-related showing low divergence between strains and haplotypes. Nevertheless, strains 
PT09143 and Bs143CITA (haplotype 2e) cluster together and the clustering of PT09172 and Bs396CITA 
demonstrated clear genomic similarities between members of two different haplotypes.  
Pairwise alignments were analyzed for differences and compared to ATCC 23445 restriction 
maps generated in silico from the sequence data using MapSolver, assuming the default settings. The 
comparison of the six chromosome I optical maps revealed the presence of one indel with 
approximately 3.5 kb in all strains, relatively to ATCC 23445, and the identification of one genetic 
inversion event in PT09143, PT09172 and Bs143CITA (Figure 3.2). This large inversion of approximately 
944.2 kb over 1.9 Mbp (49%) on chromosome I, starting at nucleotide #371383, and encompassing 
961 genes in ATCC 23445, showed similar restriction profiles in the three strains from haplotypes 2d 
and 2e. Until now and to the best of our knowledge, only one large chromosomal inversion of 640 kb 
was described in B. abortus within the members of genus Brucella (Halling et al., 2005).  
The presence of the large genetic inversion in B. suis was assessed by multiplex-PCR targeting 
the left- and right-junction sites (Figure 3.3) on a total of 176 B. suis strains, including all haplotypes, 
and on 15 reference strains from B. melitensis, B. abortus, B. ovis, B. canis, B. ceti, B. pinnipedialis and 
B. microti. The inversion was confirmed in all strains from Iberian clonal lineage (haplotypes 2d and 2e) 
but not in Central-European strains (haplotypes 2a, 2b and 2c) or any other B. suis biovars or Brucella 
species (Figure 3.3c; supplementary Table S3.2). Considering these results, it seems evident that the 
inversion occurred in the ancestor of the Iberian clonal lineage of B.suis biovar 2. 
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Figure 3.1. Map similarity cluster of chromosomes I and II of B. suis strains using unweighted pair group method with arithmetic average (UPGMA). The cluster tree is drawn 
with the lengths of branches indicating the relative similarity between two nodes. A similarity ruler is shown at the top of the tree for comparing the differences between 
maps. Whole genome BamH I in silico and optical maps of B. suis strains are represented as linear maps displaying the fragments in randomly chosen colors, with matching 
fragments sharing the same color. The clustering displayed a total of 482 fragments classes among strains. B. suis biovar 1 strain 1330 was used as an outgroup (in silico maps).  
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Figure 3.2.  Pairwise alignment of chromosome I optical maps for B. suis biovar 2 Iberian strains and in silico 
reference map. Lines connecting two chromosomal maps indicate discontinuity in the alignment of fragments. 
The chromosomal inversion relative to strain ATCC 23445 is highlighted in yellow and is indicated by crossed 
alignment lines between paired maps; unaligned restriction fragments, representing differences between two 
chromosomes, are showed in red; blue indicates aligned restriction fragments.  
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Figure 3.3. Assessment of the large genomic inversion by left- and right-junction site-specific PCR. (a) Schematic 
representation of the relative position of primers and expected amplicon sizes for strain ATCC 23445 (without 
inversion) and an inversion positive strain. (b) Primers used in multiplex-PCR targeting the left- and right regions 
of the chromosomal inversion and product size obtained with strains from the Iberian clonal lineage (inversion 
positive) and other strains. (c) Multiplex-PCR analysis of the six strains used for optical maps construction: ATCC 
23445 (haplotype 2a), PT09172 (haplotype 2d), PT09143 and Bs143CITA (haplotype 2e), Bs364CITA and 
Bs396CITA (haplotype 2c). M: 100 bp DNA size marker (Invitrogen). 
 
 
Similarly, the presence/absence of the 3.5 kb indel in chromosome I was searched by PCR and 
it was confirmed that this indel is only present in the reference strain ATCC 23445 (supplementary 
Table S3.2). BLAST searches against Brucella published genomes using the nucleotide sequence of the 
indel region in the genome of B. suis strain 1330 (ATCC 23444) as a query, identified a putative esterase 
(BR0127), a putative transmembrane protein (BR0128), an acetylransferase (BR0129), a S-
(hydroxymethyl)-glutathione dehydrogenase (pseudogene BR0130) and a transcriptional regulator 
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(BR0131). Homologous genes are present in all Brucella species except B. suis strain ATCC 23445, 
confirming the absence of this indel region in the genome sequence of this last strain. 
Regarding chromosome II optical maps, no relevant insert/deletion or other genomic 
rearrangements events were found but few missing cuts occurred leading to the fusion of fragments 
(Supplementary Table S3.1A and S3.1B).  
The comparison of optical maps of new isolates with in silico optical maps of characterized strains 
can identify potential functional, or phenotypic differences between strains, generating empirical 
markers to distinguish between identical isolates, providing a powerful tool for epidemiological studies 
(Kotewicz et al., 2007). In this work it is shown that optical maps are appropriate to distinguish closely-
related B. suis strains based on the large number of restriction sites analyzed, allowing the 
discrimination between different strains of the same biovar and haplotype, making this method a very 
accurate and useful tool to investigate transmission events and outbreaks involving pathogens of this 
species.  
 
3.2. Comparison of BamH I in silico and optical maps of ATCC 23445 
Optical maps of ATCC 23445 chromosome I and II were compared to the restriction maps 
generated in silico from the DNA sequences CP000911 and CP000912. WGM detected 139 out of 145 
and 92 out of 98 of expected fragments (95.1%) in chromosome I and II, respectively. With the 
exception of the six fragments that were not detected in each chromosome (with less than 600 bp in 
size), the optical maps recapitulate the sequence-based map. In comparison to the reference DNA 
sequences of ATCC 23445, the optical map showed an estimated loss of 746 bp (0.04%) and a gain of 
451 bp (0.03%) in chromosome I and II, respectively (Supplementary Table S3.1A and S3.1B). The 
pairwise comparisons of the restriction maps exposed two regions of misalignment: one region in 
chromosome I (8,355 bp) and one in chromosome II (46624 bp) (Figure 3.4). The reference strain ATCC 
23445 used to produce the optical map is the same strain that was used to generate the available 
whole-genome sequence, and from which the in silico maps derived. However, frequent subculturing 
can lead to selection of clone variants that accumulate point mutations occurring over time and this 
may explain some of the observed differences between map profiles. On the other hand, the expected 
resolution of optical mapping is limited to fragments over ca. 600 bp and so the restriction sites 
delimiting fragments below 750 bp (6 in each chromosome) could not be included in the optical map, 
contributing for the differences observed between in silico and optical map of reference strain. 
Additionally, sequencing and assembly errors at DNA sequences cannot be ignored as a potential 
source for further differences. However, previously published works have shown that the resolution 
and detail that optical maps provide underscore their usefulness for molecular epidemiological studies 
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and its utility to complement genome sequencing projects (Sabirova et al. 2014; Schwan et al., 2010; 
Shukla et al., 2009; Wu et al., 2009; Kotewicz et al., 2007; Zhou et al., 2004). 
 
 
 
Figure 3.4. Comparison of the BamH I optical and in silico maps of B. suis ATCC 23445. A reference bp scale is 
present on top of the maps. There are 145 BamH I restriction fragments in chromosome I in silico map and 139 
fragments in the optical map; in chromosome II, the optical map contains 92 BamH I fragments and the in silico 
map contains 98 fragments. The black lines linking maps are the alignment connectors. Similarities between maps 
are displayed in blue and differences (unaligned restriction fragments) in white. The regions of misalignment in 
chromosome I and II are indicated. 
 
 
4. Conclusion 
 
Beyond the higher strain typing resolution observed in this work with WGM, the comparative 
genomic analysis between optical and in silico maps allowed the identification of a large genomic 
inversion event in Brucella suis strains with haplotypes 2d and 2e, so far only isolated in Portugal and 
Spain and belonging to the Iberian clonal lineage. Data obtained with WGM support thus the existence 
of the Central-European clonal lineage (haplotypes 2a, 2b and 2c) and the Iberian clonal lineage 
(haplotypes 2d and 2e) already identified by MLVA and PCR-RFLP of omp genes. Molecular 
identification of both clonal lineages can be easily achieved using the multiplex-PCR procedures 
developed in this work and targeting the left- or the right-junction sites of the chromosomal inversion. 
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5. Supplementary material 
 
Supplementary Figure S3.1. Whole-genome BamH I optical maps of chromosome I and chromosome 
II of the six B. suis biovar 2 strains: ATCC 23445, Bs364CITA, Bs396CITA, PT09172, PT09143 and 
Bs143CITA. 
Supplementary Table S3.1.  (A) Chromosome I restriction fragments for each B. suis biovar 2 BamH I 
in silico and optical maps; (B) Chromosome II restriction fragments for each B. suis biovar 2 BamH I in 
silico and optical maps. 
Supplementary Table S3.2. Brucella strains used to search for the inversion in chromosome I and the 
large indel event in the reference strain B. suis ATCC 23445. 
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Supplementary Figure S3.1. Whole-genome BamH I optical maps of chromosome I and chromosome II of the six B. suis biovar 2 strains: ATCC 23445, Bs364CITA, 
Bs396CITA, PT09172, PT09143 and Bs143CITA.  
 
The clonal lineage (CE, Central-European; IB, Iberian) and the haplotype (2a, 2c, 2d and 2e) are indicated for each strain. Chromosome I and chromosome II 
BamH I optical maps of the six B. suis biovar 2 strains are displayed as a circle showing the position of cleavage sites. Each series of concentric multicolor annuli 
represents optical maps constructed from individual molecules. The consensus map (external circle) was built from the underlying maps within a minimal 
coverage of 50X. Matching restriction fragments are represented by a common color; the color coding is random to enhance contrast. Missing cuts are displayed 
as fragments that span across one or more cut sites in the consensus map. 
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Supplementary Table S3.1.  Chromosome I (A) and chromosome II (B) restriction fragments for each 
B. suis biovar 2 BamH I in silico and optical maps. 
 
(A) Chromosome I restriction fragments 
Fragment 
order number 
 in each profile 
ATCC 23445 
in silico map 
ATCC 23445 
optical map 
Bs364CITA 
optical map 
Bs396CITA 
optical map 
PT09172 
optical map 
PT09143 
optical map 
Bs143CITA 
optical map 
#1 6,188 6,668 6,720 6,716 6,793 6,759 6,775 
#2 36,822 36,745 37,450 37,821 36,906 36,951 36,670 
#3 15,396 15,513 15,690 15,515 15,695 15,589 15,700 
#4 30,947 30,501 30,780 30,920 30,193 30,420 30,101 
#5 26,589 26,156 26,293 25,980 26,261 26,517 26,329 
#6 10,391 10,277 10,263 10,299 11,110 10,534 10,294 
#7 750 1,598 1,651 1,487 7,889 1,575 1,597 
#8 7,327 7,538 7,377 7,475 8,056 7,395 7,239 
#9 4,502 4,617 8,062 8,039 4,015 8,215 8,067 
#10 3,743 3,951 3,828 3,971 19,575 4,115 3,976 
#11 19,805 19,450 19,600 19,467 4,590 19,620 19,608 
#12 4,091 4,352 4,538 4,324 5,185 4,424 4,398 
#13 4,919 5,144 5,092 5,152 23,574 5,031 5,125 
#14 23,698 23,549 23,457 23,488 23,802 23,515 23,502 
#15 23,691 23,800 23,823 23,735 77,717 24,068 23,927 
#16 77,587 77,971 77,603 77,757 30,624 78,114 77,268 
#17 30,804 30,693 30,674 30,760 18,959 30,859 30,621 
#18 19,210 19,103 19,207 18,933 24,141 18,972 19,097 
#19 20,738 20,515 20,345 20,323 4,188 24,158 24,258 
#20 2,498 2,831 2,846 2,761 6,650 4,165 4,036 
#21 4,363 4,534 4,582 4,640 11,089 6,495 6,598 
#22 1,663 2,080 2,096 1,972 5,464 11,044 11,134 
#23 5,351 5,319 5,590 5,511 3,069 5,482 5,496 
#24 6,173 6,353 6,281 6,324 24,127 3,155 3,151 
#25 2,913 3,220 3,316 3,222 7,397 24,252 24,049 
#26 25,989 25,322 25,315 25,365 10,709 7,427 7,499 
#27 4,480 4,976 4,972 4,910 8,461 10,702 10,626 
#28 6,980 7,381 7,419 7,366 2,592 8,609 8,669 
#29 26,768 26,225 26,300 26,151 4,556 2,510 2,666 
#30 36,041 35,439 35,343 35,514 1,818 4,195 4,259 
#31 5,059 5,432 5,487 5,316 3,808 1,704 1,811 
#32 4,248 4,280 4,352 4,295 29,808 3,951 3,875 
#33 4,255 4,525 4,472 4,412 14,782 29,822 29,783 
#34 9,296 9,251 9,368 9,456 16,023 14,758 14,945 
#35 21,048 20,501 20,543 20,358 14,351 16,010 16,012 
#36 8,248 8,355 8,184 8,146 12,092 14,302 14,418 
#37 9,238 9,300 9,253 9,107 2,443 12,038 12,099 
#38 3,020 3,591 3,562 3,536 4,767 2,520 2,519 
#39 15,402 15,466 15,408 15,393 2,158 4,479 4,622 
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Fragment 
order number 
 in each profile 
ATCC 23445 
in silico map 
ATCC 23445 
optical map 
Bs364CITA 
optical map 
Bs396CITA 
optical map 
PT09172 
optical map 
PT09143 
optical map 
Bs143CITA 
optical map 
#40 38,636 37,833 37,813 37,519 7,656 2,115 2,042 
#41 22,014 22,040 22,119 22,128 16,143 7,708 7,855 
#42 7,132 7,371 7,427 7,387 60,736 16,115 16,160 
#43 6,745 6,838 6,892 6,885 5,963 60,371 60,100 
#44 30,304 29,900 29,739 29,681 15,093 6,096 5,975 
#45 29,701 29,228 28,974 28,938 7,684 15,023 15,106 
#46 4,285 4,517 4,644 4,471 18,401 7,651 7,802 
#47 6,373 6,385 6,584 6,420 11,126 18,603 18,501 
#48 7,921 8,232 8,214 8,069 19,933 10,986 11,285 
#49 1,132 2,121 2,190 1,978 2,586 19,711 20,151 
#50 142 33,679 33,593 33,405 14,295 2,599 2,700 
#51 34,701 2,781 2,812 2,617 5,389 14,261 14,131 
#52 2,323 8,373 8,543 8,335 9,711 5,405 5,392 
#53 8,070 30,767 30,801 30,430 6,964 9,666 9,759 
#54 31,021 5,347 5,333 5,187 16,324 6,901 7,028 
#55 4,719 3,145 3,032 3,059 1,638 16,209 16,200 
#56 2,713 2,642 2,791 2,758 28,054 1,663 1,794 
#57 2,348 28,405 28,076 27,839 10,774 27,953 27,943 
#58 29,031 13,282 13,340 13,113 13,310 10,853 10,824 
#59 13,396 10,666 10,881 10,689 28,227 13,272 13,408 
#60 10,634 27,991 27,901 27,738 2,816 28,182 28,149 
#61 28,747 1,626 1,856 1,636 3,259 2,823 2,753 
#62 722 16,250 16,158 16,096 5,183 3,308 3,254 
#63 16,544 6,956 7,152 6,906 30,604 5,026 5,255 
#64 7,026 9,656 9,609 9,806 8,347 30,519 30,449 
#65 9,576 5,444 5,515 5,326 2,726 8,421 8,359 
#66 681 14,131 14,453 14,160 33,660 2,732 2,837 
#67 4,815 2,639 2,591 2,631 1,919 33,671 33,594 
#68 14,440 19,919 19,967 19,840 8,181 2,030 2,059 
#69 2,142 10,936 11,047 10,938 6,423 8,171 8,200 
#70 20,414 18,411 18,439 18,430 4,534 6,458 6,503 
#71 11,188 7,736 7,827 7,774 28,850 4,423 4,711 
#72 19,047 14,969 15,067 14,839 29,416 29,059 29,149 
#73 7,660 5,964 6,024 5,954 6,660 29,816 29,864 
#74 15,379 60,321 60,255 60,343 7,256 6,820 6,865 
#75 5,558 16,064 16,176 15,993 21,765 7,307 7,334 
#76 61,207 7,683 7,688 7,624 37,525 21,990 21,835 
#77 16,195 2,201 2,384 2,248 15,254 37,776 37,636 
#78 7,553 4,464 4,666 4,595 3,566 15,416 15,426 
#79 1,825 2,484 2,474 2,550 9,208 3,480 3,491 
#80 4,335 11,965 12,274 11,937 8,214 9,171 9,350 
#81 2,296 14,288 14,332 14,203 20,300 8,254 8,286 
#82 12,457 16,038 16,067 16,077 9,200 20,505 20,375 
#83 14,578 14,762 15,038 14,819 4,368 9,371 9,509 
#84 16,311 29,460 29,740 29,687 4,389 4,303 4,383 
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Fragment 
order number 
 in each profile 
ATCC 23445 
in silico map 
ATCC 23445 
optical map 
Bs364CITA 
optical map 
Bs396CITA 
optical map 
PT09172 
optical map 
PT09143 
optical map 
Bs143CITA 
optical map 
#85 14,947 3,796 3,955 3,909 5,394 4,376 4,312 
#86 30,492 1,799 1,826 1,669 35,136 5,474 5,536 
#87 3,499 4,426 4,459 4,342 26,202 35,325 35,611 
#88 149 2,572 2,484 2,604 7,198 26,163 26,204 
#89 744 8,620 8,613 8,422 4,854 7,312 7,370 
#90 3,890 10,794 10,701 10,692 25,112 4,862 5,062 
#91 2,544 7,341 7,520 7,490 3,186 25,265 25,193 
#92 8,571 23,834 24,006 24,135 6,324 3,278 3,392 
#93 10,879 3,106 3,234 3,126 5,264 6,219 6,309 
#94 7,581 5,443 5,404 5,335 1,921 5,498 5,345 
#95 24,950 11,007 11,030 10,862 4,404 1,832 2,045 
#96 2,812 6,571 6,444 6,481 2,671 4,255 4,381 
#97 5,138 3,760 3,888 3,864 11,528 2,719 2,681 
#98 11,188 15,252 15,263 15,411 11,213 11,641 11,983 
#99 6,554 11,233 11,304 11,155 25,774 11,281 11,329 
#100 3,725 26,013 26,104 25,975 3,632 26,030 25,912 
#101 15,698 3,695 3,835 3,785 5,865 3,766 3,922 
#102 11,157 5,857 5,887 5,895 48,691 5,947 6,081 
#103 210 48,966 48,418 48,758 19,821 48,726 48,923 
#104 26,167 19,869 19,972 19,839 41,310 19,927 19,883 
#105 3,286 41,347 41,371 41,793 7,003 41,559 41,706 
#106 5,466 7,010 7,159 6,934 4,520 7,075 7,103 
#107 49,516 4,521 4,455 4,409 6,874 4,500 4,443 
#108 19,884 6,890 6,802 6,841 12,025 6,866 6,918 
#109 42,337 12,053 12,062 12,062 6,508 12,097 12,019 
#110 6,769 6,491 6,520 6,428 30,343 6,484 6,590 
#111 4,163 30,304 30,373 30,285 10,243 30,346 30,355 
#112 6,640 10,240 10,316 10,276 14,083 10,386 10,216 
#113 12,110 13,971 13,884 13,944 6,561 13,988 13,953 
#114 6,200 6,638 6,588 6,625 9,477 6,583 6,693 
#115 31,207 9,498 9,640 9,610 6,865 9,429 9,299 
#116 10,176 6,951 7,277 6,935 2,869 7,188 8,535 
#117 14,109 2,693 2,734 2,790 2,868 2,605 2,971 
#118 6,538 3,041 2,981 3,043 4,708 3,040 5,797 
#119 9,761 4,662 4,653 4,630 8,497 4,567 8,432 
#120 7,051 8,488 8,587 8,507 9,908 8,474 9,952 
#121 2,631 9,950 10,050 9,931 10,348 10,000 10,308 
#122 2,898 10,200 10,239 10,307 15,501 10,266 15,410 
#123 4,420 15,479 15,584 15,489 9,535 15,635 9,513 
#124 8,462 9,580 9,521 9,398 27,214 9,513 26,970 
#125 10,205 27,004 27,000 27,080 14,688 27,017 14,560 
#126 10,378 14,665 14,593 14,529 27,274 14,691 27,184 
#127 15,380 27,130 27,164 27,290 1,903 27,435 1,969 
#128 9,474 1,986 1,967 1,875 16,206 1,937 15,864 
#129 27,636 15,976 15,990 15,858 2,037 16,077 2,046 
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Fragment 
order number 
 in each profile 
ATCC 23445 
in silico map 
ATCC 23445 
optical map 
Bs364CITA 
optical map 
Bs396CITA 
optical map 
PT09172 
optical map 
PT09143 
optical map 
Bs143CITA 
optical map 
#130 14,528 2,196 2,285 2,134 3,005 2,150 3,162 
#131 27,787 3,050 3,249 3,104 85,094 3,084 84,104 
#132 1,063 83,850 83,493 83,963 7,013 84,538 6,955 
#133 15,938 6,929 7,045 6,898 6,506 6,940 6,507 
#134 1,423 6,429 6,498 6,498 18,684 6,490 18,319 
#135 2,124 18,290 18,459 18,509 4,344 18,678 4,371 
#136 84,786 4,368 4,382 4,282 6,879 4,381 6,827 
#137 6,627 6,793 6,844 6,882 7,790 6,895 7,926 
#138 6,257 7,889 7,836 7,967 44,363 7,962 43,987 
#139 18,560 44,069 43,991 44,136  44,323  
#140 3,946       
#141 162       
#142 6,204       
#143 455       
#144 7,144       
#145 44,899       
Sum of 
fragments size 
1,923,763 1,923,017 1,931,579 1,923,966 1,926,303 1,929,739 1,929,039 
Min fragment 
size 
142 1,598 1,651 1,487 1,638 1,575 1,597 
Max fragment 
size 
84,786 83,850 83,493 83,963 85,094 84,538 84,104 
Average 
fragment size 
13,267 13,835 13,896 13,841 13,959 13,883 13,979 
Number of 
fragments 
145 139 139 139 138 139 138 
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(B) Chromosome II restriction fragments 
Fragment order 
number 
 in each profile 
ATCC 23445 
in silico map 
ATCC 23445 
optical map 
Bs364CITA 
optical map 
Bs396CITA 
optical map 
PT09172 
optical map 
PT09143 
optical map 
Bs143CITA 
optical map 
#1 4,074 4,333 4,458 4,383 4,395 4,428 4,433 
#2 17,599 17,408 17,303 17,506 17,583 17,612 17,406 
#3 3,740 4,290 4,394 4,204 4,275 4,338 4,335 
#4 12,842 12,901 12,880 12,917 12,805 12,955 12,876 
#5 17,223 16,806 16,770 16,880 16,740 16,808 16,847 
#6 14,745 14,517 14,548 14,558 14,540 14,631 14,572 
#7 13,619 13,471 13,546 13,461 13,450 13,597 13,569 
#8 18,482 18,553 18,486 18,485 18,343 18,465 18,528 
#9 21,350 21,379 21,384 21,372 21,513 21,601 21,564 
#10 26,465 26,166 26,249 26,338 26,199 26,535 26,387 
#11 33,190 32,658 32,526 32,718 32,791 32,747 32,657 
#12 2,842 3,229 3,374 3,297 3,239 3,282 3,361 
#13 8,445 8,332 8,475 8,352 8,415 9,322 9,420 
#14 15,839 15,735 15,943 15,941 15,781 15,908 15,823 
#15 300 2,173 2,276 2,121 2,166 2,189 2,232 
#16 1,162 20,092 20,285 20,285 20,340 20,317 20,231 
#17 20,333 21,558 21,847 21,851 21,672 21,854 21,962 
#18 21,788 41,728 41,606 41,830 41,696 41,920 41,873 
#19 42,392 1,615 1,770 1,356 1,477 1,685 1,581 
#20 618 7,503 7,528 7,499 7,451 7,551 7,710 
#21 7,095 30,038 30,280 30,325 30,518 30,347 30,512 
#22 31,236 3,662 3,734 3,687 3,639 3,618 3,664 
#23 3,324 3,734 3,979 3,852 3,762 3,776 3,725 
#24 3,324 9,681 9,860 9,844 9,764 9,642 9,713 
#25 9,688 8,150 8,191 8,151 8,136 8,182 8,217 
#26 8,302 17,236 17,339 17,396 17,297 17,319 17,309 
#27 17,542 10,369 10,527 10,535 10,307 10,312 10,462 
#28 10,137 2,835 2,922 2,868 2,795 2,828 2,925 
#29 2,477 27,341 27,457 27,730 27,800 27,622 27,701 
#30 27,920 43,860 44,227 44,826 44,027 44,062 44,473 
#31 44,635 23,585 23,712 23,762 23,618 23,562 23,666 
#32 23,877 11,107 11,790 11,787 11,791 11,592 11,785 
#33 11,079 11,604 11,672 11,769 11,595 11,416 11,582 
#34 11,483 9,328 9,436 9,579 9,267 9,302 9,356 
#35 9,071 2,080 2,152 2,230 2,105 2,142 2,212 
#36 1,374 42,595 42,252 43,206 42,990 42,149 42,244 
#37 43,502 18,996 1,487 19,154 18,954 1,336 1,584 
#38 474 13,162 18,721 13,307 13,201 18,607 18,473 
#39 18,742 1,967 13,164 1,995 1,878 13,110 13,288 
#40 13,155 24,835 2,050 25,164 25,084 1,939 2,107 
#41 1,218 4,936 25,101 4,974 4,904 24,906 24,943 
#42 25,767 48,417 5,030 49,001 47,886 4,834 5,049 
#43 4,364 17,474 48,295 17,745 17,557 47,190 47,739 
#44 48,947 10,345 17,721 10,347 10,415 17,446 17,792 
#45 17,741 4,107 10,384 3,892 3,913 10,284 10,376 
Chapter 3.  Whole-genome mapping of B. suis biovar 2 strains 
96 
Fragment order 
number 
 in each profile 
ATCC 23445 
in silico map 
ATCC 23445 
optical map 
Bs364CITA 
optical map 
Bs396CITA 
optical map 
PT09172 
optical map 
PT09143 
optical map 
Bs143CITA 
optical map 
#46 10,449 1,881 3,954 10,093 10,083 3,886 4,035 
#47 3,913 8,797 10,111 6,567 6,501 10,001 9,887 
#48 1,340 6,027 6,709 28,457 28,556 6,524 6,601 
#49 8,735 1,258 28,183 2,209 2,094 27,997 28,178 
#50 5,689 27,891 2,156 3,796 3,753 2,075 2,175 
#51 769 2,129 3,791 34,766 34,935 3,678 3,749 
#52 28,719 3,480 34,938 7,138 7,319 34,795 34,736 
#53 1,011 35,174 7,424 21,473 21,985 7,145 7,294 
#54 2,979 7,254 21,717 8,257 8,382 21,673 21,562 
#55 36,024 21,664 8,436 21,578 21,869 8,390 8,416 
#56 7,124 8,351 21,721 6,445 6,561 21,689 21,799 
#57 21,854 21,879 6,547 17,292 17,517 6,504 6,519 
#58 7,973 6,543 17,292 11,404 11,594 17,216 17,226 
#59 147 17,434 11,620 46,338 46,672 11,522 11,562 
#60 22,110 11,556 46,367 22,856 22,985 46,396 46,283 
#61 6,340 46,624 23,121 7,589 7,770 22,921 22,944 
#62 17,458 22,953 7,776 28,793 28,904 7,787 7,739 
#63 11,200 7,765 28,649 1,695 1,691 28,730 28,630 
#64 47,127 28,957 1,807 3,470 3,574 1,726 1,603 
#65 23,200 1,638 3,629 4,242 4,401 3,655 3,620 
#66 7,312 3,502 4,355 7,184 7,308 4,228 4,200 
#67 29,357 4,275 7,383 21,901 22,087 7,335 7,247 
#68 710 7,205 21,853 15,108 15,344 21,988 22,016 
#69 3,287 22,040 15,231 2,060 1,955 15,148 15,189 
#70 4,260 15,153 2,082 16,491 16,768 2,024 1,860 
#71 7,326 2,053 16,649 15,777 15,995 16,699 16,592 
#72 22,555 16,701 15,765 4,075 4,164 15,857 15,830 
#73 15,334 15,951 4,279 27,577 27,714 4,188 4,234 
#74 1,282 4,149 27,370 39,265 39,767 27,895 27,406 
#75 16,792 27,656 39,455 11,595 11,744 39,603 39,497 
#76 15,963 39,621 11,818 12,390 12,466 11,812 11,770 
#77 3,751 11,771 12,321 6,404 6,427 12,451 12,459 
#78 28,082 12,444 6,497 18,037 17,965 6,362 6,410 
#79 39,969 6,420 17,950 68,620 69,077 18,277 18,223 
#80 11,450 18,195 68,107 9,256 9,404 69,288 68,571 
#81 12,435 68,527 9,439 6,983 5,266 9,440 9,423 
#82 6,117 9,449 7,133 10,492 10,342 4,699 4,729 
#83 18,124 7,203 10,372 2,928 2,850 1,423 1,633 
#84 69,282 10,364 2,851 8,978 9,120 9,993 9,838 
#85 9,181 2,891 9,138 1,817 1,754 2,869 2,852 
#86 13 9,026 1,822 8,157 8,202 9,058 9,086 
#87 6,697 1,956 8,260 33,064 33,274 1,734 1,727 
#88 827 8,265 33,107 5,854 5,811 8,279 8,163 
#89 9,999 33,079 5,976 11,489 11,464 33,645 33,311 
#90 2,663 5,925 11,625 30,671 30,553 5,939 6,004 
#91 8,540 11,544 30,528   11,656 11,670 
#92 612 30,784    30,761 30,781 
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Fragment order 
number 
 in each profile 
ATCC 23445 
in silico map 
ATCC 23445 
optical map 
Bs364CITA 
optical map 
Bs396CITA 
optical map 
PT09172 
optical map 
PT09143 
optical map 
Bs143CITA 
optical map 
#93 692       
#94 7,988       
#95 34,269       
#96 5,627       
#97 11,456       
#98 31,209       
Sum of 
fragments size 
1,400,844 1,401,295 1,404,445 1,403,111 1,402,041 1,402,229 1,403,543 
Min fragment 
size 
13 1,258 1,487 1,356 1,477 1,336 1,581 
Max fragment 
size 
69,282 68,527 68,107 68,620 69,077 69,288 68,571 
Average 
fragment size 
14,294 15,231 15,433 15,590 15,578 15,242 15,256 
Number of 
fragments 
98 92 91 90 90 92 92 
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Supplementary Table S3.2. Brucella strains used to search for the inversion in chromosome I and the large indel event in the reference strain B. suis ATCC 
23445. 
Strain Identification Biovar Host species 
Country of 
origin 
  
Haplotypea 
Clonal  
lineageb 
PCR-multiplexc PCRd 
Left region (bp) Right region (bp) Amplicon (bp) 
INRA03-26 1 Swine France 1a n.a. 995 890 714 
AFSSA-03/3081-2 1 Cattle Croatia 1a n.a. 995 890 714 
AFSSA-04/115 1 Hare France 1a n.a. 995 890 714 
AFSSA-04/3025-3 1 Swine Croatia 1a n.a. 995 890 714 
REF 1330 [biovar 1; ATCC 23444] 1 Swine USA 1a n.a. 995 890 714 
AFSSA-04/2987 1 Hare France 1a n.a. 995 890 714 
AFSSA-01/5744 1 Swine Polynesia 1a n.a. 995 890 714 
AFSSA-03/2067-203 1 Swine France 1a n.a. 995 890 714 
VLA-92/29 1 Hare Mexico 1a n.a. 995 890 714 
VLA-64/24 1 Swine USA 1a n.a. 995 890 714 
VLA-F1/04 1 Hare Netherlands 1a n.a. 995 890 714 
AFSSA-96/1646-01 1 Swine France 1a n.a. 995 890 714 
REF 686 [biovar 3; ATCC 23446] 3 Swine USA 3a n.a. 995 890 714 
VLA-63/252 4 Caribou Alaska 4a n.a. 995 890 714 
REF 40 [biovar 4; ATCC 23447] 4 Reindeer Former USSR 4a n.a. 995 890 714 
VLA-63/202 4 Reindeer Poland 4a n.a. 995 890 714 
VLA-63/219 4 Reindeer Poland 4a n.a. 995 890 714 
VLA-63/198 4 Reindeer Poland 4a n.a. 995 890 714 
REF 513 [biovar 5; NCTC 11996] 5 Wild rodent Former USSR 5a n.a. 995 890 714 
AFSSA-92/11580-4528 2 Hare France 2b CE 995 890 714 
AFSSA-96/9635 2 Swine France 2c CE 995 890 714 
A183 2 Wild boar Germany 2a CE 995 890 714 
A196 2 Wild boar Germany 2a CE 995 890 714 
04RB0377 2 Wild boar Germany 2a CE 995 890 714 
05RB0007 2 Wild boar Germany 2a CE 995 890 714 
AFSSA-04/3025-1 2 Swine Croatia 2c CE 995 890 714 
05RB1442 2 Hare Germany 2a CE 995 890 714 
REF Thomsen [biovar 1; ATCC 23445] 2 Swine Denmark 2a CE 995 890 NEG 
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Strain Identification Biovar Host species 
Country of 
origin 
  
Haplotypea 
Clonal  
lineageb 
PCR-multiplexc PCRd 
Left region (bp) Right region (bp) Amplicon (bp) 
AFSSA-00/9182 2 Hare France 2b CE 995 890 714 
AFSSA-92/13000 2 Hare France 2b CE 995 890 714 
Bs364CITAe 2 Wild boar Spain 2c CE 995 890 714 
Bs365CITA 2 Wild boar Spain 2c CE 995 890 714 
Bs396CITAe 2 Wild boar Spain 2c CE 995 890 714 
C9B4 2 Wild boar Belgium 2c CE 995 890 714 
S275 2 Wild boar Belgium 2c CE 995 890 714 
C4B6 2 Wild boar Belgium 2c CE 995 890 714 
AFSSA-04/1918-1 2 Wild boar Switzerland 2c CE 995 890 714 
C13B4 2 Wild boar Belgium 2c CE 995 890 714 
C2B11 2 Wild boar Belgium 2c CE 995 890 714 
C9B3 2 Wild boar Belgium 2c CE 995 890 714 
PY69 2 Wild boar Belgium 2c CE 995 890 714 
0111602/4+9 2 Wild boar Belgium 2c CE 995 890 714 
0111602/3+8 2 Wild boar Belgium 2c CE 995 890 714 
C8B3 2 Wild boar Belgium 2c CE 995 890 714 
S120 2 Wild boar Belgium 2c CE 995 890 714 
C5B5 2 Wild boar Belgium 2c CE 995 890 714 
AFSSA-03/1483-8 2 Wild boar France 2c CE 995 890 714 
C13B1 2 Wild boar Belgium 2c CE 995 890 714 
C3B3 2 Wild boar Belgium 2c CE 995 890 714 
C13B6 2 Wild boar Belgium 2c CE 995 890 714 
C11B4 2 Wild boar Belgium 2c CE 995 890 714 
COSA13 2 Wild boar Belgium 2c CE 995 890 714 
AFSSA-00/4898 2 Cattle France 2c CE 995 890 714 
RATES5-11 2 Wild boar Belgium 2c CE 995 890 714 
C6B1 2 Wild boar Belgium 2c CE 995 890 714 
It4 2 Wild boar Italy 2c CE 995 890 714 
It5 2 Wild boar Italy 2c CE 995 890 714 
It2 2 Wild boar Italy 2c CE 995 890 714 
It3 2 Wild boar Italy 2c CE 995 890 714 
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Strain Identification Biovar Host species 
Country of 
origin 
  
Haplotypea 
Clonal  
lineageb 
PCR-multiplexc PCRd 
Left region (bp) Right region (bp) Amplicon (bp) 
AFSSA-04/770 2 Wild boar Italy 2c CE 995 890 714 
It6 2 Wild boar Italy 2c CE 995 890 714 
It1 2 Wild boar Italy 2c CE 995 890 714 
AFSSA-97/9757 2 Swine France 2c CE 995 890 714 
MASA07 2 Wild boar Belgium 2c CE 995 890 714 
AFSSA-97/4924-10 2 Swine France 2c CE 995 890 714 
AFSSA-98/7296-4204 2 Hare France 2a CE 995 890 714 
AFSSA-98/6335 2 Swine France 2b CE 995 890 714 
LNIV-4193(1)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-4193(2)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-4193(9)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-22497(475)/08 2 Sheep Portugal 2d IB 850 950 714 
LNIV-22498(697)/08 2 Sheep Portugal 2d IB 850 950 714 
LNIV-9H 2 Swine Portugal 2d IB 850 950 714 
LNIV-44821(81)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-44821(86)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-44821(79)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-3115(9)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-3514(2)/10 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-3515(6)/10 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-44401(3)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-Soc57/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-Soc64/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-Soc73/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-Soc41/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-1344(3)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-14256(72)/09 2 Swine Portugal 2d IB 850 950 714 
LNIV-231(1)/09 2 Swine Portugal 2d IB 850 950 714 
LNIV-14256(40)/09 2 Swine Portugal 2d IB 850 950 714 
LNIV-1989(112)/10 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-3115(13)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-4478(4)/09 2 Wild boar Portugal 2d IB 850 950 714 
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Strain Identification Biovar Host species 
Country of 
origin 
  
Haplotypea 
Clonal  
lineageb 
PCR-multiplexc PCRd 
Left region (bp) Right region (bp) Amplicon (bp) 
LNIV-4187(7)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-3478(3)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-468/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-Soc29/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-6552(10)/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-2739(3)/02 2 Swine Portugal 2d IB 850 950 714 
LNIV-7676/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-Soc43/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-Soc35/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-Soc50/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-1262/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-Soc39/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-1967/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-438/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-5346(1)/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-5346(16)/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-5346(3)/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-6552(3)/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-6552(8)/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-6552(2)/00 2 Swine Portugal 2d IB 850 950 714 
LNIV-2739(18)/02 2 Swine Portugal 2d IB 850 950 714 
LNIV-2739(9)/02 2 Swine Portugal 2d IB 850 950 714 
LNIV-4215(20)/01 2 Swine Portugal 2d IB 850 950 714 
LNIV-46685(15)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-9789(J10)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-9789/08 2 Wild boar Portugal 2d IB 850 950 714 
S-32 2 Swine Spain 2d IB 850 950 714 
LNIV-5414(12)/03 2 Swine Portugal 2d IB 850 950 714 
LNIV-5414(13)/03 2 Swine Portugal 2d IB 850 950 714 
LNIV-5414(2)/03 2 Swine Portugal 2d IB 850 950 714 
LNIV-5414(13)/03 2 Swine Portugal 2d IB 850 950 714 
S-34 2 Swine Spain 2d IB 850 950 714 
Chapter 3.  Whole-genome mapping of B. suis biovar 2 strains 
 
103 
Strain Identification Biovar Host species 
Country of 
origin 
  
Haplotypea 
Clonal  
lineageb 
PCR-multiplexc PCRd 
Left region (bp) Right region (bp) Amplicon (bp) 
LNIV-44406(3)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-21566(94)/09 2 Wild boar Portugal 2d IB 850 950 714 
Bs384CITA 2 Swine Spain 2d IB 850 950 714 
S-12 2 Swine Spain 2e IB 850 950 714 
LNIV-45014(4)/08 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-4477(4)/09 2 Wild boar Portugal 2e IB 850 950 714 
S-13 2 Swine Spain 2e IB 850 950 714 
LNIV-J2A/08 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-9789(J9)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-19122(J1)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-17888(J3)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-21346(J2)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-2454(J10)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-2948(1)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-2948(5)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-2948(6)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-2948(8)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-2948(9)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-1344(2)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-4189(1)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-4189(2)/09 2 Wild boar Portugal 2e IB 850 950 714 
S-22 2 Swine Spain 2d IB 850 950 714 
Bs147 2 Swine Spain 2d IB 850 950 714 
Bs146 2 Swine Spain 2d IB 850 950 714 
LNIV-4498(J1)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-4498(J9)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-4498(J4)/08 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-4498(J6)/08 2 Wild boar Portugal 2d IB 850 950 714 
S-3 2 Swine Spain 2d IB 850 950 714 
S-4 2 Swine Spain 2d IB 850 950 714 
S-1 2 Swine Spain 2d IB 850 950 714 
S-2 2 Swine Spain 2d IB 850 950 714 
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Strain Identification Biovar Host species 
Country of 
origin 
  
Haplotypea 
Clonal  
lineageb 
PCR-multiplexc PCRd 
Left region (bp) Right region (bp) Amplicon (bp) 
S-21 2 Swine Spain 2d IB 850 950 714 
S-6 2 Swine Spain 2d IB 850 950 714 
LNIV-8605(2)/10 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-8605(9)/10 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-4647(1)/09 2 Wild boar Portugal 2d IB 850 950 714 
PT09172e 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-44821(121)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-44821(122)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-44821(123)/09 2 Wild boar Portugal 2d IB 850 950 714 
LNIV-46685(20)/08 2 Wild boar Portugal 2d IB 850 950 714 
Bs144 2 Swine Spain 2e IB 850 950 714 
Bs145CITA 2 Wild boar Spain 2e IB 850 950 714 
Bs143CITAe 2 Wild boar Spain 2e IB 850 950 714 
LNIV-2948(3)/09 2 Wild boar Portugal 2e IB 850 950 714 
PT09143e 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-2948(12)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-2948(20)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-2948(27)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-2948(29)/09 2 Wild boar Portugal 2e IB 850 950 714 
LNIV-2948(34)/09 2 Wild boar Portugal 2e IB 850 950 714 
Bs145 2 Swine Spain 2e IB 850 950 714 
         
REF 16M [B.melitensis biovar 1; ATCC 23456] 1 Goat USA n.a. n.a. 995 890 714 
REF 63/9 [B.melitensis biovar 2; ATCC 23457] 2 Goat Turkey n.a. n.a. 995 890 714 
REF Ether [B.melitensis biovar 3; ATCC 23458] 3 Goat Italia n.a. n.a. 995 890 714 
REF 544 [B.abortus biovar 1; ATCC 23448] 1 Cattle England n.a. n.a. 995 890 714 
2308 [B.abortus biovar 1] 1 Cattle England n.a. n.a. 995 890 714 
S19 [B.abortus biovar 1; vaccine strain] 1 Cattle England n.a. n.a. 995 890 714 
REF 86/8/59 [B.abortus biovar 2; ATCC 23449] 2 Cattle England n.a. n.a. 995 890 714 
REF Tulya [B.abortus biovar 3; ATCC 23450] 3 Human Uganda n.a. n.a. 995 890 714 
REF 292 [B.abortus biovar 4; ATCC 23451] 4 Cattle USA n.a. n.a. 995 890 714 
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Strain Identification Biovar Host species 
Country of 
origin 
  
Haplotypea 
Clonal  
lineageb 
PCR-multiplexc PCRd 
Left region (bp) Right region (bp) Amplicon (bp) 
REF B3196 [B.abortus biovar 5; ATCC 23452] 5 Cattle USA n.a. n.a. 995 890 714 
REF 870 [B.abortus biovar 6; ATCC 23453] 6 Cattle USA n.a. n.a. 995 890 714 
REF C68 [B.abortus biovar 9; ATCC 23455] 9 Cattle USA n.a. n.a. 995 890 714 
REF 63/290 [B.ovis; ATCC 25840] na Sheep Australia n.a. n.a. 995 890 714 
REF B. canis [ATCC 23365] na Dog USA n.a. n.a. 995 890 714 
REF B2/94 [B.pinnipedialis; NCTC 12890] na Seal Scotland n.a. n.a. 995 890 714 
REF B1/94 [B.ceti; NCTC 12891] na Dolphin Scotland n.a. n.a. 995 890 714 
B. microti strain CCM 4915 na Wild rodent Rep.Czech n.a. n.a. 995 890 714 
 
a PCR-RFLP analysis of  omp31, omp2a and omp2b genes using the restriction enzymes AvaII, HaeIII, NcoI, StyI, EcoRI and KpnI. P1 to P3 refer to restriction 
patterns observed for each enzyme; NC: not cleaved. 
b Clonal lineage of biovar 2 strains: CE, Central-European; IB: Iberian; n.a.: not applicable. 
c PCR-multiplex at the left and right flanking region to confirm the presence of the genetic inversion in Iberian strains. 
d PCR to confirm the presence of the indel in B. suis strains; NEG, negative in PCR. 
e Strains used for the production of optical maps. 
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1. Introduction 
  
 Brucella suis biovar 2 infection in wild boar (Sus scrofa) is widespread in the Iberian Peninsula, and 
it was previously described that the majority of B. suis biovar 2 strains circulating in Portugal and Spain 
share specific molecular characteristics establishing an Iberian clonal lineage (Ferreira et al. 2016). Yet, 
above Ebro’s river, in the North-East region of Spain, it has been isolated strains from wild boars similar 
to those isolated in different Central-European countries, in both pigs and wild boars (Muñoz et al., 
2010).  
 Knowing the genome as exactly as possible is of fundamental value to microbial biology. In the past 
thirty years, DNA sequencing technologies and applications have undergone tremendous 
development, driven the development of second-generation sequencing methods, or next generation 
sequencing (NGS), that became an alternative to traditional Sanger DNA sequencing (Grada and 
Weinbrecht, 2013). The Illumina next-generation sequencing technology (www.illumina.com) is a 
breakthrough platform based on massively parallel sequencing of millions of fragments that uses its 
proprietary reversible terminator-based sequencing chemistry. This approach ensures high accuracy 
and true base-by-base sequencing, eliminating sequence-context specific errors and enabling 
sequencing through homopolymers and repetitive sequences. Sequence reads are aligned against a 
reference genome and genetic differences are called using specially developed data analysis pipeline 
software. The Illumina sequencing workflow is based on three steps: libraries preparation from any 
nucleic acid sample, production of clonal clusters by amplification, and sequencing using massively 
parallel synthesis. Template preparation consists of building a library of nucleic acids (DNA or 
complementary DNA - cDNA) and amplifying that library. Sequencing libraries are constructed by 
fragmenting the DNA (or cDNA) sample and ligating adapter sequences (synthetic oligonucleotides of 
a known sequence) onto the ends of the DNA fragments. Once constructed, libraries are clonally 
amplified in preparation for sequencing. Illumina utilizes ridge amplification to form template clusters 
on a flow cell (Quail et al., 2012; Berglund et al., 2011).  
 Whole-genome Optical Mapping (WGM) technology is a recent tool that creates a single molecule 
high-resolution in situ ordered restriction map of a bacterial genome (Shukla et al., 2009). Such optical 
maps were used with success not only to determine genomic organization and perform comparative 
genomics to identify genomic rearrangements (such as insertions, deletions, duplications, and 
inversions),  but also to validate and finish sequence contigs and genomic placement during sequencing 
projects (Ferreira et al., 2016; Mariano et al., 2016; Bosch et al., 2013; Hall et al., 2013; Fey et al., 2012; 
Mellmann et al. 2011; Deurenberg et al., 2007; Kotewicz et al., 2007; Valouev et al., 2006; Zhou et al., 
2004; Lim et al., 2001).  
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 Consensus optical maps of five B. suis biovar 2 field strains isolated from wild boars in Portugal and 
Spain were previously generated from the restriction patterns obtained at single-molecule level with 
BamH I (Ferreira et al., 2016). In this work the genomic sequences of these B. suis biovar 2 strains, 
including three Iberian (one from haplotype 2d and two haplotype 2e) and two Central-European 
(haplotype 2c), were obtained by Illumina HiSeq 2000 technology using a paired-end 35 bp protocol, 
reads were de novo assembled using de Bruijn graph method, and scaffolding was guided by optical 
mapping method, allowing high confidence and prompt disclosure of typical sequence assembly 
problems.  
 
 
2. Material and Methods 
 
2.1. B. suis strains and DNA isolation 
From the set of biovar 2 isolates, five strains representative of the two circulating clonal lineages 
in Iberian Peninsula were chosen and sequenced to full closure. B. suis biovar 2 strains PT09143 
(haplotype 2e) and PT09172 (haplotype 2d) were isolated from wild boars in two different regions of 
Portugal, one in the south (Alentejo) and other in the North (Trás-os-Montes), respectively. Strains 
Bs143CITA (haplotype 2e), Bs364CITA and Bs396CITA (both from haplotype 2c) were kindly provided 
by JM Blasco from the Centro de Investigación y Tecnología Agroalimentaria de Aragón (CITA, 
Zaragoza, Spain). The three strains were isolated from wild boars from two regions in the North of 
Spain, Asturias (Bs143CITA) and Aragón (northeast region, above the Ebro River) (Table 4.1.1). Strains 
were previously biotyped according to standard bacteriological procedures (Alton et al., 1988), and 
characterized through PCR-restriction fragment length polymorphism (RFLP) analysis for the omp2a, 
omp2b, and omp31 genes (Vizcaíno et al., 1997; Cloeckaert et al., 1995) and by multilocus variable-
number tandem-repeat (VNTR) assay (MLVA) (Le Flèche et al., 2006) as described before (see 
Supplementary Tables S2.2.1 and S2.2.2 in Subchapter 2.2). Total genomic DNA was extracted and 
purified using the PureLink Genomic DNA Kit (Invitrogen Life Technologies, USA). An aliquot of the DNA 
was subjected for analysis using the Bioanalyzer (Agilent technologies) and was confirmed for no 
degradation. An aliquot of 10 µg of DNA was used for the sequencing and the remaining stock was 
maintained for further sequencing and completion of gaps. In addition, reference strains B. suis 1330 
(biovar 1; ATCC 23444) and B. suis strain Thomsen (biovar 2; ATCC 23445) were obtained from the 
American Type Culture Collection (ATCC, USA), and used for validation of PCR methods.  
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2.2. Sequencing and de novo assembly 
Genomic libraries were created using Truseq DNA sample preparation kit and genomic sequences 
obtained by Illumina HiSeq 2000 technology with a paired-end 35-bp protocol. The quality analysis of 
the reads was done using the FastQC software 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Only reads with Phred score Q>30 (i.e., 
Error Probability <0.001) were considered for de novo assembly (depth coverage aptx: 100X), using de 
Bruijn graph method (Velvet version 1.2.09; Zerbino and Birney, 2008). Visual inspection of alignment 
of fastq reads for each contig was performed using Table vs 1.14.04.10. Scaffolding was guided by 
optical mapping method (MapSolver version 3.2; OpGen Technologies, Inc.) and gap filling was 
performed by PCR and Sanger method (Sanger et al., 1977). Low coverage regions and all regions 
containing insertions or deletions (INDELs) in comparison with B. suis ATCC 23445, were confirmed by 
Sanger resequencing (Supplementary Table S4.1.1). Chromosome-wide comparisons of those five 
strains and B. suis reference strains ATCC 23445 and 1330 were made using an approach based in 
Mummer algorithm implemented at Kodon V3.62. Genomic alignment of concatenated chromosome 
was performed by superstretch approach: DNA seed 15 matches in windows size of 25 bases, minimal 
stretch length 60 bases, and minimal cut-off for stretch identity of 60% in a screening window of 30 
bases were used. 
 
2.3. Sequence-to-map comparison 
Genomic DNA from the five strains was extracted and optical maps were prepared using the Argus 
Whole Genome Mapping System (OpGen, Inc., Madison, USA). A consensus optical map was produced 
for each strain from the restriction pattern obtained at single-molecule level. Sequence-to-map 
comparisons were performed using MapSolver software (OpGen Technologies, Inc.). Sequence FASTA 
files from each chromosome were converted to in silico restriction maps for direct comparison to the 
Optical maps. Comparisons were accomplished by aligning the sequence with the optical maps 
according to their restriction fragment pattern. Alignments were generated with a dynamic 
programming algorithm which finds the optimal location, or placement, of a sequence contig by first 
performing a global alignment of the sequence contig against the optical map.   
 
2.4. Functional annotation 
The ORF detection and primary functional annotation was made through Rapid Annotations using 
Subsystems Technology (RAST) (Aziz et al., 2008), 23S rRNA and tRNA genes were identified using 
RNAmmer (Lagesen et al.,  2007) and tRNAscan-SE 1.21 (Lowe and Eddy, 1997). Functional enrichment 
was performed using Gene Ontology (GO) (The Gene Ontology Consortium, 2000), InterPro and Kyoto 
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Encyclopedia of Genes and Genomes (KEGG) databases, using Blast2GO pipeline (version 2.7.1) (Götz 
et al., 2008). Search for phage at the sequenced genomes and strains B. suis ATCC 23445 and 1330 was 
made using PHAST (PHAge Search Tool) (Zhou et al., 2011). For ORFs without functional information 
attributed by RAST server nor Blast2GO, annotation was obtained by query with BLASTn algorithm 
against nr/nt database from NCBI (May 10, 2014) using standard configuration. Annotation was 
curated manually. Data consolidation, mining and querying was performed using MySQL InnoDB 
engine (5.0.95). Scripting and parsing was made using Python (2.7.3) (Van Rossum, 2007).  
 
2.5. Nucleotide sequence accession numbers 
Genome accession numbers to GenBank database are listed in Table 4.1.1. 
 
Table 4.1.1. Listing of strains and respective genome accession numbers. 
Genome Clonal lineage (Haplotype) Country 
GenBank accession number 
(chr I/ chrII) 
PT09172 Iberian (2d) Portugal CP007693.1/ CP007694.1 
PT09143 Iberian (2e) Portugal CP007691.1/ CP007692.1 
Bs143CITA Iberian (2e) Spain CP007695.1/ CP007696.1 
Bs364CITA Central-European (2c) Spain CP007697.1/ CP007698.1 
Bs396CITA Central-European (2c) Spain CP007720.1/ CP007721.1 
 
 
3. Results and Discussion 
 
The full genomes of PT09172, PT09143, Bs143CITA, Bs364CITA and Bs396CITA were reconstructed 
from a range of 8,408,102 to 12,172,794 high-quality reads (Phred score >30) per strain, generated by 
Illumina HiSeq 2000 technology, with a paired-end 35-bp protocol. Reads were de novo assembled into 
contigs using de Bruijn graph method, resulting in depth coverage ranging from 89X to 128X. The 
assembly yielded between 55 to 116 contigs and the genome expected sizes ranged from 3,293,158 to 
3,304,238 bp. Summary of statistics of assembly process is presented in Table 4.1.2.  
For all strains, the structural chromosomal organization was confirmed using high-resolution whole-
genome optical mapping (OpGen Technologies, Inc.).  Optical mapping produces a barcode-like genetic 
map of restriction sites with the depicted sites arranged in the order they occur in the genome. The 
consensus map was built within a minimal coverage of 50X, generating 228 to 232 fragments, with 
sizes ranging from 1.5 to 85 kb (see Supplementary Tables S3.2A e S3.2B in Chapter 3). The optical 
maps defined unique genome landmarks in each of the strains and demonstrated the ability of this 
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method to determine the relative placement and orientation of sequence fragments produced during 
the assembly process.  
 
 
4.1.2. Summary statistics for assembly of five B. suis biovar 2 strains isolates from wild boars. 
Statistics PT09143 PT09172 Bs143CITA Bs364CITA Bs396CITA 
Number of raw reads 8,408,102 12,172,794 10,795,456 10,091,666 8,423,200 
Sequencing Coverage depth (X) 89.36 128.13 113.65 106.10 88.57 
Number of reads used 8,123,604 11,727,505 10,434,053 9,524,505 8,150,997 
Kmer used (Velvet) 21 23 21 29 21 
Estimated Genome Size (bp) 3,293,158 3,297,697 3,301,707 3,302,044 3,304,238 
Number of molecules 2 2 2 2 2 
Median coverage depth 35.59 44.86 45.90 19.79 35.70 
Number of contigs 116 65 61 55 77 
N50 56,902 100,353 122,343 123,75 83,863 
Max. contig (bp) 163,9 208,981 284,642 256,126 215,336 
Min. contig (bp) 611 611 611 611 542 
 
 
General features of the B. suis biovar 2 genomes are summarized in Table 4.1.3. The five B. suis 
biovar 2 genomes have similar sizes, and are composed of two circular chromosomes (I and II) with 
approximately 1.93 and 1.40 Mb, and the genome sequence length ranged from 3,324,539 (Bs143CITA) 
and 3,328,972 bp (Bs364CITA). The overall GC contents of Chr I and Chr II were 57.1% and 57.3%, 
respectively. The five genomes contain three identical rRNA operons (Supplementary Table S4.1.2), 
one in Chr I and two located in Chr II, and a set of 54 tRNAs genes were predicted (Supplementary 
Table S4.1.3). Established from homology-based search and from protein-structural-motif 
identification, high-confidence protein-coding genes were predicted ranging from 3,014 (PT09143) to 
3,027 (Bs396CITA) coding sequences, and the number of pseudogenes varied between 87 (Bs396CITA) 
and 91 (Bs364CITA). The predicted coding sequences (CDS) and respective functional identification for 
each genome can be seen in Supplementary Table S4.1.4, allocated in 
http://www.mediafire.com/file/ducz93rz73wmu29/Supplementary_Table_S4.1.4_A-E.xlsx. Both 
chromosomes are highly similar to the two chromosomes of B. suis biovar 2 ATCC 23445 reference 
strain. However, unexpectedly, the combined use of NGS and optical mapping technologies permitted 
the identification and location of a genetic inversion of ~944 kb in Chr I of the three strains from Iberian 
clonal lineage. This inversion has been demonstrated to be specific of Iberian clonal lineage strains 
(haplotype 2d and 2e) (Ferreira et al., 2016). 
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Table 4.1.3. Characteristics of Brucella suis biovar 2 genomes. 
Genome PT09143 PT09172 Bs143CITA Bs364CITA Bs396CITA 
Chr I size (bp) 1,926,480 1,926,716 1,926,295 1,927,594 1,927,083 
Chr II size (bp) 1,398,285 1,398,326 1,398,244 1,401,378 1,401,375 
Total size (bp) 3,324,765 3,325,042 3,324,539 3,328,972 3,328,458 
CDS 3,014 3,015 3,015 3,018 3,027 
Genes 3,167 3,168 3,168 3,173 3,178 
Hypothetical proteins 774 726 790 750 745 
Pseudogenes 89 89 89 91 87 
Frameshifted genes 67 65 67 66 62 
rRNA 9 9 9 9 9 
tRNA 54 54 54 54 54 
ncRNA 1 1 1 1 1 
Chr, chromosome; CDS, coding sequence; rRNA, ribosomal RNA; tRNA, transfer RNA; ncRNA, non-coding RNA 
 
 
4. Conclusion 
 
The full genomes of the five B. suis biovar 2 field strains were promptly obtained using a 
combination of Illumina, Sanger and optical mapping technologies. Until now, only the whole-genome 
of the reference strain of B. suis biovar 2 strain Thomsen (ATCC 23445) was available for comparative 
analysis. The release of additional complete genomes of other strains isolated from different animal 
hosts may facilitate intra-generic comparative analysis of the species or genus. Further, as more whole-
genome sequences of different strains are published, the biological implications of genomic plasticity 
in Brucella phylogeny will be clarified.  
 
 
5. Supplementary material 
 
Supplementary Table S4.1.1. Low coverage regions and indels confirmed by Sanger resequencing 
(Reference positions to B. suis ATCC 23445). 
Supplementary Table S4.1.2. Ribosomal RNA (rRNA) operons identified using RNAmmer. 
Supplementary Table S4.1.3.  Transference RNA (tRNA) genes identified using tRNAscan-SE 1.21. 
Supplementary Table S4.1.4. Predicted coding sequences (CDS) and respective functional annotation 
for B. suis biovar 2 genomes. Data allocated at: 
http://www.mediafire.com/file/ducz93rz73wmu29/Supplementary_Table_S4.1.4_A-E.xlsx 
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Supplementary Table S4.1.1. Low coverage regions and indels confirmed by Sanger resequencing 
(Reference positions to B. suis ATCC 23445).  
Locus  Sequence (5`- 3`) Chr. Start Stop Product (bp) Observation 
Bs_I-63691F CTCACGGCAGAAAAGAAAGG I 63,691 63,952 262 Low coverage 
region Bs_I-63691R AAATATCCGCGTCGAGAATG 
Bs_I-79518F TGCACACGTAGGGTCGATA I 79,420 80,357 938 INDEL 
Bs_I-79518R CACCCAGATGTTCGGCTAT 
Bs-I_125655F CGGATTCCTCTTCACCTTCA  I 134,207 134,309 103 INDEL 
Bs_I-125655R GGGCAGCTCATGACTTTTGT 
Bs_I-143457F GTCATCACGCTCCAGGTCTT I 143,472 ---------- No amplification 
In ATCC 23445 
INDEL 
BS-I_143457R CCTGCACACATCAGAACGTC 
Bs_I-649504F AGTTGAAGCGCAGCTGAGTA I 649,504 650,234 731 Low coverage 
region Bs_I-649504R TGCTAAATTGTGGGCCTTTT 
Bs_I-650861F CCGAAGCCGTTGAATATGT I 650,770 651,020 251 INDEL 
Bs_I-650861R CAGCATAGTTGAAGCGCAG 
Bs_I-892731F ACGCCCTTGATGGTGATTA I 892,313 892,927 615 INDEL 
Bs_I-892731R TTCGATTCTGACGTGACCTG 
Bs_I-1022840F GCTGTGACGGGTAATTTGAA I 1,022,785 1,023,071 287 INDEL 
Bs_I-1022840R GTGCTTGCCAATGAGAAGAC 
Bs_I-1036525F CCAGAAATCAGTCCAGTGGA I 1,036,480 1,036,679 200 INDEL 
Bs_I-1036525R GAGCTTGTGTTTGGTGGTGT 
Bs_I-1042003F ACTGAACAGGCTGAGAGCC I 1,041,944 1,042,224 281 INDEL 
Bs_I-1042003R GGAATAATTTTCCACGCCA 
Bs-I_1115894F TGCGGTCATGAATGTGTTCT  I 1,115,794 1,116,428 635 INDEL 
Bs-I_1115894R CAGCGAGGATTACGATCCAT 
Bs_I-1171662F AAGATGTGGATCCGGTGAC I 1,171,597 1,171,839 243 INDEL 
Bs_I-1171662R AAGTTATTGCGCTTCAGCG 
Bs_I-1207470F CCGGTGTTATTTTCGTTTCA I 1,207,421 1,207,590 170 INDEL 
Bs_I-1207470R AAAATATCGAAGACCTCGCC 
Bs_I-1355983F TAGGCTGCCTGGAATTCATC I 1,355,304 1,356,288 985 INDEL 
Bs_I-1355983R CGGCAAGTTCACCTCTGACT 
Bs_I-1420091F GCATATTTTACCCCAAAGCC  I 1,420,091 1,420,711 621 Low coverage 
region Bs_I-1420091R ATTTTGAACCAGAGCGGTTG 
Bs_I-1423445F TTTCTTATTCCACCCGATCC I 1,423,358 1423655 298 Low coverage 
region Bs_I-1423445R CAAAATGTTACTGCGTGAAGC 
Bs_I-1439474F CGCGTTCAGAATAGTTCAGTG I 1,439,402 1,439,604 203 INDEL 
Bs_I-1439474R GAACGTCCATAGGTCCGAA 
Bs_I-1627483F CAATCCACAGGAGATCGGT I 1,627,421 1,627,602 182 INDEL 
Bs_I-1627483R GCTTCACGGGTATCATGTACA 
Bs_I-1660136F TTCTCTTCCGTGCTGCCTAT I 1,660,136 1,660,747 612 Low coverage 
region 
Bs_I-1660136R GGAGGGTGACAGAAGAATGG 
Bs_I-1902495F ATGAGAAGCCGGAAGTTGA I 1,902,416 1,903,238 823 INDEL 
Bs_I-1902495R CTTCGCCCTTCACAACCTT 
Bs_II-84685F ACTGGCGATGATCGAAAAG II 84,616 84,868 253 INDEL 
Bs_II-84685R GCTGCAACCATGGTTTCAC 
Bs_II-84796F ACGAGGAAGAGGATAATGGC II 84,732 84,848 117 INDEL 
Bs_II-84796R GCTGCAACCATGGTTTCAC 
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Locus Sequence (5`- 3`) Chr. Start Stop Product (bp) Observation 
Bs_II-117281F TCGGAAATGGACGAATATCA II 117,306 117,533 228 INDEL 
Bs_II-117281R TTCTTGTCGTCGGAAATGTC 
Bs_II-350983F CCATTGGTTTGAAGCGTTCT II 350,806 351,225 420 INDEL 
Bs_II-350983R CAGCACATTCGAGGATGAGA 
Bs_II-524675F ACCCGTCGTCTACGACAATC II 524,559 525,024 466 INDEL 
Bs_II-524675R ATAACCTTCGGTCGGAACA 
Bs_II-679647F AGTGGATTTTGGTGCGTTTC II 679,366 680,717 1,352 INDEL 
Bs_II-679647R AAGATGAGCGGGAAATGTTG 
Bs_II-680354F CTTTATTCGCAGCGGTAGG II 680,064 680,542 479 INDEL 
Bs_II-680354R CCGACATATTTGTTGAACGAA 
Bs_II-779882F GCCAAGTGTGACCGGTATTA II 779,838 780,069 232 INDEL 
Bs_II-779882R ACGGATTGTCCCTCTCCTT 
Bs_II-799189F AGCTGCGCGAAATAAAAATC II 799,189 799,841 653 Low coverage 
region Bs_II-799189R AGATTGCAGGCCATCTTCAT 
Bs_II-1098566F CACCCCCAACTACTCACAAA II 1,098,538 1,098,776 239 INDEL 
Bs_II-1098566R TCTCGTTTTACGGCGGAAT 
Bs_II-1146197F GTAACGGCCCTGACCATAGA  II 1,145,848 1,146,540 693 INDEL 
Bs_II-1146197R CGGTTTGAGGAACTGGAAAA 
Bs_II-1303711F CACCCCCAACTACTCACAAA II 1,303,711 1,304,495 785 Low coverage 
region Bs_II-1303711R CGCTTCTGTGAGTTCTGTGC 
Bs_II-1310854F TATTATTCACTTTGAGCGGCA II 1,310,801 1,312,970 2170 INDEL 
Bs_II-1310854R AACTGCAAAAGCTTGGCTG 
 
F, primer forward; R, primer reverse; I, chromosome I; II, chromosome II 
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Supplementary Table S4.1.2. Ribosomal RNA (rRNA) operons identified using RNAmmer. 
 
 
 I, chromosome I; II, chromosome II 
 
 
 
  
rRNA Chr. PT09143 PT09172 Bs143CITA Bs364CITA Bs396CITA 
5S I 1,600,883..1,600,996 1,601,095..1,601,208 1,600,779..1,600,892 1,601,977..1,602,090 1,601,441..1,601,554 
23S I 1,601,212..1,604,120 1,601,424..1,604,332 1,601,108..1,604,016 1,602,306..1,605,214 1,601,770..1,604,678 
16S I 1,604,894..1,606,366 1,605,106..1,606,578 1,604,790..1,606,262 1,605,988..1,607,460 1,605,452..1,606,924 
5S II 2,989,860..2,989,973 2,990,105..2,990,218 2,989,633..2,989,746 2,991,970..2,992,083 2,991,453..2,991,566 
23S II 2,990,189..2,993,097 2,990,434..2,993,342 2,989,962..2,992,870 2,992,299..2,995,207 2,991,782..2,994,690 
16S II 2,993,871..2,995,343 2,994,116..2,995,588 2,993,644..2,995,116 2,995,981..2,997,453 2,995,464..2,996,936 
5S II 3,195,048..3,195,161 3,195,294..3,195,407 3,194,819..3,194,932 3,197,154..3,197,267 3,196,641..3,196,754 
23S II 3,195,377..3,198,285 3,195,623..3,198,531 3,195,148..3,198,056 3,197,483..3,200,391 3,196,970..3,199,878 
16S II 3,199,059..3,200,531 3,199,305..3,200,777 3,198,830..3,200,302 3,201,165..3,202,637 3,200,652..3,202,124 
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Supplementary Table S4.1.3.  Transference RNA (tRNA) genes identified using tRNAscan-SE 1.21. 
 
tRNA 
Type 
Chr. 
Anti-
Codon 
PT09143 PT09172 Bs143CITA Bs364CITA Bs396CITA 
Begin End size Begin End size Begin End size Begin End size Begin End size 
Ala I GGC 21,049 20,977 -72 21,049 20,977 -72 21,049 20,977 -72 21,049 20,977 -72 21,049 20,977 -72 
Pro I CGG 200,015 200,088 73 115,315 115,388 73 200,019 200,092 73 200,692 200,765 73 200,692 200,765 73 
Phe I GAA 272,278 272,206 -72 170,643 170,571 -72 272,283 272,211 -72 272,955 272,883 -72 272,955 272,883 -72 
Thr I GGT 278,565 278,636 71 176,930 177,001 71 278,570 278,641 71 279,242 279,313 71 279,242 279,313 71 
Arg I ACG 292,644 292,571 -73 191,009 190,936 -73 292,649 292,576 -73 293,310 293,237 -73 293,310 293,237 -73 
Glu I TTC 421,393 421,322 -71 421,373 421,302 -71 421,396 421,325 -71 527,445 527,516 71 527,389 527,460 71 
Tyr I GTA 442,197 442,278 81 442,178 442,259 81 442,201 442,282 81 646,470 646,383 -87 646,415 646,328 -87 
Gly I TCC 442,306 442,376 70 442,287 442,357 70 442,310 442,380 70 720,407 720,480 73 720,296 720,369 73 
Trp I CCA 443,802 443,874 72 443,783 443,855 72 443,806 443,878 72 721,045 721,118 73 720,934 721,007 73 
Leu I GAG 607,161 607,080 -81 607,085 607,004 -81 607,178 607,097 -81 779,682 779,609 -73 779,612 779,539 -73 
Leu I GAG 615,417 615,336 -81 615,341 615,260 -81 615,434 615,353 -81 794,139 794,067 -72 794,070 793,998 -72 
Leu I TAA 643,998 643,916 -82 643,921 643,839 -82 644,003 643,921 -82 794,549 794,622 73 794,480 794,553 73 
Gly I CCC 725,659 725,729 70 725,644 725,714 70 725,652 725,722 70 887,637 887,716 79 887,245 887,324 79 
Arg I CCG 726,510 726,437 -73 726,495 726,422 -73 726,503 726,430 -73 926,681 926,609 -72 926,292 926,220 -72 
Val I CAC 726,927 726,998 71 726,912 726,983 71 726,920 726,991 71 952,585 952,514 -71 952,196 952,125 -71 
Thr I TGT 752,832 752,904 72 752,816 752,888 72 752,825 752,897 72 953,002 953,075 73 952,613 952,686 73 
Leu I TAG 791,876 791,797 -79 791,867 791,788 -79 791,872 791,793 -79 953,853 953,783 -70 953,464 953,394 -70 
Asp I GTC 884,821 884,748 -73 884,812 884,739 -73 884,818 884,745 -73 1,035,565 1,035,647 82 1,035,175 1,035,257 82 
Val I TAC 885,231 885,303 72 885,222 885,294 72 885,228 885,300 72 1,064,143 1,064,224 81 1,063,753 1,063,834 81 
Pro I GGG 899,689 899,762 73 899,680 899,753 73 899,686 899,759 73 1,072,399 1,072,480 81 1,072,009 1,072,090 81 
Arg I TCT 958,312 958,239 -73 958,455 958,382 -73 958,316 958,243 -73 1,235,772 1,235,700 -72 1,235,382 1,235,310 -72 
Pro I TGG 958,950 958,877 -73 959,093 959,020 -73 958,954 958,881 -73 1,237,268 1,237,198 -70 1,236,898 1,236,828 -70 
Ser I GCT 1,032,887 1,032,974 87 1,033,029 1,033,116 87 1,032,885 1,032,972 87 1,237,377 1,237,296 -81 1,237,007 1,236,926 -81 
Gln I TTG 1,151,912 1,151,841 -71 1,152,053 1,151,982 -71 1,151,908 1,151,837 -71 1,258,190 1,258,261 71 1,257,812 1,257,883 71 
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tRNA 
Type 
Chr. 
Anti-
Codon 
PT09143 PT09172 Bs143CITA Bs364CITA Bs396CITA 
Begin End size Begin End size Begin End size Begin End size Begin End size 
Lys I CTT 1,313,446 1,313,518 72 1,313,485 1,313,557 72 1,313,345 1,313,417 72 1,314,327 1,314,399 72 1,313,950 1,314,022 72 
Met I CAT 1,445,417 1,445,344 -73 1,445,639 1,445,566 -73 1,445,315 1,445,242 -73 1,446,532 1,446,459 -73 1,445,968 1,445,895 -73 
Met I CAT 1,563,802 1,607,730 73 1,564,015 1,564,088 73 1,563,696 1,563,769 73 1,564,892 1,564,965 73 1,564,355 1,564,428 73 
His I GTG 1,565,633 1,611,246 -73 1,565,846 1,565,773 -73 1,565,527 1,565,454 -73 1,566,723 1,566,650 -73 1,566,186 1,566,113 -73 
Gln I CTG 1,580,316 1,640,755 70 1,580,529 1,580,599 70 1,580,210 1,580,280 70 1,581,406 1,581,476 70 1,580,869 1,580,939 70 
Met I CAT 1,600,791 1,681,562 -73 1,601,004 1,600,931 -73 1,600,685 1,600,612 -73 1,601,880 1,601,807 -73 1,601,343 1,601,270 -73 
Ala I TGC 1,604,532 1,689,045 -72 1,604,745 1,604,673 -72 1,604,426 1,604,354 -72 1,605,621 1,605,549 -72 1,605,084 1,605,012 -72 
Ile I GAT 1,604,622 1,689,224 -73 1,604,835 1,604,762 -73 1,604,516 1,604,443 -73 1,605,711 1,605,638 -73 1,605,174 1,605,101 -73 
Leu I CAA 1,693,030 1,693,111 81 1,693,227 1,693,308 81 1,692,880 1,692,961 81 1,694,178 1,694,259 81 1,693,604 1,693,685 81 
Ala I CGC 1,730,560 1,730,488 -72 1,730,756 1,730,684 -72 1,730,408 1,730,336 -72 1,731,707 1,731,635 -72 1,731,133 1,731,061 -72 
Arg I CCT 1,774,788 1,774,861 73 1,774,986 1,775,059 73 1,774,617 1,774,690 73 1,775,934 1,776,007 73 1,775,342 1,775,415 73 
Val II GAC 1,937,268 3,874,465 -71 1,937,522 1,937,451 -71 1,937,097 1,937,026 -71 1,938,393 1,938,322 -71 1,937,881 1,937,810 -71 
Asp II GTC 2,204,082 4,175,291 -73 2,204,383 2,204,310 -73 2,203,894 2,203,821 -73 2,205,280 2,205,207 -73 2,204,762 2,204,689 -73 
Ser II TGA 2,438,821 4,416,117 -86 2,439,125 2,439,039 -86 2,438,628 2,438,542 -86 2,440,032 2,439,946 -86 2,439,513 2,439,427 -86 
Lys II TTT 2,471,261 4,481,011 -72 2,471,565 2,471,493 -72 2,471,068 2,470,996 -72 2,472,472 2,472,400 -72 2,471,953 2,471,881 -72 
Cys II GCA 2,503,156 4,443,326 70 2,503,459 2,503,529 70 2,502,961 2,503,031 70 2,504,369 2,504,439 70 2,503,853 2,503,923 70 
Asn II GTT 2,507,591 4,452,055 -71 2,507,895 2,507,824 -71 2,507,396 2,507,325 -71 2,508,804 2,508,733 -71 2,508,288 2,508,217 -71 
Thr II CGT 2,703,358 4,644,732 72 2,703,647 2,703,719 72 2,703,154 2,703,226 72 2,705,438 2,705,510 72 2,696,937 2,705,009 72 
Gly II GCC 2,763,467 4,764,949 71 2,763,756 2,763,827 71 2,763,261 2,763,332 71 2,765,547 2,765,618 71 2,765,046 2,765,117 71 
Gly II GCC 2,893,279 4,821,339 71 2,893,532 2,893,603 71 2,893,073 2,893,144 71 2,895,401 2,895,472 71 2,894,876 2,894,947 71 
Leu II CAG 2,923,319 4,881,431 83 2,923,578 2,923,661 83 2,923,111 2,923,194 83 2,925,440 2,925,523 83 2,924,916 2,924,999 83 
Ser II GGA 2,940,747 4,916,290 86 2,941,007 2,941,093 86 2,940,540 2,940,626 86 2,942,868 2,942,954 86 2,942,344 2,942,430 86 
Met II CAT 2,989,766 4,916,786 -73 2,990,027 2,989,954 -73 2,989,549 2,989,476 -73 2,991,887 2,991,814 -73 2,991,362 2,991,289 -73 
Ala II TGC 2,993,507 4,924,269 -72 2,993,768 2,993,696 -72 2,993,290 2,993,218 -72 2,995,628 2,995,556 -72 2,995,103 2,995,031 -72 
Ile II GAT 2,993,597 4,924,448 -73 2,993,858 2,993,785 -73 2,993,380 2,993,307 -73 2,995,718 2,995,645 -73 2,995,193 2,995,120 -73 
Glu II CTC 3,008,545 4,954,488 71 3,008,806 3,008,877 71 3,008,328 3,008,399 71 3,010,666 3,010,737 71 3,010,141 3,010,212 71 
Ser II CGA 3,186,829 5,150,177 86 3,187,090 3,187,176 86 3,186,609 3,186,695 86 3,188,945 3,189,031 86 3,188,424 3,188,510 86 
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tRNA 
Type 
Chr. 
Anti-
Codon 
PT09143 PT09172 Bs143CITA Bs364CITA Bs396CITA 
Begin End size Begin End size Begin End size Begin End size Begin End size 
Met II CAT 3,194,956 5,166,272 -73 3,195,217 3,195,144 -73 3,194,736 3,194,663 -73 3,197,072 3,196,999 -73 3,196,551 3,196,478 -73 
Ala II TGC 3,198,697 5,173,755 -72 3,198,959 3,198,887 -72 3,198,477 3,198,405 -72 3,200,813 3,200,741 -72 3,200,292 3,200,220 -72 
Ile II GAT 3,198,787 5,173,934 -73 3,199,049 3,198,976 -73 3,198,567 3,198,494 -73 3,200,903 3,200,830 -73 3,200,382 3,200,309 -73 
 
Ala, alanine; Arg, arginine; Asn, asparagine; Asp, aspartate; Cys, cysteine; Gln, glutamine; Glu, glutamic acid; Gly, glycine; His, histidine; Ile, isoleucine; Leu, leucine; 
Lys, lysine; Met, methionine; Phe, phenylalanine; Pro, proline; Ser, serine; Thr, threonine; Trp, tryptophan; Tyr, tyrosine; Val, valine.  
A,   adenine; C, cytosine; G, guanine; T, thymine. 
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1. Introduction 
 
Brucella suis is a group of facultative intracellular pathogens that infect a broad range of animals 
and humans. This species is divided into five biovars, denominated from biovar 1 to 5, that are associated 
with certain hosts. Considerable diversification within the B. suis clade has been observed by different 
molecular approaches and probable relationships among the biovars and their preferential hosts were 
suggested (Wattan et al., 2009; Foster et al., 2009; Whatmore et al., 2007; Le Flèche et al., 2006). Biovars 
1, 2 and 3 infect suidae and are the etiological agent of swine brucellosis, but the infection caused by 
biovars 1 and 3 differs from that caused by biovar 2 in host specificity and geographical distribution. In 
the context of public health, biovar 2 is very rarely pathogenic for humans, whereas biovars 1 and 3 are 
highly pathogenic causing severe disease in human beings (EFSA, 2009). B. suis biovar 2 is found only in 
Europe and also infects hares, being accept that both the wild boar (Sus scrofa) and the European hare 
(Lepus europaeus) are the wild reservoirs of this biovar and the source of transmission of infection to 
outdoor or extensively reared pigs (Godfroid et al., 2013). Previous studies on the genetic structure of 
B. suis biovar 2 population by Multiple Locus Variable-number Tandem Repeat Analysis (MLVA) (Duvnjak 
et al., 2015; Kreizinger et al., 2014; Li et al., 2013; Garcia-Yoldi et al., 2007; Le Flèche et al., 2006), PCR-
RFLP analysis of omp31, omp2a and omp2b genes (Ferreira et al., 2016; Munoz et al., 2010; Garcia-Yoldi 
et al., 2007; Ferrão-Beck  et al., 2006) and whole-genome optical mapping  (Ferreira et al., 2016) 
supported evidence for the existence of two circulating lineages in Iberian Peninsula (Portugal and 
Spain): the Central-European and the Iberian clonal lineages. The later had been described exclusively 
in Iberian Peninsula, in both isolates from pigs and wild boars, mainly below the Ebro River suggesting a 
genomic specialization and local adaptation.  
The fitness of a pathogen may vary from host to host. The way that pathogen evolves, within or 
outside a host, and the strategy used by the host to resist infection can potentially be a  determinant for 
pathogen specialization and an important driver of the evolution of virulence. Host specificity is 
associated with a number of genomic signatures, including genomic degeneration and genomic 
rearrangements (Bäumler et al., 2013). Recently, the complete genome sequences of five B. suis biovar 
2 strains representative of Iberian and Central-European clones, isolated from wild boars in Portugal and 
Spain, have been released (Ferreira et al., 2014a, 2014b), and it was shown that the Iberian lineage is 
further characterized by the presence of a large chromosomal inversion (Ferreira et al., 2016). 
In order to a better understanding of the mechanisms for evolution and specialization of Iberian 
lineages, in this study, comparative analysis of B. suis biovar 2 with other Brucella species were 
performed to disclose the genomic and structural differences between Iberian and Central-European 
clones and further discuss the potential factors that favor evolution towards host specialization. 
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2. Material and Methods 
 
2.1. Bacterial strains and genetic characterization 
A total of 190 Brucella spp. strains were used for PCR validation assays, including 22 reference strains 
representative of eight Brucella species and 168 B. suis isolates, comprising 11 from biovar 1, 152 biovar 
2, one biovar 3 and four biovar 4. Among B. suis biovar 2 isolates, 104 were representative of the Iberian 
clonal lineage and 48 of Central-European clonal lineage. Phenotypic characterization of all Brucella spp. 
isolates were performed as previously described (Alton et al., 1988). All B. suis isolates were previously 
subjected to PCR-RFLP analysis of omp2a and omp2b (Cloeckaert et al., 1995) and omp31 (Vizcaíno et 
al. 1997) genes, to assess the different haplotypes, and by target-PCR to confirm the presence of the 
large inversion in B. suis biovar 2 Iberian clonal lineage (Ferreira et al., 2016). All data regarding strain 
characterization can be seen in Supplementary Tables S2.1 and S2.2 in Subchapter 2.2, and in 
Supplementary Table S3.2 in Chapter 3.  
 
2.2. Comparative genomic analysis 
The analysis involved the full sequences of the five newly sequenced genomes of B. suis biovar 2 
(PT09143, PT09172, Bs143CITA, Bs364CITA and Bs396CITA. For details on sequencing, assembly and 
annotation see subchapter 4.1), and 18 Brucella spp. complete genomes available at the time of analysis 
from eight of the 12 recognized species: five B. suis genomes from biovar 1, 2, 3 and 5; four B. melitensis 
genomes from biovars 1 and 2; three B. abortus genomes from biovar 1, including the vaccine strain S19; 
two genomes from B. canis and one each from B. ovis, B. microti, B. pinnipedialis and B. ceti. The genome 
of Ochrobactrum anthropi was used as outgroup (Table 4.2.1). All DNA sequences were obtained by FTP 
from the NCBI genome database. Whole-Genome Multiple Sequence Alignment (WG-MSA) of 
concatenated chromosomes I and II was performed by superstretch approach using as reference the 
annotated sequence of strain B. suis ATCC 23445: DNA seed 10 matches in windows size of 25 bases, 
minimal stretch length 60 bases, minimal cut-off for stretch identity of 60% in screening windows of 30 
bases was used. Clustering analysis was performed using Unweighted Pair Group Method using 
Arithmetic averages (UPGMA). To allow for accurate alignment between superstretches and avoid false 
positive mutations, optimized alignment overlapping stretches settings were used. A minimum of 75% 
of DNA identity and a stretch window of 100 bp were used for determination of orthology. Chromosomal 
alignment and clustering analysis were conducted in Kodon V3.62 (Applied Maths, Belgium).  In order to 
identify large inserts associated to Iberian vs Central-European strains, multiple whole-genome 
alignment of the sequenced PT09143 plus Bs396CITA strain were made by nucmer3.1 (Kurtz et al., 2004), 
using as reference strain ATCC 23445.  
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Single Nucleotide Polymorphism (SNP; including silent, missense and intergenic) and INDEL 
(insertions and deletions) calling was performed only when superstretch was shown between, at least, 
the template and query sequence. A window size for scoring mutation clustering of 10 bp was used for 
mutation quality score. Clustering, distance and score was calculated to assess the significance or quality 
for each mutation. The number of mutations was counted within the window size. Quality cut-off value 
was optimized for each alignment by using the 90th percentile of the Poison distribution for score values 
obtained for each type of mutation. The dN/dS ratio (i.e. the ratio of the number of non-synonymous 
substitutions per non-synonymous site to the number of synonymous substitutions per synonymous 
site) was used as an indicator of selective pressure acting on a protein-coding gene.  
 
2.3. Evolutionary whole-genome-based studies 
The relationships among Brucella spp. genomes were determined using WG-MSA and clustering 
analysis was performed using UPGMA. All positions containing gaps and missing data were eliminated. 
Chromosomal alignment and clustering analysis were conducted in Kodon V3.62.  
The evolutionary history was inferred from genome-wide SNPs using Neighbour-Joining (NJ) and 
Maximum Likelihood (ML) methods available in MEGA6 (Tamura et al., 2013). The initial trees were 
drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to 
infer the phylogenetic trees. All positions containing gaps and missing data were eliminated. Final 
phylogenetic trees were obtained using ML method based on the Tamura-Nei model. 
The evolutionary history was also inferred from INDELs information obtained from WG-MSA and 
coded as binary characters (1 if gap present, 0 if absent). Each instance in the 0/1 matrix corresponds to 
a single INDEL character, which may reflect either an insertion or a deletion relatively to reference 
sequence. The quality score was optimized based in a set of parameters to discriminate effective INDELS: 
quality score, INDEL size, number of neighboring SNPs and INDELs, position of the second different base 
pair, and INDELs distance to the edge on assembled contig. Likewise, only INDELs with quality scores < 1 
and sizes > 15 bp were considered. A minimum spanning tree (MST) was generated from a subset of 
randomize INDELs using BioNumerics version 6.6 (Applied Maths, Belgium). 
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Table 4.2.1. List of genomes used for comparative genomic and phylogenetic analysis. 
NCBI Reference sequence 
(Chr I/ Chr II) 
Strain Identification Biovar Host 
NC_010169.1/ NC_010167.1 B. suis ATCC 23445 2 Hare 
NZ_CP007691.1/ NZ_CP007692.1 B. suis PT09143 2 Wild boar 
NZ_CP007693.1/ NZ_CP007694.1 B. suis PT09172 2 Wild boar 
NZ_CP007695.1/ NZ_CP007696.1 B. suis Bs143CITA 2 Wild boar 
NZ_CP007697.1/ NZ_CP007698.1 B. suis Bs364CITA 2 Wild boar 
NZ_CP007720.1/ NZ_CP007721.1 B. suis Bs396CITA 2 Wild boar 
NC_016797.1/ NC_016775.1 B. suis VBI22 1 Swine 
NC_004310.3/ NC_004311.2 B. suis 1330 1 Swine 
NC_015857.1/ NC_015858.1 B. pinnipedialis B2/94 Not applicable Dolphin 
NZ_CP007719.1/ NZ_CP007718.1 B. suis bv.3 str. 686 3 Seal 
NC_016778.1/ NC_016796.1 B. canis HSKA52141 Not applicable Dog 
NC_010103.1/ NC_010104.1 B. canis ATCC 23365 Not applicable Dog 
NC_013119.1/ NC_013118.1 B. microti CCM 4915 Not applicable Wild rodent 
NZ_CP007717.1/ NZ_CP007716.1 B. suis 513UK 5 Wild boar 
NC_022905.1/ NC_022906.1 B. ceti TE10759-12 Not applicable Seal 
NC_007618.1/ NC_007624.1 B. abortus 2308 1 Cattle 
NC_006932.1/ NC_006933.1 B. abortus 9-941 1 Cattle 
NC_010742.1/ NC_010740.1 B. abortus S19 1 Vaccine 
NC_012441.1/ NC_012442.1 B. melitensis ATCC 23457 2 Goat 
NC_009505.1/ NC_009504.1 B. ovis ATCC 25840 Not applicable Sheep 
NC_017246.1/ NC_017246.1 B. melitensis M5-90 1 Sheep 
NC_017244.1/ NC_017244.1 B. melitensis M28 1 Sheep 
NC_003317.1/ NC_003318.1 B. melitensis 16M 1 Goat 
NC_009667.1/ NC_009668.1 Ochrobactrum anthropi ATCC 49188 Not applicable Not applicable 
 
 
2.4. PCR assessment of INDEL events 
All the INDELs found that were discriminative of B. suis biovar 2 Iberian clonal lineage were assessed 
by PCR in the collection of the 190 Brucella strains previously described. Primers for each lNDEL were 
designed using the nucleotide positions relative to the reference strain ATCC 23445 and specificity of all 
the primers was confirmed by BLAST analysis against the published genome sequence of the reference 
strain. The primer sequences and expected amplicon sizes are provided in Table 4.2.2. Genomic DNA 
from each strain was prepared using the High Pure PCR Template Preparation Kit (Roche Diagnostics, 
Mannheim, Germany) according to the manufacturer. PCR amplification was performed in a total 
volume of 25 µl containing 25 ng of DNA, 1X PCR reaction buffer, 1 U of Taq DNA polymerase (Promega, 
USA), 200 mM of each dNTPs and 0.3 mM of each flanking primers. Amplifications were performed in a 
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MyCycler thermal Cycler (Bio-Rad, France). An initial denaturation step at 95 ºC for 3min was followed 
by 30 cycles of denaturation at 95 ºC for 20 s, primer annealing at 56 ºC for 30 s and elongation at 72 ºC 
for 30 s. The final extension step was performed at 72 ºC for 5 min. Five microliters of amplification 
products were loaded on a 2% standard agarose gel and run under a voltage of 8 V/cm for 60-90 min. A 
100 bp ladder (Invitrogen, USA) was used as molecular size marker. 
 
 
4.2.2. List of the primers used for assessment of the INDEL events differentiating the two B. suis biovar  
2 clonal lineages. 
 
CE, Central-European strains; IB, Iberian strains. 
 
 
3. Results and Discussion 
 
3.1. Phylogenomic relationships of B. suis biovar 2 
To understand the genomic specialization observed in Iberian Peninsula, the genetic structure and 
evolutionary relationships of the B. suis strains isolated at Iberian Peninsula were assessed by three 
Whole-Genome based phylogeny approaches: Multiple Sequence Alignment (WG-MSA); Single 
Nucleotide Polymorphism distribution (WG-SNP) and Insertion and deletion distribution (WG-INDEL). 
The analysis involved the full sequence of the five new genomes and 18 Brucella complete genomes. All 
genomes with the exception of B. suis 686 (biovar 3) have two circular chromosomes (Table 4.2.1).  
INDEL Primer sequence 5' → 3' 
Amplified region 
in ATCC 23445 
Chr 
Affected CDS 
in ATCC 23445 
PCR product expected 
size (bp) 
CE IB (only 2e) 
SI79506 
F 
R 
tgcacacgtagggtcgata 
cacccagatgttcggctat 
79,420..80,357   I BSUIS_A0075 938 260 
SI1356057 
F 
R 
taggctgcctggaattcatc 
cggcaagttcacctctgact 
1,355,436..1,356,288 I Intergenic 853 765 
SI1423448 
F 
R 
tttcttattccacccgatcc 
caaaatgttactgcgtgaagc 
1,423,358..1,423,655 I Intergenic 298 298 (218) 
SI1627485 
F 
R 
caatccacaggagatcggt 
gcttcacgggtatcatgtaca 
1,627,421..1,627,600 I BSUIS_A1714 180 129 
SI2041144 
F 
R 
tcggaaatggacgaatatca 
ttcttgtcgtcggaaatgtc 
107,306..107,533 II Intergenic 228 228 (171) 
SI2603410 
F 
R 
agtggattttggtgcgtttc 
aagatgagcgggaaatgttg 
679,423..680,774 II 
BSUIS_B0700; 
BSUIS_B0701 
1,352 508 
LI3234619 
F 
R 
tattattcactttgagcggca   
aactgcaaaagcttggctg 
1,310,801..1,312,970 II 
BSUIS_B1354-
BSUIS_B1357 
2,170 174 
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The WG-MSA analysis was performed for the concatenated chromosomes of each genome and 
the resultant similarity matrix was used for clustering of the 23 genomes (Figure 4.2.1).  The UPGMA 
dendrogram grouped Brucella spp. genomes into two highly distinct clusters (I and II) according to their 
nucleotide sequence identity. Cluster I grouped the genomes of three B. abortus strains, B. suis 686 
(biovar 3) and three strains of B. suis biovar 2 Iberian clonal lineage (PT09172, PT09143 and Bs143CITA). 
Cluster II gathered the remaining 16 Brucella genomes. The average nucleotide identity (ANI) between 
cluster I and cluster II was 74%, which was lower than expected. ANI is one of the most robust 
measurements of genomic relatedness between strains. However, genomic structural organizations 
such as chromosomal inversions or translocations events may affect the identity values even though 
little impact is observed in gene content (Chun & Rainey, 2014). Indeed, B. abortus presents an inversion 
of 640 kb in chr II (Foster et al., 2009; Halling et al., 2005; Michaux-Charachon et al., 1997) and B. suis 
biovar 2 strains PT09172, PT09143 and Bs143CITA present an inversion in chr I with approximately 944 
kb (Ferreira et al., 2016), as well as the known 210-kb segment of chr I translocated to chr II (Ferreira et 
al., 2016; Foster et al., 2009; Wattan et al., 2009). Moreover, strain 686 from B. suis biovar 3, the unique 
reference strain with a single chromosome of 3.3 Mbp (Jumas-Bilak et al., 1998), also revealed an 
inversion of 790 kb, located between nucleotide #285,192 and #1,074,164 (ATCC 23445 reference 
positions), in a similar region as the inversion occurring in biovar 2 strains from the Iberian clonal lineage 
(cluster I). To the best of our knowledge, this is the first description of a genomic inversion in B. suis 
biovar 3 and of chromosomal structural rearrangements as evolutive features shared by biovar 2 and 
biovar 3 strains. 
To unveil the evolutionary history of B. suis biovar 2 imprinted on the genomic background, WG-
SNP analysis was performed to remove the effect of chromosomal rearrangements (translocations and 
inversions) on B. suis phylogeny. Whole-genome alignment of the 23 Brucella strains yielded a total 
30,255 and 332,119 putative SNPs in comparison to the reference genome and outgroup strain, 
respectively (data can be found in Supplementary Table S4.2.1-A, allocated at 
http://www.mediafire.com/file/2mm9zdwo7lyovm2/Supplementary_Table_S4.2.1_A-C.xlsx). The 
evolutionary distances were computed assuming equality of substitution pattern among lineages and of 
substitution rates among sites using the Maximum Composite Likelihood method and clustered by 
Neighbor-Joining method (Figure 4.2.2). The unrooted tree sorts the Brucella genomes into eight clades, 
as follows: the B. suis biovar 2 clade (A); the B. suis-B. canis clade (B); the B. suis biovar 5 clade (C); the 
B. microti clade (D); the B. ovis clade (E); the B. pinnipedialis-B. ceti clade (F); the B. abortus clade (G), 
and the B. melitensis clade (H) (Figure 4.2.2). These results are in accordance with several phylogenetics 
studies using WG-SNP or MLST data (Sankarasubramanian et al., 2016; Foster et al., 2012; Audic et al., 
2009; Wattan et al., 2009; Foster et al., 2009; Whatmore et al., 2007; Chain et al., 2005). The B. suis 
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biovar 2 isolates form two distinct phylogenetic groups in clade A, one corresponding to the Central-
European clonal lineage (subclade A1) and the other to the Iberian clonal lineage (subclade A2), thus 
giving additional phylogenetic support at genome level for the occurrence of these clonal lineages 
already revealed by chromosome I optical maps (Ferreira et al., 2016). Moreover, the evolutionary 
history inferred from the 944 kb inversion region distinctive of subclade A2 and from 210 kb translocated 
region of clade A showed no differences in comparison to whole-genome analysis. Alike topologies were 
observed for coding and non-coding regions (data not shown). Thus, the mechanisms for genomic 
specialization on the Iberian lineages seem to be independent of the chromosomal rearrangement 
events observed in these clades. 
 
 
 
 
Figure 4.2.1. Comparative chromosome mapping of 23 Brucella spp. genomes. Genomic alignment of 
concatenated chromosomes I and II was performed by superstretch approach: DNA seed 10 matches in windows 
size of 25 bases, minimal stretch length 60 bases, minimal cut-off for stretch identity of 60% in screening windows 
of 30 bases was used. Each cell in the matrix displays the identity score, with a corresponding color scale. The scale 
goes from black, corresponding with 100% identity, over blue towards white (0% identity). The left-to-right 
diagonal of the matrix contains those cells representing the comparison of sequences compared to themselves. 
The value in each cell represent the percentage of repetitive regions for that sequence. Clustering analysis was 
performed using UPGMA. All positions containing gaps and missing data were eliminated. The genome of O. 
anthropi was used as outgroup. 
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Figure 4.2.2. Evolutionary relationships inside genus Brucella inferred from WG-SNP analysis. Rooted phylogenetic 
tree with O. anthropi as outgroup; all positions containing gaps and missing data were eliminated and a total of 
332,119 positions was used in the final dataset. The unrooted Brucella phylogenetic tree is shown in more detail, 
involving a total of 30,255 positions in the final dataset and depicting eight clades (A to H). The evolutionary history 
was inferred by using the Maximum Likelihood method. The tree with the highest log likelihood (-193253.4180) is 
shown. The percentage of trees in which the associated taxa clustered together is shown next to the branches. 
Initial tree(s) for the heuristic search were obtained automatically by applying Neighbor-Joining and BioNJ 
algorithms to a matrix of pairwise distances estimated using the Maximum Composite Likelihood (MCL) approach, 
and then selecting the topology with superior log likelihood value. The tree is drawn to scale, with branch lengths 
measured in the number of substitutions per site. Evolutionary analyses were conducted in MEGA6.  
 
 
The WG-SNP approach relies on reference-based mapping and do not detect variations in 
regions that are not present in the reference sequence (i.e. ATCC 23445), being suitable only for 
comparison of the core genome shared among all strains. WG-INDELs are largely ignored in phylogenetic 
reconstruction but provide a suite of markers complementary to nucleotide substitutions with 
enormous potential for molecular phylogenetics (Ashkenazy et al., 2014; Luan et al., 2013; Redelings 
and Suchard, 2007). In order to confirm the phylogenetic relationships suggested by the former 
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approaches, a minimal spanning tree (MST) was generated from the 3,052 effective INDELs (data can be 
found in Supplementary Table S4.2.1-B, 
http://www.mediafire.com/file/2mm9zdwo7lyovm2/Supplementary_Table_S4.2.1_A-C.xlsx).  
A total of 1,156 INDELs were unique to O. anthropi and 1,896 INDELs were found among Brucella 
species. The MST was built using a data set of 255 representative INDELs, which included seven Iberian 
specific INDELs and a subset of 248 randomly chosen INDELs from the 3,052. Evolutionary relationships 
based on WG-INDELs are congruent with those from WG-SNP analysis, further revealing B. suis biovar 2 
Central-European clonal lineage genomes allocated in a well-defined cluster, from which the other B.suis 
biovars and Brucella species seems to evolve (Figure 4.2.3). Therefore, we can speculate that biovar 2 
Iberian clonal lineage evolved from the Central-European clonal lineage, representing an on-going 
allopatric speciation process as described for other specialized pathogenic bacteria (Georgiades & 
Raoult, 2010). 
Brucella species are able to infect multiple hosts but B. suis biovar 2 is highly adapted to wild 
boars (Olsen & Palmer, 2014). In fact, the results obtained from the three whole-genome approaches 
suggest the genomic specialization of B. suis biovar 2 on the Iberian Peninsula to be independent of a 
specific genomic event(s) but instead driven by host specialization, establishing an ecovar.  
 
3.2. Comparative genomics of B. suis biovar 2  
High homology (>98%) between Brucella spp. are normally found in association with their 
preferred hosts and has apparently resulted in adaptive changes over time (Ficht, 2010). Phylogenomic 
relationships have supported the existence of two B. suis biovar 2 phylogenetic groups well separated 
from B. suis biovar 1 and 3. The comparative genomics analysis was focused on the detection of 
distinctive genetic events between those two lineages. The inter- and intraspecies comparative analysis 
revealed several biovar-, haplotype- and strain-specific genetic polymorphisms that can implicate 
further genetic determinants related to host specificity and genomic specialization on B. suis. A set of 
chromosomal rearrangements and polymorphisms, including SNPs and INDELs, were found and will be 
further discussed in the following sections. 
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Figure 4.2.3. Minimum spanning tree depicting the genomic relationships of Brucella species based on WG-INDELs 
analysis. A data set of 255 representative INDELs was used, including 7 Iberian ecovar specific INDELs and a subset 
of 248 randomly chosen INDELs from the 3,052 INDELs obtained from the comparative analysis of 23 Brucella 
genomes and O. anthropi (outgroup). Colour codes are associated with Brucella spp. groups and the number of 
changes between patterns is presented. The MST was constructed with a categorical coefficient using BioNumerics 
version 6.6. 
 
 
3.2.1. Large chromosomal rearrangements in B. suis biovar 2 genomes 
The chromosomal organization of the six B. suis biovar 2 strains was examined by BamH I optical 
mapping and the pairwise alignment between optical and in silico maps allowed the identification of 
two major chromosomal rearrangements (one translocation event and one inversion) occurring in 
B. suis biovar 2 genomes, pointing out the degree of genome plasticity in B. suis species (Ferreira et al., 
2016).  
The 210 kb region translocated from Chr I to Chr II, associated to IS711, in the six biovar 2 studied 
genomes (Figure 4.2.4) was firstly described in B. suis biovar 2 and 4 reference strains (Jumas-Bilak et 
al., 1998). The translocate region share 99% similarity with B. suis 1330 and encompasses genes with 
most functions assigned to processes such as transcription, replication and repair, carbohydrate 
metabolism and metabolism of co-factors and vitamins. Moreover, five tRNAs genes and six ribosomal 
proteins (L21, L27, L31, L32, L36 and S16) were moved to Chr II, and 14 coding regions in B. suis biovar 
2 don’t have orthologs in B. suis 1330 genome.  
The most surprising rearrangement found was the 944 kb chromosomal inversion present in strains 
PT09143, PT09172 and Bs143CITA (B. suis biovar 2 clade, subcluster A1, Iberian clonal lineage) and 
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covering 49% of the Chr I (Ferreira et al., 2016). Chr I encodes the majority of the core metabolic 
machinery for processes such as transcription, translation, and protein synthesis (Paulsen et al., 2002). 
Although changing gene location, the majority (>95%) of annotated coding regions were found to share 
98-100% sequence identity with ATCC 23445 and both genomes from the Central-European clonal 
lineage.  
 
 
 
Figure 4.2.4. Translocation event in B. suis biovar 2 strains. (A) Pairwise alignment of chromosome I and II optical 
and in silico maps for B. suis biovar 2 strain ATCC 23445 and B. suis biovar 1 strain 1330. Lines connecting two 
chromosomal maps indicate discontinuity in the alignment of fragments. The translocated region is highlighted in 
the red circles; unaligned restriction fragments, representing differences between two chromosomes, are showed 
in white; blue indicates aligned restriction fragments. (B) Schematic representation of both circular chromosomes. 
Open red box indicates the translocated region in chromosome I of B. suis biovar 1 and in chromosome II of B. suis 
biovar 2; blue triangles symbolize the rrn loci; yellow boxes represents the insertion sequence IS711. 
 
 
At left and right crossover points, the inversion disrupted a Tripartite ATP-independent 
periplasmic (TRAP) dicarboxylate transporter, DctM subunit (C-terminus truncated, ortholog to ATCC 
23445 BSUIS_A0375 and 1330 BR0344; nucleotide #371,383 in ATCC 23445), and an integral membrane 
protein TerC (N-terminus truncated, ortholog to ATCC 23445 BSUIS_A1382 and 1330 BR1332; nucleotide 
#1,316,165 in ATCC 23445), respectively (Figure 4.2.5). The TRAP transporters are a large family of 
substrate-binding protein (SBP)-dependent secondary transports found in bacteria and archaea. These 
transporters have three domains that were defined on the basis of orthology to the three proteins that 
constitute the Dct system in Rhodobacter capsulatus (Forward  et al., 1997), comprising a SBP of the 
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DctP or TAXI families and two integral membrane proteins that form the DctQ and DctM protein families. 
Orthologs of the three genes can be found in all Brucella species (BSUIS_A0374 to BSUIS_A0376 
orthologs in ATCC 23445) although dctQ and dctP were found to be variable within B. abortus, B. canis, 
and B. melitensis. The gene dctM is well conserved in Brucella spp. except in B. suis biovar 2 strains from 
Iberian ecovar, probably resulting in the inactivation of this gene in those strains. In B. melitensis 16M 
the Dct operon (BMEI1579- BMEI11581) was predicted to be involved in the transport of mannitol 
although no experimental evidences exist, but in R. capsulatus, dctP, dctQ, and dctM genes were shown 
to be essential for C4-dicarboxylate transport (Forward  et al., 1997). Mannose is both an important 
precursor in the O-antigen biosynthetic pathway and in the production of the inner core moiety of 
lipopolysaccharide (LPS) (Cardozo et al., 2006; Zygmunt et al., 1988). Loss of the ability to uptake 
mannitol can influence LPS structure and subsequently host immune responses.  At the right crossover, 
the interrupted ORF codes for a TerC, a protein possibly involved in tellurium resistance (inorganic ion 
transport and metabolism). This membrane protein harbors a CBS domain that is usually associated to 
enzymatic domains, membrane transporters or DNA-binding domains, playing an important role in host 
interactions.  
Taking into consideration the genomic rearrangements occurring in biovar 2 genomes and the 
possible effects in whole genome structure, it can be accepted that those events were tolerated from 
an evolutionary point of view, but probably changed the metabolism of B. suis biovar 2 strains resulting 
in host adaptation. In fact, chromosomal divergence has been detected in related species, and this might 
create bacteria sufficiently different to escape the immune system and establish an infection in new 
hosts (Hughes, 2000). 
 
3.2.2. Distinctive SNPs of B. suis biovar 2 Iberian ecovar and functional assessment 
The number of SNPs, including intergenic, missense and silent, obtained amongst the Brucella 
genomes relatively to B. suis ATCC 23445 are shown in Table 4.2.3. Eighty-five percent of the SNPs were 
identified in coding regions and in average 55% are missense mutations, affecting genes associated with 
different classes of cellular functions. The distribution of SNPs along the genome (SNPs per 200 kb) 
showed no evident differences for the aforementioned chromosomal inversion at Chr I from Iberian B. 
suis biovar 2 strains (Supplementary Figure S4.2.1, 
http://www.mediafire.com/file/3m9xsgpsfbf17tx/Supp.Figure_S4.2.1_SNPs_distribution.pdf). The five 
B. suis biovar 2 strains shared 4,107 SNPs. Two-hundred and seven SNPs were unique to strains 
belonging to the Iberian ecovar (PT09143, PT09172 and Bs143CITA) and 232 discriminate the Central-
European strains Bs364CITA and Bs396CITA. Among these, 104 missense SNPs were found specifically 
in strains from Iberian ecovar.  
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In the three strains from the Iberian ecovar was observed a relative and preferential accumulation 
of missense SNPs among the annotated genes associated to transporter/ efflux systems, other 
membrane receptors, metabolism processes, transcriptional regulators, regulatory proteins, cell 
replication, SOS response/DNA repair and ribosomal proteins (Figure 4.2.6). The majority of 
discriminative mutations were associated to membrane related molecules (29%; n= 30) and enzymes 
involved in catabolism process (20%; n=21). These mutations can be related to molecular tropism to a 
specific environment or animal host. 
 
 
 
 
Figure 4.2.5. Left and right crossover points of the large inversion present in B. suis biovar 2 Iberian ecovar. Dot-
blot graphic demonstrating the presence of the 944 kb inversion in Chr I of B. suis biovar 2 strains from Iberian 
ecovar (1.9 Mb, aprox. 49%). As an example, the comparison of B. suis PT09143 (as the representative strain from 
Iberian ecovar) with B. suis Bs396CITA (representative of the Central-European clonal lineage) is shown. The right 
and left crossover points are shown. The inversion disrupted a Tripartite ATP-independent periplasmic (TRAP) 
dicarboxylate transporter, DctM subunit (nucleotide #371,383 in ATCC 23445), and an integral membrane protein 
TerC (nucleotide #1,316,165 in ATCC 23445), respectively. Chromosomal alignment was conducted in Kodon V3.62.  
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Table 4.2.3. Resume of mutation analysis of Brucella spp. genomes using B. suis ATCC 23445 as 
reference. 
NCBI Reference sequence 
(Chr I/ Chr II) 
Strain Identification Biovar Host INDELs  
SNPs 
Int. Mis. Sil. Total  
NC_010169.1/ NC_010167.1 B. suis ATCC 23445 2 H - - - - - 
NZ_CP007697.1/ NZ_CP007698.1 B. suis Bs364CITA 2 WB 59 171 269 148 588 
NZ_CP007720.1/ NZ_CP007721.1 B. suis Bs396CITA 2 WB 68 271 296 167 734 
NZ_CP007693.1/ NZ_CP007694.1 B. suis PT09172 2 WB 79 285 398 241 924 
NZ_CP007691.1/ NZ_CP007692.1 B. suis PT09143 2 WB 77 232 438 263 933 
NZ_CP007695.1/ NZ_CP007696.1 B. suis Bs143CITA 2 WB 104 307 451 270 1,028 
NC_016797.1/ NC_016775.1 B. suis VBI22 1 SW 358 719 2,716 1,540 4,975 
NC_004310.3/ NC_004311.2 B. suis 1330 1 SW 373 737 2,669 1,573 4,979 
NC_015857.1/ NC_015858.1 B. pinnipedialis B2/94 na D 470 781 2,962 1,547 5,290 
NZ_CP007719.1/ NZ_CP007718.1 B. suis bv.3 str. 686 3 SW 395 773 2,986 1,680 5,439 
NC_016778.1/ NC_016796.1 B. canis HSKA52141 na Dog 388 808 3,020 1,649 5,477 
NC_010103.1/ NC_010104.1 B. canis ATCC 23365 na Dog 390 836 2,989 1,723 5,548 
NC_013119.1/ NC_013118.1 B. microti CCM 4915 na WR 384 1,023 2,865 1,676 5,564 
NZ_CP007717.1/ NZ_CP007716.1 B. suis 513UK 5 WR 400 855 3,067 1,643 5,565 
NC_022905.1/ NC_022906.1 B. ceti TE10759-12 na S 576 1,027 3,804 2,053 6,884 
NC_007618.1/ NC_007624.1 B. abortus 2308 1 C 601 1,172 4,488 2,494 8,154 
NC_006932.1/ NC_006933.1 B. abortus 9-941 1 C 595 1,172 4,508 2,482 8,162 
NC_010742.1/ NC_010740.1 B. abortus S19 1 Vac 610 1,159 4,515 2,493 8,167 
NC_012441.1/ NC_012442.1 B. melitensis ATCC 23457 2 G 581 1,216 4,717 2,614 8,547 
NC_009505.1/ NC_009504.1 B. ovis ATCC 25840 na SH 815 1,239 4,569 2,745 8,553 
NC_017246.1/ NC_017246.1 B. melitensis M5-90 1 SH 635 1,218 4,744 2,613 8,575 
NC_017244.1/ NC_017244.1 B. melitensis M28 1 SH 589 1,226 4,750 2,650 8,626 
NC_003317.1/ NC_003318.1 B. melitensis 16M 1 G 675 1,141 5,641 2,031 8,813 
na, not applied. 
Host: C, cattle; D, dolphin; G, goat; H, hare; S, seal; SH, sheep; SW, swine; WB, wild boar; WR, wild rodent; Vac, 
vaccine. 
SNPs: Int., intergenic; Mis., missense; Sil., silent. 
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Figure 4.2.6. Distribution of putative missense mutations between the two distinct B. suis biovar 2 ecovars. The 
Venn diagram shows the number of unique SNPs between B. suis biovar 2 Iberian ecovar (PT09143, PT09172 and 
Bs143CITA), B. suis biovar 2 Central-European lineage (Bs364CITA and Bs396CITA) and the remaining Brucella spp. 
genomes. The associated pie chart shows the breakdown of the functional categories assigned to unique SNPs of 
Iberian ecovar. 
 
 
3.2.3. INDELs differentiative of biovar 2 Iberian ecovar 
The comparative analysis of the effective INDELs disclosed 10 INDELs in coding regions, including 
one Large INDEL (LI ≥ 1 kb), and three intergenic INDELs were found to be specific of strains PT09143, 
PT09172 and Bs143CITA representative of Iberian ecovar (Supplementary Table S4.2.1-B, 
http://www.mediafire.com/file/2mm9zdwo7lyovm2/Supplementary_Table_S4.2.1_A-C.xlsx). The LI 
with, 1,996 bp in Chr II (LI3234619), is present in one region encoding ORFs BSUIS_B1354 to 
BSUIS_B1357 in ATCC 23445 within one Brucella flagellar gene cluster. BSUIS_B1354, BSUIS_B1355 and 
BSUIS_B1357 (BRA1127, BRA1128 and BRA1130 orthologs in 1330) code for hypothetical proteins 
without any specific functional domains. BSUIS_B1356 (BRA1129 ortholog in 1330) is predicted to code 
a flagellar protein FlgJ, possessing an N-terminal domain responsible for proper rod assembly. Primers 
(LI3234619-F and LI3234619-R) directed to flanking regions were used for INDEL search, confirming the 
presence of this INDEL in strains PT09143, PT09172, Bs143CITA and in the 104 biovar 2 strains from 
Iberian ecovar. Although brucellae were considered non-motile bacteria for a long time, it was recently 
proved that B. melitensis produces a functional flagellum with the characteristics of a sheathed flagella 
described in other organisms, produced only transiently at the end of the exponential phase of growth. 
The bacterial flagellum is a complex apparatus assembled of at least 31 different proteins, with similar 
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organization in all Brucella genomes with genes distributed in three clusters on the small chromosome 
(Ferooz and Letesson, 2010; Chain et al., 2005; Fretin et al., 2005). It is documented that flagellar genes 
are required for the establishment of in vivo infection in mice and goats (Zygmunt et al., 2006; Fretin et 
al., 2005). Consequently, the inactivation (due to point mutations or INDELs) or loss of key flagellar genes 
would influence the formation of a functional flagellum and therefore several functions can be affected, 
such as protein export or adhesion (Haiko and Westerlund-Wikström et al., 2013).  
Among the nine small INDELs (SI<1 kb) in coding regions, three specific SIs were further evaluated 
due to their location in genome and eventual importance in evolution and genomic specialization of B. 
suis biovar 2 Iberian ecovar.  SI79420 (678 bp) occurs within a CDS coding for an outer membrane protein 
ortholog to ATCC 23445 BSUIS_A0075 and 1330 BR0072, which have been described as a putative 
autotransporter adhesin (Chain et al., 2005; Paulsen et al., 2002). In fact, different proteins belonging to 
autotransporter family have been identified in Brucella genomes, sharing a common domain 
organization: an N-terminal secretion signal, a divergent and functional domain (passenger domain) and 
a conserved C-terminal region (Ruiz-Ranwez et al., 2013a, 2013b; Posadas et al., 2012; Tsolis et al., 2009; 
Chain et al., 2005). The alignment of the orthologs genes in the different species indicated that this 
INDEL occurs within the passenger domain, showing a range in similarity (at the nucleotide level) to 
BSUIS_A0075, from 98% (Bs364CITA and Bs396CITA), to 72% similarity (PT09143, PT09172 and 
Bs143CITA). SI79420 probably caused the inactivation of the protein but it remains to be seen if this 
protein is functional or if differences within the passenger domain contribute to host or tissue specificity 
or clinical manifestations in wild boars or pigs. SI1627421 (59 bp) affects a permease, ortholog to ATCC 
23445 BSUIS_A1714 and 1330 BR1873, associated to autotransporter proteins. The three strains from 
Iberian clonal lineage presented the 59 bp INDEL next to the C-terminus. Since almost all of the known 
autotransporters are involved in functions related to the invasion process, the difference in the number 
of active autotransporters, and the variation within them, may play a role in the ability of each species 
to interact with its host and may thus be an important contributor to virulence (Chain et al., 2005; 
Paulsen et al., 2002). Lastly, SI2603410 (844 bp) represent an event that causes the elimination of one 
insertion sequence. The IS711 insertion sequence is unique to Brucella species, and its copy number in 
the genome varies between species and biovars, being regarded as key determinants of genome 
plasticity and have been suggested to provide significant adaptive changes to genomes. Seven complete 
copies of this insertion sequence are recognized in B. suis 1330 and 13 in ATCC 23445 (Audic et al., 2011), 
as well as in strains Bs364CITA and Bs396CITA. However, strains PT09143, PT09172 and Bs143CITA 
present 12 copies of this insertion element, including orfA and orfB genes. From the three intergenic 
INDELs, the SI1356057 (88 bp) is located between a GntR family transcriptional regulator and a ketol-
acid reductoisomerase. In ATCC 23445, a CDS coding for a hypothetical protein (BSUIS_A1430) is 
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annotated among the GntR family transcriptional regulator (BSUIS_A1429), and the ketol-acid 
reductoisomerase (BSUIS_A1431). Orthologous of the three genes are also present in both Central–
European strains, but BSUIS_A1430 ortholog is missing in PT09143, PT0172 and Bs143CITA. Additionally, 
two intergenic SIs specific for strains PT09143 and Bs143CITA (Iberian ecovar, haplotype 2e), one in Chr 
I with 77 bp (SI1423448), and other in Chr II with 47 bp (SI2041144) were found. Nevertheless, no 
frameshift is expected or promoter region seemed to be affected by those two described INDELs.  
The six abovementioned SIs were searched by targeted-PCRs in the 190 Brucella strains and it was 
confirmed that those events were specific of Iberian ecovar (Supplementary Table S4.2.2). 
Lastly, no INDELs were found to affect genes known to participate in virulence, such as 
lipopolysaccharide biosynthesis, two-component regulatory system BvrR/BvrS, type IV secretion system 
VirB or erythritol catabolic pathway.  
 
 
4. Conclusion 
 
In this work, a full genome comparative analysis of five B. suis biovar 2 strains isolated from wild 
boars belonging to the main circulating clonal lineages in Iberian Peninsula together with the publicly 
available Brucella spp. genomes was performed. Brucella spp. are genetically high conserved and have 
apparently slow evolutionary rates. Nevertheless, it was observed that B. suis biovar 2 strains from 
Iberian clonal lineage are differentiated from those from Central-European clonal lineage not only by 
the presence of one large inversion in Chr I but also by a number of specific SNPs, deletions and 
insertions. Additionally, the mutational enrichment of Iberian lineage was associated to genes encoding 
membrane proteins described with potential of interaction with external stimulus, as well as to genes 
with impact on the metabolism of the pathogen. However, future work should be done to better 
understand the metabolic consequences of these disarrangements and their impact in pathogenicity or 
virulence in a wide range of hosts, including man. 
This genomic specialization and local adaptation of strains establish an Iberian ecovar, raising an 
important question regarding the mechanisms responsible for putative tropisms as response to 
adaptation to a specific host and/or pathobiological conditions. 
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5. Supplementary material 
 
Supplementary Table S4.2.1. List of mutations disclosed in the comparative genomic analysis of 23 
Brucella genomes and Ochrobactrum anthropi using as reference the annotated sequence of strain B. 
suis ATCC 23445. (A) List of SNPs; (B) List of INDELs; (C) List of INDELs differentiative of B. suis biovar 2 
Iberian ecovar. Data can be seen at 
http://www.mediafire.com/file/2mm9zdwo7lyovm2/Supplementary_Table_S4.2.1_A-C.xlsx. 
Supplementary Figure S4.2.1. Distribution of SNPs along the genome (SNPs per 0,2 Mb). Data can be 
seen at http://www.mediafire.com/file/3m9xsgpsfbf17tx/Supp.Figure_S4.2.1_SNPs_distribution.pdf. 
Supplementary Table S4.2.2.  Brucella strains used to search for the specific INDELs of Iberian Ecovar. 
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Supplementary Table S4.2.2.  Brucella strains used to search for the specific INDELs of Iberian ecovar. 
Strain Biovar Host Country SI79506 SI1356057 SI1423448 SI1627485 SI2041144 SI2603410 LI3234619 
                      
REF 1330 1 Swine USA 598 714 297 180 228 508 2,170 
REF ATCC 23445 2 Hare Denmark 938 853 297 180 228 1,352 2,170 
REF 686 3 Swine USA 598 714 297 180 228 508 2,170 
REF 40 4 Reindeer Former USSR 598 714 297 180 228 508 2,170 
REF 513 5 Wild rodent Former USSR 598 765 297 180 228 508 2,170 
REF 16M 1 Goat USA 598 765 297 180 228 508 2,170 
REF 63/9 2 Goat Turkey 598 765 297 180 228 508 2,170 
REF Ether 3 Goat Italia 598 765 297 180 228 508 2,170 
REF 544 1 Cattle England 2,293 765 297 180 228 508 2,170 
REF 2308 1 Cattle USA 2,293 765 297 180 228 508 2,170 
S19 1 Cattle USA 598 765 297 180 228 508 2,170 
REF 86/8/59 2 Cattle England 598 765 297 180 228 508 2,170 
REF Tulya 3 Human Uganda 598 765 297 180 228 508 2,170 
REF 292 4 Cattle USA MB 765 297 180 228 508 2,170 
REF B3196  5 Cattle USA MB 765 297 180 228 508 2,170 
REF 870 6 Cattle USA MB 765 297 180 228 508 2,170 
REF C68 9 Cattle USA MB 765 297 180 228 508 2,170 
REF 63/290 na Sheep Australia 598 765 297 180 228 508 2,170 
REF 5K33 na Dog USA 598 714 297 180 228 508 2,170 
REF B1/94 na Dolphin Scotland 598 853 297 180 228 508 2,170 
B2/94 na Seal Scotland 598 765 297 180 228 508 2,170 
CCM 4915 na Wild rodent Rep.Czech 1,276 765 297 180 228 508 2,170 
                      
Field Isolates                     
INRA 1 Swine France 598 714 297 180 228 508 2,170 
96/ 1646-01 1 Swine France 598 714 297 180 228 508 2,170 
01/ 5744 1 Swine Polynesia 598 714 297 180 228 508 2,170 
03/ 2067-203 1 Swine France 598 714 297 180 228 508 2,170 
03/ 3081-2 1 Goat Croatia 598 714 297 180 228 508 2,170 
04/ 115 1 Hare France 598 714 297 180 228 508 2,170 
04/ 2987 1 Human France 598 714 297 180 228 508 2,170 
04/ 3025-3 1 Swine Croatia 598 714 297 180 228 508 2,170 
64/24 1 Swine USA 598 714 297 180 228 508 2,170 
F1/04 1 Human Netherlands 598 714 297 180 228 508 2,170 
92/29 1 Human Mexico 598 714 297 180 228 508 2,170 
98/ 7296-4204 2 Hare France 938 853 297 180 228 1,352 2,170 
A183 2 Wild boar Germany 938 853 297 180 228 508 2,170 
A196 2 Wild boar Germany 938 853 297 180 228 508 2,170 
04RB0377 2 Wild boar Germany 938 853 297 180 228 508 2,170 
05RB0007 2 Wild boar Germany 938 853 297 180 228 508 2,170 
05RB1442 2 Hare Germany 938 853 297 180 228 508 2,170 
74/11 2 Unknown Denmark 938 853 297 180 228 1,352 2,170 
92/ 11580-4528 2 Hare France 938 853 297 180 228 1,352 2,170 
92/ 13000 2 Hare France 938 853 297 180 228 1,352 2,170 
98/ 6335 2 Swine France 938 853 297 180 228 1,352 2,170 
00/ 9182 2 Hare France 938 853 297 180 228 1,352 2,170 
96/ 9635 2 Swine France 938 853 297 180 228 1,352 2,170 
97/ 4924-10 2 Swine France 938 853 297 180 228 1,352 2,170 
97/ 9757 2 Swine France 938 853 297 180 228 1,352 2,170 
00/ 4898 2 Bovine France 938 853 297 180 228 1,352 2,170 
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Strain Biovar Host Country SI79506 SI1356057 SI1423448 SI1627485 SI2041144 SI2603410 LI3234619 
03/ 1483-8 2 Wild boar France 938 853 297 180 228 1,352 2,170 
04/ 770 2 Wild boar Italy 938 853 297 180 228 1,352 2,170 
04/ 1918-1 2 Wild boar Switzerland 938 853 297 180 228 1,352 2,170 
04/ 3025-1 2 Swine Croatia 938 853 297 180 228 1,352 2,170 
S120 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
COSA 13 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
MASA 07 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
PY69 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
RATE S5-11 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C13B6 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C2B11 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C9B4 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C6B1 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C8B3 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C9B3 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C13B1 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C13B4 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C4B6 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C5B5 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C3B3 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
C11B4 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
S275 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
0111602/4+9 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
0111602/3+8 2 Wild boar Belgium 938 853 297 180 228 1,352 2,170 
It1 2 Wild boar Italy 938 853 297 180 228 1,352 2,170 
It2 2 Wild boar Italy 938 853 297 180 228 1,352 2,170 
It3 2 Wild boar Italy 938 853 297 180 228 1,352 2,170 
It4 2 Wild boar Italy 938 853 297 180 228 1,352 2,170 
It5 2 Wild boar Italy 938 853 297 180 228 1,352 2,170 
It6 2 Wild boar Italy 938 853 297 180 228 1,352 2,170 
Bs364CITA 2 Wild boar Spain 938 853 297 180 228 1,352 2,170 
S-365   2 Wild boar Spain 938 853 297 180 228 1,352 2,170 
Bs396CITA 2 Wild boar Spain 938 853 297 180 228 1,352 2,170 
7676/00 2 Swine Portugal 260 765 297 129 228 508 174 
438/00 2 Swine Portugal 260 765 297 129 228 508 174 
5346(1)/00 2 Swine Portugal 260 765 297 129 228 508 174 
5346 (16)/00 2 Swine Portugal 260 765 297 129 228 508 174 
5346(3)/00 2 Swine Portugal 260 765 297 129 228 508 174 
1967/00 2 Swine Portugal 260 765 297 129 228 508 174 
6552(3)/00 2 Swine Portugal 260 765 297 129 228 508 174 
6552(8)/00 2 Swine Portugal 260 765 297 129 228 508 174 
6552(2)/00 2 Swine Portugal 260 765 297 129 228 508 174 
6552(10)/00 2 Swine Portugal 260 765 297 129 228 508 174 
 S1 2 Swine Spain 260 765 297 129 228 508 174 
 S2 2 Swine Spain 260 765 297 129 228 508 174 
 S3 2 Swine Spain 260 765 297 129 228 508 174 
 S4 2 Swine Spain 260 765 297 129 228 508 174 
 S22 2 Swine Spain 260 765 297 129 228 508 174 
 S32 2 Swine Spain 260 765 297 129 228 508 174 
 S34 2 Swine Spain 260 765 297 129 228 508 174 
 S6 2 Swine Spain 260 765 297 129 228 508 174 
 S21 2 Swine Spain 260 765 297 129 228 508 174 
2739 (3)/02 2 Swine Portugal 260 765 297 129 228 508 174 
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Strain Biovar Host Country SI79506 SI1356057 SI1423448 SI1627485 SI2041144 SI2603410 LI3234619 
2739(8)/02  2 Swine Portugal 260 765 297 129 228 508 174 
2739(9)/02  2 Swine Portugal 260 765 297 129 228 508 174 
5414(12)/03  2 Swine Portugal 260 765 297 129 228 508 174 
5414(13)/03  2 Swine Portugal 260 765 297 129 228 508 174 
5414(2)/03  2 Swine Portugal 260 765 297 129 228 508 174 
5414(13)/03 2 Swine Portugal 260 765 297 129 228 508 174 
468/00 2 Swine Portugal 260 765 297 129 228 508 174 
1262/00 2 Swine Portugal 260 765 297 129 228 508 174 
S/29/2000 2 Swine Portugal 260 765 297 129 228 508 174 
S/35/2000 2 Swine Portugal 260 765 297 129 228 508 174 
S/39/2000 2 Swine Portugal 260 765 297 129 228 508 174 
S/41/2000 2 Swine Portugal 260 765 297 129 228 508 174 
S/43/2000 2 Swine Portugal 260 765 297 129 228 508 174 
S/50/2000 2 Swine Portugal 260 765 297 129 228 508 174 
S/57/2000 2 Swine Portugal 260 765 297 129 228 508 174 
S/64/2000 2 Swine Portugal 260 765 297 129 228 508 174 
S/73/2000 2 Swine Portugal 260 765 297 129 228 508 174 
00/ 5952-1 2 Swine Portugal 260 765 297 129 228 508 174 
Bs146 2 Swine Spain 260 765 297 129 228 508 174 
Bs147 2 Swine Spain 260 765 297 129 228 508 174 
UK1 2 Swine Unknown 260 765 297 129 228 508 174 
2454(J10)/ 08 2 Wild boar Portugal 260 765 297 129 228 508 174 
4498 (J1)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
4498(J9)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
4498(J4)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
4498(J6)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
9789 (J9)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
9789 (J10)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
9789 (Feto)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
19122 (J1)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
17888 (J3)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
21346 (J2)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
22497 (475)/08 2 Sheep Portugal 260 765 297 129 228 508 174 
22498 (697)/08 2 Sheep Portugal 260 765 297 129 228 508 174 
46685 (15)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
46685 (20)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
44401(3)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
44406(3)/08 2 Wild boar Portugal 260 765 297 129 228 508 174 
3115 (9)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
3115 (13)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
1344 (2)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
1344 (3)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
3478 (3)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
14256 (40)/09 2 Swine Portugal 260 765 297 129 228 508 174 
14256 (72)/09 2 Swine Portugal 260 765 297 129 228 508 174 
231 (1)/09 2 Swine Portugal 260 765 297 129 228 508 174 
21566 (94)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
44821(81-f)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
44821 (86-b)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
44821 (79-f)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
1989 (112-Fa)/10 2 Wild boar Portugal 260 765 297 129 228 508 174 
PT09172 2 Wild boar Portugal 260 765 297 129 228 508 174 
44821 (121)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
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Strain Biovar Host Country SI79506 SI1356057 SI1423448 SI1627485 SI2041144 SI2603410 LI3234619 
44821 (122)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
44821 (123)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
S-384 2 Swine Spain 260 765 297 129 228 508 174 
4187(7)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
4478(4)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
4647(1)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
4193(1)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
41932)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
4193(9)/09 2 Wild boar Portugal 260 765 297 129 228 508 174 
3514(2)/10 2 Wild boar Portugal 260 765 297 129 228 508 174 
3515(6)/10 2 Wild boar Portugal 260 765 297 129 228 508 174 
4215 (20)/01 2 Swine Portugal 260 765 297 129 228 508 174 
9H 2 Swine Portugal 260 765 297 129 228 508 174 
 S27 2 Swine Spain 260 765 218 129 171 508 174 
 S12 2 Swine Spain 260 765 218 129 171 508 174 
 S13 2 Swine Spain 260 765 218 129 171 508 174 
Bs144 2 Swine Spain 260 765 218 129 171 508 174 
Bs145 2 Swine Spain 260 765 218 129 171 508 174 
J2A-F/CM/08 2 Wild boar Portugal 260 765 218 129 171 508 174 
45014 (4)/08 2 Wild boar Portugal 260 765 218 129 171 508 174 
2948 (1)/09 2 Wild boar Portugal 260 765 218 129 171 508 174 
2948 (5)/09 2 Wild boar Portugal 260 765 218 129 171 508 174 
PT09143 2 Wild boar Portugal 260 765 218 129 171 508 174 
2948 (34)/09 2 Wild boar Portugal 260 765 218 129 171 508 174 
4189 (1)/09 2 Wild boar Portugal 260 765 218 129 171 508 174 
4189 (2)/09 2 Wild boar Portugal 260 765 218 129 171 508 174 
Bs143CITA 2 Wild boar Spain 260 765 218 129 171 508 174 
S-145 (PN-II) 2 Wild boar Spain 260 765 218 129 171 508 174 
4477 (4)/09 2 Wild boar Portugal 260 765 218 129 171 508 174 
8605(2)/10 2 Wild boar Portugal 260 765 218 129 171 508 174 
8605(9)/10 2 Wild boar Portugal 260 765 218 129 171 508 174 
UK 6/04 3 Human India 598 714 297 180 228 508 2,170 
63/252 4 Caribou Alaska 598 714 297 180 228 508 2,170 
63/198 4 Reindeer Poland 598 714 297 180 228 508 2,170 
63/202 4 Reindeer Poland 598 714 297 180 228 508 2,170 
63/219 4 Reindeer Poland 598 714 297 180 228 508 2,170 
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Concluding remarks 
 
The brucellosis infection in pigs, in Portugal as well as in other European countries, has been 
practically silent for years. The control standards for this animal host only concerned the screening of 
breeding animals for artificial insemination and for export. However, in recent years there has been an 
increase in the number of cases of B. suis biovar 2 in pigs with abortions and positive serology 
reactions, especially in extensive farms. This has major economic impact since it hampers the free 
movement of animals and the commerce of their products. Currently, there is a great lack of 
knowledge about the epidemiological aspects of this infection, the population structure of B. suis 
biovar 2 isolates, its geographic distribution and host specificity. Direct interaction between infected 
wildlife and livestock at a local interface may be the most important driver for periodic spillback 
transmission of Brucella. Therefore, there is a need for critical deliberation of its epidemiology, 
pathogenesis and diagnosis to improve prevention and management at local, regional, national and 
global levels. 
 As reviewed in Chapter 1, most studies on Brucella spp. are based on B. abortus, B. melitensis 
and B. suis (biovar 1), which are the most important species regarding its worldwide distribution and 
virulence for Man. Nevertheless, swine brucellosis due to B. suis biovar 2 is an emerging disease in 
Europe associated with extensive swine farms and high density of infected wild boars. Although the 
few work developed to understand the epidemiological relationships and the phylogeny of this 
pathogen, a considerable intraspecies genetic diversity has already been observed. One of the main 
questions addressed in this thesis is related with the characterization of differences between B. suis 
biovar 2 Iberian strains and those from Central Europe, and further unveil strain specific genomic 
variations associated with geographic origins. Moreover, it is unknown which molecular or 
physiological mechanisms are responsible for the loss of virulence of this biovar to humans. Further 
sequencing of the genomes of Iberian field strains seemed thus crucial to disclose the structure and 
distinctive features of B. suis pan-genome, as well as its evolutive history, host preference and 
geographic partitioning.  
The “gold standard” for the diagnosis of brucellosis is the bacterial isolation.  However, the 
slow growth of Brucella species, combined with their requirement for highly nutritious media means 
that selective reagents must be incorporated to prevent overgrowth of contaminant organisms that 
can be inhibitory to some Brucella strains. Additionally, the use of increasingly powerful genotyping 
tools for the characterization of pathogens has become a standard component of infectious disease 
surveillance and outbreak investigations.  
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In Portugal, the Laboratório Nacional de Referência de Saúde Animal from INIAV, is the 
Nacional Reference Laboratory for Animal Brucellosis. Nevertheless, the diagnosis is mainly focused 
on bovine and caprine brucellosis and isolation of B. abortus and B. melitensis. Although B. suis 
infection has been previously demonstrated in swine and wild boars, few B. suis isolates were obtained 
and their molecular characterization was limited to few studies. In Chapter 2, a selective medium, 
LNIV-M, was developed and evaluated for the primary isolation of B. suis in comparison with other 
media. Accordingly, LNIV-M was formulated using less inhibitory antibiotics, improving the quality of 
bacteriological diagnostic and enhancing the number of B. suis isolates from wild boars and swine from 
different regions of Portugal. The studies presented in subchapters 2.1 and 2.2 aimed to extend our 
understanding on the prevalence and molecular epidemiology of B. suis biovar 2 in Portugal. Since 
knowledge of predominant circulating strains is a prerequisite for any epidemiological study, accurate 
molecular typing procedures were applied to a collection of B. suis isolates, that included isolates from 
Portugal as well as isolates from other European countries. By using Suis-ladder multiplex PCR and 
PCR-RFLP analysis of omp2a, omp2b and omp31 genes, five haplotypes were identified among biovar 
2 isolates, with specific haplotypes restricted to Portugal and Spain (2d and 2e) and haplotypes 2a, 2b 
and 2c widespread in Europe (except Portugal). The genetic diversity of B. suis population was 
evaluated using MLVA based on 16 genetic markers (MLVA-16). The analysis grouped biovar 2 isolates 
in two clusters according to their geographic origins and haplotypes, defining the Iberian (Portugal and 
Spain) and the Central-European clonal lineages. Furthermore, an extended analysis was performed 
using a subset of 11 markers and publicly available data for 350 additional strains, revealing a high 
genetic divergence amongst B. suis strains based on their hosts and highlighting the close relationship 
between strains from swine, wild boars and hares. Beyond corroborating the existence of Iberian and 
Central-European biovar 2 clonal lineages and pointing to the evolution of biovar 2 Iberian clonal 
lineage from Central-European by an allopatric speciation event, an ongoing colonization of Iberian 
Peninsula with specific MLVA-11 genotypes was also observed. 
In Chapter 3, optical maps were used to compare closely related B. suis biovar 2 strains. Optical 
mapping is a technology able to quickly generate high resolution ordered whole-genome restriction 
maps of bacteria, being a proven approach to search for diversity among bacterial isolates. We 
performed the BamH I whole-genome optical maps of five B. suis biovar 2 field strains, isolated from 
wild boars in Portugal and Spain, representative of the two clonal lineages circulating in Iberian 
Peninsula as well as of the reference strain B. suis biovar 2 ATCC 23445 (Central-European lineage, 
Denmark). Each strain showed a distinct, highly individual configuration of 228–231 BamH I fragments, 
distributed in the two chromosomes. Nevertheless, a low divergence was globally observed in 
chromosome II (1.6%) relatively to chromosome I (2.4%). Optical mapping also disclosed genomic 
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events associated with B. suis strains in chromosome I, namely one INDEL (3.5 kb) and one large 
inversion (944 kb). The INDEL was found to be specific of the reference strain ATCC 23445 and the large 
inversion was shown to be an exclusive genomic marker of the Iberian clonal lineage of biovar 2.  
The upmost goal of the work described here was to obtain the complete and annotated 
genome sequences of five B. suis biovar 2 Iberian field strains in order to better understand the 
mechanisms of evolution and specialization of Iberian lineages (Chapter 4). In Subchapter 4.1, the full 
genomes of five B. suis biovar 2 field strains were promptly obtained using a combination of Illumina, 
Sanger and optical mapping technologies. Besides validating the existence of an inversion in biovar 2 
Iberian clonal lineage, and thus reinforcing the plasticity of Brucella genomes, the optical maps defined 
unique genome landmarks in each of the strains and demonstrated the ability of this method to 
determine the relative placement and orientation of sequence fragments produced during the 
assembly process, being very useful for closing genomes. The comparative genomic analysis of B. suis 
biovar 2 together with publicly available Brucella spp. genomes using three whole-genome approaches 
(Subchapter 4.2) showed that brucellae are genetically highly conserved organisms that have 
apparently slow evolutionary rates. Nevertheless, it was observed that B. suis biovar 2 strains from 
Iberian clonal lineage are differentiated from those from Central-European clonal lineage not only by 
the presence of one large inversion in Chr I but also by a number of specific SNPs and biovar-, 
haplotype- and strain-specific insertion-deletion (INDELs) events that could explain differences in 
virulence and host specificities. It was observed that most of the discriminative mutations were 
associated to membrane related molecules (29%) and enzymes involved in catabolism process (20%). 
Moreover, our results suggest the genomic specialization of B. suis biovar 2 on the Iberian Peninsula 
to be independent of a specific genomic event(s), raising an important question regarding the 
mechanisms responsible for putative tropisms as response to adaptation to a specific host and/or 
pathobiological conditions. In nature, brucellae are isolated as they multiply within their preferential 
host. This has led to the suggestion that the different strains of Brucella are clones that have co-evolved 
independently with their mammalian hosts. One of the permanent mysteries of Brucella remains the 
basis of their host specificity in the face of the relatively minor genetic variation between species. 
Identification of genetic differences provides a realistic framework for examining the biological basis 
of host specificity. In addition, seven polymorphic regions with epidemiological marker potential (e.g. 
exclusive of B. suis Iberian clonal lineage) were identified and evaluated using the target-PCR 
procedures established in this work. 
In conclusion, it was demonstrated that two B. suis biovar 2 clonal lineages circulates in Europe 
and a genomic specialization and local adaptation of strains in Iberian Peninsula established an Iberian 
ecovar. However, it is suggested that the mechanisms for this genomic specialization were 
 Chapter 5. Concluding remarks and future perspectives 
 
 
160 
independent of the chromosomal rearrangement events observed. Furthermore, the results obtained 
in this work point to the evolution of this biovar 2 Iberian ecovar from the Central-European clonal 
lineage by an allopatric speciation event.  
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Future perspectives 
 
At the end of the work here described and discussed, particular questions remain to be 
answered. One refers to the biological significance of the chromosomal inversion detected in Iberian 
strains. The inversion disrupted a TRAP dicarboxylate transporter, DctM subunit, and an integral 
membrane protein TerC. The dctM gene is well conserved in Brucella spp. except in strains from Iberian 
clonal lineage. Additional investigation is required to understand and analyze the potential impact of 
this inversion in the metabolism of B. suis biovar 2 strains belonging to the Iberian ecovar.  
In relation with the polymorphisms found on genes coding for flagellar and outer membrane 
proteins described as belonging to putative autotransporter family, it remains to be clarified and 
proved if those changes would influence the formation of a functional flagellum and consequently 
affect several functions such as protein export or adhesion. Likewise, future work should be done to 
realize if the inactivation of specific autotransporter proteins would contribute to host-pathogen 
interactions thus influencing B. suis biovar 2 virulence. In fact, no INDELs were found to affect genes 
known to participate in virulence and it is known that the genomes of Brucella species have low 
polymorphisms. This can be an advantage because if polymorphisms are relatively rare, the ones we 
identified are likely to be important to understand B. suis biovar 2 molecular tropism for wild boars or 
pigs. 
Another relevant topic concerns the results that suggest the ancestral origin of Brucella genus 
to be related to B. suis biovar 2, supporting its use in the design of novel vaccines based on targets that 
are universally conserved across all major pathogenic Brucella species. With the advent of whole-
genome sequencing and advances in bioinformatics, the vaccinology field is radically changed.  Control 
and eradication of brucellosis require sanitary programs, based on the screening of animals and 
diagnosis of the disease, and, as a prophylactic measure, the use of vaccines. The availability of an 
efficacious vaccine is thus an important future objective that should be considered as a priority.  
 
 
